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I. Developmental regulation of the growth plate
Skeletal development is a highly orchestrated process in which all the players involved ought 
to be perfectly co-ordinated and regulated in order to achieve harmonious and symmetrical 
growth. Most of the skeleton is formed by endochondral ossification, including the long, 
short, and irregular bones (1;2). In the process of endochondral ossification, mesenchymal 
cells differentiate into chondrocytes, which then provide a cartilage template for bone 
morphogenesis. 
 Endochondral ossification occurs at two distinct centres of ossification in the 
vertebrate long bone – the primary (diaphyseal) and the secondary (epiphyseal) centres 
(3). Bone development initiates at the primary centre. The secondary (epiphyseal) centre 
is ossified later. During this process, the segregation of chondrocytes at different stages of 
differentiation between the diaphysis and the epiphysis forms the growth plate. 
 The epiphyseal growth plate is regulated by a wide array of autocrine and paracrine 
molecules (3). Signalling through Indian hedgehog (Ihh), parathyroid hormone-related 
peptide (PTHrP; also known as PTHLH), bone morphogenetic proteins (BMPs), fibroblast 
growth factor (FGFs), and others, modulates and regulates chondrocyte proliferation and 
hypertrophy (3).  Another important growth factor for both embryonic and post-natal 
development is insulin-like growth factors (IGF-1 and IGF-2). While IGF-2 is important for 
normal embryonic growth (4), IGF-1 appears to regulate post-natal growth (5). IGF-1 and 
IGF-2 are known to signal through the type I IGF receptor (IGF1R) in target tissues (6). Both 
circulating and locally produced IGF-1 stimulate chondrocyte proliferation in the growth 
plate (7). 
 The cartilaginous extracellular matrix produced by and surrounding the terminally 
differentiated hypertrophic chondrocytes is calcified. Following vascular invasion, 
osteogenic progenitors are recruited to this calcified area, replacing it by trabecular bone (3). 
Proteoglycans and collagens are the most abundant matrix components of the growth 
plate. Proteoglycans are localized intracellularly (usually in secretory granules), at the cell 
surface, or in the extracellular matrix (8). Their biological functions are highly diversified (8). 
Proteoglycans play an important role on various cellular processes, such as cell adhesion, 
motility, and proliferation, further to differentiation and tissue morphogenesis (8). Most of 
these effects depend on binding of signalling molecules to the glycosaminoglycan side chains. 
Proteoglycans influence the distribution of these signalling molecules in the extracellular 
matrix, their receptor binding affinity and the responses of cells to secreted protein factors 
(8;9).
 Mutations affecting the biosynthesis of either proteoglycans or glycosaminoglycans 
alter the interaction between a cell and its micro-environment and are the cause of several 
human disorders. Several of these disorders are associated with a skeletal phenotype (10).
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II. Peripheral cartilaginous bone tumours
Cartilaginous bone tumours are characterized by production of a chondroid matrix. They 
are classified based on their histological and radiological features, location, and clinical 
behaviour. Cartilaginous bone tumours can form on the surface of bones, as in sporadic or 
multiple osteochondromas, or within the bones, as in sporadic or multiple enchondromas. 
These originally benign tumours often carry significant morbidity and risk of developing 
chondrosarcoma.
 Osteochondromas are the most common benign bone tumours of childhood and 
adolescence (11). They are characterized by sporadic (non-familial/solitary) or multiple 
(hereditary) cartilage-capped bony projections from the metaphyses of endochondral 
bones adjacent to the growth plate and develop during skeletal growth (12). Multiple 
osteochondromas, previously called hereditary multiple exostoses, is an autosomal dominant 
disorder with a prevalence of 1 in 18,000 (13). Patients with multiple osteochondromas are 
often short in stature and have bowed bones that can restrict movement and ultimately result 
in joint dislocation (13). In contrast, patients with sporadic lesions may develop symptoms 
on the affected side only. Sporadic and multiple lesions are histologically indistinguishable 
(12;14). 
 Multiple osteochondromas is characterized by genetic variability, which partially 
explains inter- and intra-familial phenotypic variation often found in these patients (15). The 
majority of the hereditary cases are caused by point mutations (70-75%). Small deletions 
involving single or multiple exons are found in about 10% of all hereditary cases (16-18). 
Large deletions have been identified in few cases (15). No genomic alterations are detected 
in about 10-15%. In some of these negative cases, somatic mosaicism with large genomic 
deletions of EXT1 and EXT2 has been described as the underlying mechanism of multiple 
osteochondromas formation (19). In sporadic osteochondromas, homozygous deletions of 
EXT1 are often identified (20). 
 EXT1 and EXT2 encode type II transmembrane glycosyltransferases (21;22), whose 
functions are not fully known. EXT1 and EXT2 form a hetero-oligomeric complex in the Golgi 
apparatus of most human cells that participate in chain elongation in heparan sulphate 
biosynthesis (23;24). During endochondral ossification, heparan sulphate regulates the 
range of Ihh signalling, and thus proliferation of growth plate chondrocytes (3).
Albeit the genetic correlation between mutations in EXT1/EXT2 and osteochondromas, the 
mechanism by which alterations in heparan sulphate biosynthesis leads to osteochondroma 







Neoplastic transformation of an osteochondroma occurs in less than 1% of patients with 
sporadic osteochondromas and 1-3% of patients with multiple osteochondromas (26). 
Neoplastic transformation usually occurs 20-60 years after the cessation of osteochondroma 
growth that happens at the time of the fusion of the epiphyseal growth plate at puberty 
(12;14).
III. Zebrafish as a model system to study human skeletal disorders 
As a vertebrate, zebrafish, Danio rerio, is more closely related to humans than are yeast, 
worms or flies.  Many features of zebrafish development have been characterized, including 
early embryonic patterning, development of the musculoskeletal system as well as aspects 
of cell fate and lineage determination.  Zebrafish has several valuable features as a model 
organism for study of vertebrate development.
 Zebrafish embryos are transparent and accessible throughout development. In live 
embryos, techniques for ablation and transplantation of individual cells have been used 
to explore questions about induction and cell fate (27). Because of their relatively short 
reproductive cycle, the large number of progeny that can be produced, and the relatively 
small space needed to maintain large numbers of offspring, zebrafish is an efficient model 
system for genetic analysis (28;29). 
 Mutations in exostosin genes, dackel (dak/ext2) and boxer (box/exlt3), cause 
in zebrafish cartilage defects that strongly resemble those seen in patients with multiple 
osteochondromas (27). As zebrafish cartilaginous skeleton develops by similar mechanisms 
to that of humans, dak/ext2 and box may be a powerful model for the study of 
osteochondromagenesis.
IV. Scope of the study and outline of the thesis
In the past decades, our knowledge on the epiphyseal growth plate regulation and peripheral 
cartilaginous tumour formation has increased significantly. Although some milestones have 
been achieved to date, our studies address many remaining questions on these topics:
 1. Zebrafish as a model system to study human skeletal disorders.
 2. Developmental regulation of the epiphyseal growth plate in relation to the 
  formation of osteochondroma.
 3. The role of EXT1 and EXT2 genes in the formation of a secondary peripheral 
  chondrosarcoma.
 4. Clues to the mechanisms of neoplastic transformation of osteochondroma 
  towards secondary peripheral chondrosarcoma.
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The most relevant literature on the epiphyseal growth plate and peripheral cartilaginous 
tumours is reviewed in Chapter 2. Chondrocytes interact with each other and with their 
micro-environment. These interactions are modulated by proteoglycans and other 
molecules and lead to the formation of a polarized tissue, such as the epiphyseal growth 
plate. The zebrafish (Danio rerio) exhibits fast development, a growth plate-like organization 
of its craniofacial skeleton and an availability of various mutants, making it a powerful model 
for the study of human skeletal disorders with unknown aetiology. Five zebrafish lines with 
known mutations in genes involved in proteoglycan synthesis were studied in Chapter 
3. Each mutant displays different phenotypes related to: (a) cartilage morphology; (b) 
composition of the extracellular matrix; (c) ultrastructure of the extracellular matrix; and (d) 
the intracellular ultrastructure of chondrocytes. In addition, these zebrafish mutants might 
bring to light new candidate genes for human skeletal disorders. 
 Mutations in exostosin genes in zebrafish - dackel (dak/ext2) - cause cartilage 
defects that strongly resemble those seen in patients with multiple osteochondromas, and 
lead to a heparan sulphate deficiency (27). Heparan sulphate modulates receptor-ligand 
binding of many growth factors. The impact of mutations in the ext2 gene in the zebrafish 
craniofacial skeleton development was investigated in Chapter 4. 
 Several growth factors diffuse across the extracellular matrix creating short and long 
range signalling. The distribution of these signalling molecules in a gradient fashion is shown 
to be established by proteoglycans (30). Cytochemical staining with positively charged dyes 
(e.g., polyethyleneimine-PEI) allows visualisation of proteoglycans and provides a detailed 
description of how proteoglycans are distributed throughout the cartilage matrix. The 
distribution of proteoglycans was studied in the five zebrafish mutants described above and 
in the epiphyseal growth plate and osteochondroma (Chapter 5). In addition, the distribution 
of proteoglycans throughout the cartilage matrix might shed light on the regulation of the 
epiphyseal growth plate and the formation of osteochondroma. 
 Primary cilia are specialized cell surface projections present on most eukaryotic 
cells (31;32). They function as signalling apparatus of the cells that receives and transduces 
mechanical and chemical signals from the neighbouring cells and the extracellular matrix 
(33). Primary cilia have been associated with vertebrate planar cell polarity and loss of 
cell polarity has been hypothesised to be involved in osteochondroma formation. The link 
between primary cilia and cell polarity in the epiphyseal growth plate and osteochondroma 







The role of EXT1 and EXT2 genes in secondary peripheral chondrosarcoma formation 
was studied in Chapter 7. The homozygous inactivation of the EXT genes required for 
osteochondromagenesis and the mixture of cells with distinct genetic background within 
the osteochondroma cap raised the possibility of non-involvement of the EXT1/EXT2 genes 
in the genesis of peripheral chondrosarcoma. Moreover, the presence of wild-type cells in 
the osteochondroma cap is not just an incidental component (34) and they might play a role 
during neoplastic transformation of osteochondroma. 
 Clues to the mechanisms of neoplastic transformation of osteochondroma towards 
secondary peripheral chondrosarcoma may give reliable histological criteria to properly 
identify each tumour type. An initial step in the process of defining histological criteria for 
guiding the diagnosis of peripheral cartilaginous tumours is to assess diagnostic reliability 
among specialized bone-tumour pathologists, as measured by intraclass correlation 
coefficient (35). A second step is to identify common histological criteria among the 
concordant cases, aiming to have histological parameters that characterize each tumour 
type (Chapter 8).
 Endochondral ossification is a multistep process in which a cartilaginous model is 
gradually replaced by bone (3). Like in the epiphyseal growth plate, endochondral ossification 
takes place deep to the cartilage cap of osteochondroma and secondary peripheral 
chondrosarcoma (12). Two critical steps of endochondral ossification are the deposition of 
collagen X-rich matrix and blood vessel attraction/invasion (3). Formation of a collagen X-rich 
matrix and vascularisation might be useful prognostic markers of neoplastic transformation 
of an osteochondroma and were studied in Chapter 9. 
Finally, the achievements of the study are summarised and possible future directions of 
research are indicated in Chapter 10.
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Epiphyseal growth plate and secondary peripheral
chondrosarcoma: the neighbours matter
Carlos E. de Andrea and Pancras C.W. Hogendoorn




Chondrocytes interact with their neighbours through their cartilaginous extracellular 
matrix (ECM). Chondrocyte–matrix interactions compensate the lack of cell–cell contact 
and are modulated by proteoglycans and other molecules. The epiphyseal growth plate 
is a highly organized tissue responsible for long bone elongation. The growth plate is 
regulated by gradients of morphogens that are established by proteoglycans. Morphogens 
diffuse across the ECM, creating short- and long-range signalling that lead to the formation 
of a polarized tissue. Mutations affecting genes that modulate cell–matrix interactions 
are linked to several human disorders. Homozygous mutations of EXT1/EXT2 result in 
reduced synthesis and shortened heparan sulphate chains on both cell surface and matrix 
proteoglycans. This disrupts the diffusion gradients of morphogens and signal transduction 
in the epiphyseal growth plate, contributing to loss of cell polarity and osteochondroma 
formation. Osteochondromas are cartilage-capped bony projections arising from the 
metaphyses of endochondral bones adjacent to the growth plate. The osteochondroma cap 
is formed by cells with homozygous mutation of EXT1/EXT2 and committed stem cells/wild-
type chondrocytes. Osteochondroma serves as a niche (a permissive environment), which 
facilitates the committed stem cells/wild-type chondrocytes to acquire secondary genetic
changes to form a secondary peripheral chondrosarcoma. In such a scenario, the micro-
environment is the site of the initiating processes that ultimately lead to cancer.





Skeletal development is a highly orchestrated process in which all the players involved ought 
to be perfectly coordinated and regulated in order to achieve harmonious and symmetrical 
growth. During mammalian skeletal development, long, short and irregular bones are 
formed by endochondral ossification [1,2]. 
 Endochondral ossification begins when progenitor chondrocytes derived from 
mesenchymal cells pack densely (so-called ‘condensation’). Cells of condensation form a 
cartilaginous template that is ultimately replaced by bone (Figure 1). Cell–cell interactions and 
the transcription factor Sox9 regulate the formation of these condensations [3]. Cell adhesion 
molecules, such as N-cadherin and N-CAM, are important in establishing an aggregation 
centre by recruiting mesenchymal cells from surrounding tissue [2]. Sox9 plays a key role in the 
differentiation of progenitor chondrocytes into chondrocytes by modulating the expression 
of cartilage-specific genes, such as type II and type XI collagen genes [3]. Down-regulation of 
N-CAM by the binding of syndecan to fibronectin and activation of homeobox genes (ie Msx-
1 and Msx-2 ) by the presence of BMP-2 and BMP-4 stop condensation growth and initiate 
pre-chondrocyte differentiation (Figure 1) [3]. An abundant cartilaginous extracellular matrix 
(ECM) surrounds mature chondrocytes. Cell–cell interactions found in the condensations are 
now replaced by interactions between chondrocytes via their ECM. These interactions are 
mediated by proteoglycans and have important effects on chondrocyte functions [4,5]. 
 Post-natal endochondral bone formation is found in the epiphyseal growth plate. 
The epiphyseal growth plate is a highly organized, cartilaginous template needed for the 
elongation of long bones. Structurally, the epiphyseal growth plate can be divided into three 
distinct zones [6]. In the resting zone, chondrocytes are non-polarized and irregularly arranged. 
Resting chondrocytes serve as precursors (committed stem cell pool) for proliferative 
chondrocytes. In the proliferating zone, cell division of chondrocytes occurs perpendicular 
to the long axis of the growing bone (Figure 1). Proliferating chondrocytes have to undertake 
a series of cell movements/rotations (intercalation) and shape changes to align one on top of 
the other to generate the typical chondrocyte columns of the growth plate (Figure 1) [7–9]. 
Once acquired, this columnar organization is maintained. Chondrocytes require adhesion 
to cartilaginous ECM for all types of shape changes. Integrins are an important family of 
receptors that mediate chondrocyte–matrix adhesion [10]. Integrins regulate centrosome 
function, the assembly of the mitotic spindle and cytokinesis [11]. In β1-null growth plates, 
chondrocytes display mitotic figures perpendicular to the long axis, but they stay side-by-
side and failed to move over each other and form columns, suggesting that β1 integrins 
regulate chondrocyte shape and rotation [12]. In the hypertrophic zone, chondrocytes stop 
proliferating and change their expression profile to synthesize type X collagen and to prepare 







The process of endochondral bone formation in the epiphyseal growth plate may be 
considered as a patterning process that begins with chondrocytes proliferation and ends 
with matrix ossification. The endochondral chondrocytes undergo successive sequences 
of cell division, matrix secretion, cell hypertrophy, apoptosis and matrix calcification/
mineralization.
 Although many biological processes contribute to the formation and organization 
of the epiphyseal growth plate and the initiation of tumours related to the growth plate 
(osteochondromas and secondary peripheral chondrosarcomas), this review focus on 
how chondrocytes interact with their ECM to establish cell polarity or not, contributing to 
morphogenesis and, in the case of neoplastic growth, to tumourigenesis.
Gradients modulating the organization of the epiphyseal growth plate
According to positional information concepts, cells acquire ‘positional values’ in a three-
dimensional (3D) coordinate system which are later interpreted as leading to the formation 
of the appropriated structure at that position [13–15]. ‘Positional values’ are conferred by 
morphogens [16]. Concentration gradients of morphogens allows for their diffusion into the
developing tissue, generating short- and long-range signalling molecules. Subsequently, 
chondrocytes at different positions along the epiphyseal growth plate are exposed to 
different concentrations of morphogens. The transduction of these signalling molecules is 
crucial for the formation of distinct zones. Each zone has different patterns of proliferation, 
differentiation and cell morphology.
 Several models explain the formation of morphogen gradients, such as passive 
diffusion, planar transcytosis and others [17]. In planar transcytosis, morphogens move from 
the source by active transport, through repeated endocytosis and re-secretion [17].
 Throughout the ECM, the distribution of morphogens in a gradient fashion is shown 
to be established by proteoglycans [5,18,19]. Proteoglycans are found in the ECM and 
attached to the cell membrane in virtually all types of tissue. They are composed of highly 
diverse core proteins, to which one or more glycosaminoglycans chains are covalently linked. 
Proteoglycans influence the morphogens-receptor, binding affinity and responses of cells to 
secreted proteins [4].
 Recently, by studying the distribution of the proteoglycans anionic sites, it has been 
shown that, in zebrafish cartilage and in the human epiphyseal growth plate, proteoglycans 
are distributed in a gradient fashion [20]. A concentration gradient of proteoglycans in the 
cartilaginous ECM is observed as a function of the distance from the cell surface. Therefore, 
proteoglycans regulate the distribution of morphogens across the ECM [17].
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 Proteoglycans, such as heparan and chondroitin sulphate, function in concert to 
establish an Indian hedgehog (Ihh) gradient, either through affecting its diffusion or by 
protecting it from degradation [19]. Ihh is a key regulator of the epiphyseal growth plate. 
The balance between chondrocyte proliferation and chondrocyte hypertrophy is regulated 
by a negative feedback loop involving Ihh and parathyroid hormone-related peptide (PTHrP; 
also known as PTHlH) [21,22]. Ihh is secreted by pre-hypertrophic chondrocytes and diffuses 
away from its site of synthesis regulating proliferation in a pool of cells that precedes them 
within the columns of stacked chondrocytes, namely chondrocytes from the resting and 
proliferating zone [6].
Figure 1. Endochondral bone formation and the epiphyseal growth plate. (A) Mesenchymal cells 
condense. (B) Cells of condensation become chondrocytes. (C) Several sequences of chondrocytes 
proliferation and hypertrophy regulated by highly coordinated signalling pathways form cartilage 
templates for bone formation. (D, E) Cell–matrix interactions, in part mediated by primary cilia, 
organize the cartilage templates (ie the epiphyseal growth plate); (D) in columns of proliferating and 
hypertrophic chondrocytes. The hypertrophic chondrocytes are ultimately replaced by bone. Double 







Additionally, Ihh signals to the cells of perichondrium and up-regulates their synthesis 
of PTHrP. PTHrP diffuses to the pre-hypertrophic zone and signals to the PTH/PTHrP 
receptor expressed on pre-hypertrophic chondrocytes to suppress their differentiation into 
hypertrophic chondrocytes [22]. 
 Ihh induces the expression of several bone morphogenetic proteins (BMP) in the 
flaking perichondrium/ periosteum and the proliferating chondrocytes [21]. BMP is a group 
of proteins within the transforming growth factor-β (TGF-β) superfamily. BMP and Ihh 
signals act in parallel to induce chondrocyte proliferation [21]. Additionally, BMP signalling 
stimulates expression of Ihh [21,23]. Finally, BMP signals independent of the Ihh/PTHrP 
pathway delaying the process of hypertrophic differentiation [21]. 
The polarization of the epiphyseal growth plate
Cell polarity can be defined as a structurally and functionallyasymmetric organization in 
which the nonrandom positioning of each organelle, the function of which contributes to 
cell asymmetry, is preserved and transmitted through cell division [24]. Planar cell polarity 
coordinates cell behaviour in a two-dimensional (2D) plane. Spatial information that 
organizes planar polarity and ultimately a tissue is shown to be transmitted locally from one 
cell to the next [25]. Input from neighbouring cells can influence the behaviour of
individual cells as well as the orientation of groups of cells that respond as a unit to ‘positional 
values’ [25].
 The core planar cell polarity is regulated by Wingless-type (Wnt) molecules that 
comprise a family of 19 lipid-modified secreted glycoproteins, such as Wnt5A. Wnt molecules 
are diffusible morphogens, which interact with heparan sulphate proteoglycans to generate 
a gradient throughout the tissue [26]. By binding to frizzled (Fzd) cell surface receptors, 
Wnt molecules signal via different pathways, including the canonical Wnt/β-catenin, non 
canonical Wnt/Ca2+ and non-canonical Wnt/planar cell polarity pathways [27,28]. 
 Planar cell polarity pathway has been demonstrated to regulate chondrocyte 
polarity in the epiphyseal growth plate [9]. Non-polarized resting chondrocytes, which are 
committed progenitor cells responsible for the generation of proliferating chondrocytes, 
become polarized proliferating chondrocytes assuming a precise position and orientation in 
the epiphyseal growth plate, creating columns of stacked cells (Figure 1). Planar cell polarity 
pathway comprises molecules such as Wnt5A, the Rho family of GTPases and Gpi-anchored 
proteins. These molecules are shown to regulate orientated cell division and movements 
(intercalation) of chondrocytes (Figure 1) [7–9]. 
 Vertebrate planar cell polarity has been linked to primary cilia, which are specialized 
cell surface projections present on most eukaryotic cells [29,30]. The primary cilia function as 
the signalling ‘antennae’ of the cells that receives and transduces mechanical and chemical 
signals from the neighbouring cells and the ECM (Figure 1) [31].
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During development, the positioning of the primary cilium of the hair cells in the sensory 
epithelium leads and predicts the polarity of each stereociliary bundle, supporting the 
hypothesis that primary cilia direct the polarization of hair cells [32,33].
 In the resting growth plate chondrocytes, primary cilia do not acquire a clear pattern 
of orientation. However, in the proliferating and hypertrophic chondrocytes, primary cilia 
are orientated parallel to the longitudinal axis of the bone (Figure 1) [34]. The polarization 
of primary cilia in the proliferating and hypertrophic zones of the epiphyseal growth plate 
creates a virtual axis that crosses the centre of each column of stacked chondrocytes (Figure 
1). The parallel ciliary axes across the epiphyseal growth plate seem to represent the planar 
polarity axis of the chondrocyte, and consequently of the entire epiphyseal growth plate
[34].
 In epithelial cells, the activation Rho GTPase takes place at the primary cilium’s 
basal body [35]. In the mouse growth plate, Rho GTPase has been shown to
control tissue polarity [9]. Moreover, conditional deletion of Kif3a in the growth plate 
chondrocytes results in the depletion of cilia and loss of columnar organization [8], suggesting 
the loss of tissue polarity. Kif3a, a subunit of the anterograde kinesin-II intraflagellar
transport machinery, is required the formation of primary cilia [36]. Therefore, primary cilia 
seem to play a role in the polarization of the epiphyseal growth plate. 
 Taken together, the lack of cell–cell contact in the epiphyseal growth plate turns cell–
matrix interaction critical. In such a scenario, chondrocytes interact with their neighbouring 
chondrocytes and distant cells. These interactions are shown to be partially mediated by 
primary cilia that regulate and modulate the functions of the epiphyseal growth plate (Figure 
1).
 The epiphyseal growth plate’s fate is to be resorbed after the pubertal growth 
spurt, at the time of sexual maturation [37]. The resorption and fusion of the growth plate 
follow the cessation of growth and are regulated by both systemic mechanisms (ie oestrogen 
hormone) and local mechanisms, intrinsic to the growth plate [38,39]. It has been described 
that the growth plate chondrocytes have a finite proliferative capacity [39]. Therefore, the 
fusion of the growth plate is triggered when the proliferative potential of the chondrocytes 
is exhausted and finally all the remaining chondrocytes are replaced by bone, in which the 








Mutations affecting the biosynthesis of either proteoglycans or glycosaminoglycans alter the 
interaction between a cell and its micro-environment and are the cause of several human 
disorders. Several of these disorders are associated with a skeletal and articular phenotype 
[40]. 
 Mutations in EXT1 (8q24.1) and EXT2 (11p11) genes are associated with 
osteochondromas [41–44]. EXT1 and EXT2 encode type II transmembrane glycosyltransferases
[45,46], whose functions are not fully known. EXT1 and EXT2 form a hetero-oligomeric 
complex in the Golgi apparatus of most human cells that participate in chain elongation in 
heparan sulphate biosynthesis [47,48]. Albeit the genetic correlation between mutations in 
EXT1/EXT2 and osteochondromas, the mechanism by which alterations in heparan sulphate 
biosynthesis leads to osteochondroma is not entirely understood. As heparan sulphate acts 
as a coreceptor for fibroblast growth factors and BMPs [49], and regulates the diffusion of 
Ihh [19] and members of the Wnt family [26], improper elongation of heparan sulphate 
chains may result in a variety of growth factor signalling defects and impaired cell–matrix 
interactions, which ultimately may result in osteochondroma formation (Figure 2).
 Osteochondromas are the most common benign bone tumours of childhood and 
adolescence [50]. They are characterized by sporadic (non-familial/solitary) or multiple 
(hereditary) cartilage-capped bony projections from the metaphyses of endochondral 
bones adjacent to the growth plate and develop during skeletal growth [51]. Multiple 
osteochondromas, previously called hereditary multiple exostoses, is an autosomal dominant 
disorder with a prevalence of 1 in 18 000 [52]. Patients with multiple osteochondromas are 
often short in stature and have bowed bones that can restrict movement and ultimately 
result in joint dislocation [52]. In contrast, patients with sporadic lesions may develop 
symptoms on the affected side only. Sporadic and multiple lesions are morphologically 
indistinguishable [51,53]. 
 Multiple osteochondromas is characterized by genetic variability, which partially 
explain inter- and intrafamilial phenotypic variation often found in these patients [54]. The 
majority of the hereditary cases are caused by point mutations (70–75%). Small deletions 
involving single or multiple exons are found in about 10% of all hereditary cases [55–57]. 
Large deletions have been identified in few cases [54]. No genomic alterations are detected 
in about 10–15%. In some of these negative cases, somatic mosaicism with large genomic 
deletions of EXT1 and EXT2 has been described as the underlying mechanism of multiple
osteochondromas formation [58]. In sporadic osteochondromas, homozygous deletions of 
EXT1 are often identified [42].
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A propitious micro-environment for osteochondromagenesis
Model systems have provided significant insight into osteochondromagenesis. Zebrafish 
dackel (dak/ext2) mutant has cartilage defects that strongly resemble those seen in patients 
with multiple osteochondromas [59]. Interestingly, dak chondrocytes (chondrocytes with 
homozygous mutation in ext2) behave as wild-type cells when juxtaposed with heparan 
sulphate-secreting cells and form osteochondroma-like outgrowths when implanted at the 
edge of wild-type cartilage [60]. This shows that the secretion of heparan sulphate from the 
neighbouring wild-type chondrocytes is able to rescue the chondrocytes with homozygous 
mutation in ext2. Only, at the edge of the cartilage elements, where the level of heparan 
sulphate is decreased, chondrocytes with homozygous mutation in ext2 are able to form 
outgrowths [60].
 Studies using Cre recombinase drivers to generate Ext1 knockouts in mouse skeletal 
cells show that somatic loss of the wild-type Ext1 allele is needed for osteochondroma 
formation [61]. Recently, it has been shown that, in humans and in animal models, cells with 
functional EXT are being integrated into the osteochondroma cartilaginous cap [20,34,61,62]. 
These cells might be wild-type chondrocytes from the epiphyseal growth plate or stem cells 
from the neighbouring tissue. Recently, a subset of cells in the osteochondroma cap has been 
shown to express nestin, a protein marker for neural stem cells [63]. Although nestin levels 
are higher in younger patients, nestin-positive cells are also identified in older adults [63], 
suggesting the presence of committed stem cells or cells with stem cells properties in the 
osteochondroma cap. The occurrence of osteochondroma in childhood after haematopoietic 
stem cell transplantation has been reported in the literature [64]. Osteochondromas after 
stem cell transplantation are linked to total-body irradiation and their cause is still unclear. 
They might be the result of a prolonged duration of epiphyseal opening caused by damage 
to bone and cartilage at the epiphysis [64]. Alternatively, the growth hormone treatment 
that is often indicated to patients with total-body irradiation and haematopoietic stem cell 
transplantation [65] may disturb the process of endochondral ossification, triggering the 
committed stem cells from the epiphyseal growth plate or from the neighbouring tissue to 
form outgrowths. 
 The wild-type cells in the osteochondroma cap may create an environment 
conducive for chondrocytes with homozygous inactivation of EXT1/EXT2 to proliferate and 
grow [66], probably providing a certain threshold level and distribution of heparan sulphate 
proteoglycans. 
 By studying the distribution of the anionic sites of proteoglycans, it has been shown 
that the mosaic mixture of wild-type chondrocytes and chondrocytes with homozygous 
inactivation of EXT1/EXT2 confers to the osteochondroma cap a scattered distribution of 







Areas with a growth plate-like distribution of proteoglycans in gradients possibly contain 
chondrocytes with functional EXT1/EXT2. Areas with reduced amount of proteoglycans 
with no gradient formation have probably chondrocytes with homozygous inactivation 
of EXT1/EXT2. It has been shown that cell polarity is lost in osteochondroma, which is 
reflected either by the random orientation of primary cilia in the tumour or the lack of these 
organelles in some osteochondroma cells [34]. Interestingly, the columns of stacked cells in 
osteochondroma retained the growth plate’s cell polarity, in which primary cilia are aligned 
in a common axis, indicating the presence of wild-type chondrocytes in the tumour [34].
 Most likely, the formation of an osteochondroma takes place when epiphyseal 
growth plate chondrocytes with homozygous inactivation of EXT1/EXT2 disrupt the diffusion 
gradients and signal transduction. Cells with homozygous inactivation of EXT1/EXT2 lose 
their ability to respond to polarity signals [34]. Hypothetically, shorter heparan sulphate 
chains disrupt the polarity function of primary cilia in osteochondroma cells, which leads 
to loss of cell/tissue polarity. If cells with homozygous inactivation of EXT1/EXT2 are located 
immediately adjacent to the perichondrium, they are able to escape the proteoglycan 
gradient generated by neighbouring wild-type chondrocytes and form outgrowths (Figure 
2).
 A similar mosaic of cells with functional and dysfunctional EXT1/EXT2 might be 
present in the epiphyseal growth plate of patient with multiple osteochondromas. In such 
a scenario, the orientation of primary cilia in the epiphyseal growth plate of patients with 
osteochondromas and in the osteochondromas themselves might be similar: polarized in the 
subset of cells that are organized into columns (wild-type chondrocytes) and non-polarized 
in the subset of cells that are haphazardly organized (cells with homozygous inactivation of 
EXT1/EXT2). Speculatively, the epiphyseal growth plate of a subset of patients with multiple 
osteochondromas does not show the typical columns of stacked chondrocytes, which might 
explain the short stature and the bowed bones often seen in those patients. The lack of 
availability of epiphyseal growth plate material from those patients does not allow to verify 
the hypothesis. Interestingly, mice with mutations in genes related to cell polarity processes 
display epiphyseal growth plates with loss of columnar organization, which decrease 
longitudinal growth and increase lateral expansion of the bone [9]. 
 In mouse model of hereditary human osteochondromas based on stochastic, tissue-
specific inactivation of Ext1, it has been demonstrated that osteochondromas develop quickly 
during the early post-natal period, corresponding to rapid bone growth [62]. Additionally, 
wild-type cells constitute the major population of cells in the tumour [62]. It indicates that 
homozygous inactivation of Ext1 in a small fraction of chondrocytes is required and sufficient 
for the initiation of osteochondromas in this model. In human osteochondromas, it has 
been shown by fluorescence in situ hybridization (FISH) with an EXT1 probe that cells with 
homozygous deletion of EXT1 constitute the major population of cells in the tumour [67].
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Figure 2. Osteochondroma- and secondary peripheral chondrosarcomagenesis. (A) The secretion of 
heparan sulphate from the neighbouring wild-type growth plate chondrocytes is able to rescue the 
cells with homozygous inactivation of EXT1/EXT2 (blue cells). (B) A pool of cells with homozygous 
inactivation of EXT1/EXT2 disrupts the diffusion gradients and signal transduction in the epiphyseal 
growth plate. These cells do not respond to polarity signals, leading to loss of cell/tissue polarity. (C) 
When located adjacent to the perichondrium (arrow), cells with homozygous inactivation of EXT1/
EXT2 form outgrowths (osteochondroma). (D) The osteochondroma cap is then shaped by wild-type 
cells (red cells) and/or committed stem cells (white cells) and homozygous mutant cells. (E) Secondary 
peripheral chondrosarcoma originates from EXT1/EXT2 homozygous mutant cells or wild-type cells or 
committed stem cells that acquire genetic(s) alteration(s).
 It is plausible to foresee that number of wild-type cells in the osteochondroma 
cap varies depending on the patient’s age, decreasing upon osteochondroma maturation. 
However, the lack of tumour samples from infants with osteochondromas do not allow 
further verification whether wild-type cells constitute the major population of cells in 
more immature osteochondromas. It is unlikely that wild-type cells in the osteochondroma 
cap are just an incidental component [62]. Hypothetically, variable ratio between wild-
type chondrocytes and cells with homozygous inactivation of EXT1/EXT2 may explain why 
osteochondromas cease to grow at the time of sexual maturation and eventually are resorbed 
[68]. This indicates that the epiphyseal growth plate and osteochondroma may share, to 
some extent, similar hormonal regulation. The resorbed osteochondromas, which are in 
general small lesions [68], might be composed mainly by wild-type cells intermingled by few 
cells with homozygous inactivation of EXT1/EXT2. Once the fusion of the epiphyseal growth 
plate begins, the growth of an osteochondroma composed predominantly by wild-type cells 
decreases. As in the epiphyseal growth plate, the cartilaginous matrix of osteochondroma 
might be replaced by bone and, in the absence of a conducive environment produced 
by the wild-type cells, cells with homozygous inactivation of EXT1/EXT2 may die and the 





This indicates that the epiphyseal growth plate and osteochondroma may share, to some 
extent, similar hormonal regulation. The resorbed osteochondromas, which are in general 
small lesions [68], might be composed mainly by wild-type cells intermingled by few cells 
with homozygous inactivation of EXT1/EXT2. Once the fusion of the epiphyseal growth 
plate begins, the growth of an osteochondroma composed predominantly by wild-type cells 
decreases. As in the epiphyseal growth plate, the cartilaginous matrix of osteochondroma 
might be replaced by bone and, in the absence of a conducive environment produced 
by the wild-type cells, cells with homozygous inactivation of EXT1/EXT2 may die and the 
osteochondroma cap could be finally resorbed. In contrast, the unresorbed osteochondromas 
might be formed predominately by cells with homozygous inactivation of EXT1/EXT2. It 
is possible to foresee that the high ratio of mutated cells over the non-mutated cells may 
create an environment that shield osteochondroma from the mechanisms that regulate the 
epiphyseal growth plate, preventing the wild-type cells that could lead the resorption of the 
osteochondroma cap from dying. 
Micro-environment promoting and inducing secondary peripheral chondrosarcoma 
formation
The ‘double-edged sword’ role of the micro-environment has become more and more 
prominent in either suppressing or promoting tumour formation [69]. The micro-environment 
provides signalling to mediate cell proliferation, differentiation and death, regulating tissue 
architecture and remodelling [70]. The micro-environment is also able to suppress and 
revert processes that ultimately lead to cancer. Conversely, the micro-environment has 
also been described to modulate tumour formation, growth and spread. It means that the 
micro environment can disrupt tissue homeostasis and promote cancer development. The 
destabilization of tissue homeostasis has a variety of causes, including the production of 
toxic substances by the stromal cells and/or other cell types, ie leading to impairment of 
signalling molecules [70,71].
 Recently, it has been described that either benign or malignant tumour cells can 
create a special microenvironment that might lead to the formation of a new and different 
tumour type [72]. This model of tumour formation has been called a ‘niche-based’ model 
of of oncogenesis, in which a change in a specific niche/micro-environmental cell can serve 
as the primary moment in a multi-step process towards malignancy of a supported, but 
distinct, cell type.  Evidences for niche-induced oncogenesis come from Shwachman–
Bodian–Diamond syndrome and secondary peripheral chondrosarcoma.
 Shwachman–Diamond syndrome is an autosomal recessive disorder characterized 
by bone marrow dysfunction, neurocognitive impairment, pancreatic insufficiency and 
hepatopathy [73]. It is caused by mutations in the Shwachman–Bodian Diamond syndrome, 





micro-environment that may poise wildtype haematopoietic cells for genetic events initiating 
malignant transformation [74]. This syndrome illustrates the ability of primary alterations 
in the bone marrow micro-environment to initiate specific events that lead to secondary 
genetic alterations in other cells. 
 The role of the micro-environment in secondary peripheral chondrosarcoma 
formation has been recently described (Figure 2) [67]. Secondary peripheral chondrosarcoma 
is a malignant cartilage-producing tumour that arises from the cartilage cap of an 
osteochondroma [75]. It has been shown that, while homozygous mutations in EXT1/
EXT2 are crucial for the formation of an osteochondroma, genetic alteration(s) in other 
gene(s) than EXT1/EXT2 is(are) the causing event(s) of a subset of secondary peripheral 
chondrosarcoma [67]. Additionally, IDH1/IDH2 mutations are shown not to be involved in 
secondary peripheral chondrosarcomas formation [76]. Malignant progression of secondary 
peripheral chondrosarcomas is characterized by a high percentage of loss of heterozygosity 
(ie CDKN2A/p16, TP53, RB1) and ploidy ranging from half to twice the normal DNA content 
[77–79]. It suggests that p16, p53 and RB1 are involved in neoplastic transformation of an 
osteochondroma.
 The osteochondroma cells with homozygous inactivation of EXT1/EXT2 are thought 
to create a permissive micro-environment that facilitates the EXT wild-type cells to acquire 
secondary genetic changes. The EXT wild-type cells may be committed stem cells or wild 
type chondrocytes. Such a scenario also points to a niche-based model of oncogenesis. It 
means that a pool of committed stem cells/wild-type chondrocytes might be found in the 
osteochondroma cap. The stem cells are committed to differentiate into chondrocytes and, 
once acquiring genetic alterations in other genes than EXT1/EXT2 and IDH1/IDH2, originate 
chondrosarcomas and not other type of bone tumours. It has been proposed that sarcoma in 
general is a differentiation disease, caused by mutations hampering terminal differentiation 
of mesenchymal stem cells [80]. Depending on the lineage and the stage of differentiation 
at the time of the mutation, sarcomas with variable phenotype and histological grade could 
be initiated [80]. Gene expression profiles of differentiated chondrosarcoma (ie low-grade 
chondrosarcomas) share similarities with fully differentiated chondrocytes (ie growth plate 
chondrocytes and osteochondroma cells), whereas less differentiated chondrosarcomas (ie 
high-grade chondrosarcomas) show overlap with pre-chondrogenic stages of mesenchymal 
stem cells [81]. This means that clonal selection occurs during malignant progression from 
low-grade to high-grade chondrosarcoma and favours expansion of cell clones with gene 
expression profile similar to those of mesenchymal stem cells. These cell clones with a stem 
cell-like genotype suggest that the committed stem cells found in the osteochondroma cap 
or neighbouring tissue are the cells of origin of secondary peripheral chondrosarcomas. 
These cells then acquire genetic alteration(s) (ie p16 or p53 or RB1 or others) that give 







homozygous inactivation of EXT1/EXT2. Consequently, secondary peripheral 
chondrosarcomas are presumably a clonal growth of neoplastic cells, while osteochondromas 
are clonal growth of different cell types (ie committed stem cells/wild-type chondrocytes 
and cells with homozygous inactivation of EXT1/EXT2). Hypothetically, secondary 
peripheral chondrosarcomas may arise from clonal growth of committed stem cells/
wild-type chondrocytes or cells with homozygous inactivation of EXT1/EXT2 (Figure 2). 
Osteochondromas cells originating chondrosarcoma is a rare event, base on the fact that 
very few secondary peripheral chondrosarcomas display homozygous deletion of EXT1/EXT2 
[67].
 Neoplastic transformation of an osteochondroma occurs in <1% of patients with 
sporadic osteochondromas and 1–3% of patients with multiple osteochondromas [75]. 
Neoplastic transformation usually occurs 20–60 years after the cessation of osteochondroma 
growth that happens at the time of the fusion of the epiphyseal growth plate at puberty [41]. 
It is difficult and challenging to address how the osteochondroma cells with homozygous 
inactivation of EXT1/EXT2 facilitate secondary genetic changes in EXT wild-type cells. 
Considering that osteochondromas are cartilagecapped bony projections arising on the 
external surface of bones, it can be speculated that an osteochondroma is constantly exposed 
to risk of injury and micro-trauma that might lead the committed stem cells/wild type 
chondrocytes, either in the tumour or in the neighbouring tissue, to become more prone to 
acquire genetic alterations. The question why committed stem cells/wild-type chondrocytes 
and not EXT-mutated cells predominantly acquire genetic changes that lead to malignancy 
is answered by the fact that EXT1 mutation gives the cells a proliferative disadvantage. The 
hypothesis that alterations in EXT give the cells a proliferative disadvantage comes from a 
study in multiple myeloma showing that mutation in EXT1 leads to decreased tumour growth 
[82], and from the fact that EXT-null chondrocytes do not grow in vitro [56].
 Eventually, secondary peripheral chondrosarcoma can transform into 
dedifferentiated chondrosarcoma, which consists of two components, a well-differentiated 
chondrosarcoma juxtaposed to a high-grade undifferentiated (non-cartilaginous) 
sarcoma [83]. Dedifferentiation might occur through environmental factors and/or when 
subsequent mutations drive the differentiated chondrosarcoma cells to undergo to an 
earlier developmental stage. Alternatively, mutated undifferentiated cells located in the 
chondrosarcoma through asymmetric cell division might give rise to chondrosarcoma cells 
and to equivalent undifferentiated cells. Genetic alterations in the undifferentiated cells may 
confer a proliferative advantage, which leads to an undifferentiated sarcoma.
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Conclusion and future perspectives
In the epiphyseal growth plate, in osteochondroma and in secondary peripheral 
chondrosarcoma, the way that chondrocytes interact with each other and to their micro 
environment has gradually been unveiled. In the epiphyseal growth plate, these interactions 
lead to the formation of a polarized tissue. Cells in the epiphyseal growth plate harbouring 
homozygous mutations in EXT1/EXT2 disrupt the diffusion gradients and signal transduction, 
leading to the loss of cell polarity and contributing to the formation of an osteochondroma. 
Osteochondroma acts as a niche (a permissive environment), which facilitates the committed 
stem cells/wild-type chondrocytes located in its cap to acquire secondary genetic changes to 
form a secondary peripheral chondrosarcoma.
 The identification of a committed stem cell pool in the osteochondroma cap and 
the isolation of these cells might unveil their potential to originate a malignant tumour. 
Massive sequencing is expected to identify the driving mutation in secondary peripheral 
chondrosarcoma formation.
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Proteoglycans are molecules consisting of protein cores onto which sugar chains, i.e., 
glycosaminoglycans (GAGs) such as heparan or chondroitin sulphates, are attached. 
Proteoglycans are produced by nearly all cells, and once secreted they become a major 
component of the extracellular matrix. Cartilage is particularly rich in proteoglycans, and 
changes in the structure and composition of GAGs have been found in osteochondromas 
and osteoarthritis. The zebrafish (Danio rerio) exhibits fast development, a growth plate-
like organization of its craniofacial skeleton and an availability of various mutants, making 
it a powerful model for the study of human skeletal disorders with unknown aetiology. We 
analysed skeletons from five zebrafish lines with known mutations in genes involved in 
proteoglycan synthesis: dackel (dak/ext2), lacking heparan sulphate; hi307 (β3gat3), deficient 
for most GAGs; pinscher (pic/slc35b2), presenting defective sulphation of GAGs and other 
molecules; hi954 (uxs1), lacking Notch and most GAGs due to impaired protein xylosylation; 
and knypek (kny/gpc4), missing the protein core of the Glypican-4 proteoglycan. Here we 
show that each mutant displays different phenotypes related to: (a) cartilage morphology; 
(b) composition of the extracellular matrix; (c) ultrastructure of the extracellular matrix; and 
(d) the intracellular ultrastructure of chondrocytes, proving that sulphated GAGs orchestrate 
the cartilage intra- and extracellular ultrastructures. The mild phenotype of the hi307 
mutant suggests that proteoglycans consisting of a protein core and a short sugar linker 
might suffice for proper chondrocyte stacking. Finally, knypek supports the involvement of 
Glypican-4 in the craniofacial phenotype of Simpson–Golabi–Behmel syndrome and suggests 
GPC4 as a modulator of the overgrowth phenotype that is associated with this syndrome 
and is primarily caused by a mutation in GPC3. Moreover, we speculate on the potential 
involvement of SLC35B2, β3GAT3 and UXS1 in skeletal dysplasias. This work promotes the 
use of zebrafish as a model of human skeletal development and associated pathologies. 
Keywords: bone; cartilage; electron microscopy; glycans; osteochondroma; skeletal 
dysplasia; zebrafish
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Introduction
The development, growth and functionality of living organisms require the presence of 
poly- and oligosaccharides known as glycans. Unbranched polysaccharides such as heparan 
sulphate (HS), chondroitin sulphate (CS), dermatan sulphate (DS) and keratan sulphate (KS) 
constitute a group of glycosaminoglycans (GAGs) and, when attached to a protein, form 
proteoglycans. GAGs/proteoglycans are produced by nearly all types of cells, but they 
are especially abundant in the cartilage extracellular matrix, where, together with other 
components of the extracellular matrix, they control many cellular events, such as adhesion, 
migration and differentiation [1]. This regulatory function is attributed to the various binding 
properties of GAGs. GAGs not only bind proteins but, also retain water molecules, thereby 
maintaining cartilage elasticity. Hence, it is not surprising that changes in GAG/proteoglycan 
structure and composition have physiological and pathological implications. For example, 
mutations in EXT1 or EXT2, two genes that are crucial for the biosynthesis of HS, cause the 
development of osteochondroma, a benign cartilage-capped bone tumour [2]. Mutations 
in other HS-related genes have also been linked to skeletal conditions; e.g. mutation in 
PERLECAN leads to dyssegmental dysplasia [3], disruption of GLYPICAN 3 causes Simpson–
Golabi–Behmel syndrome [4], mutation in GLYPICAN 6 results in recessive omodysplasia [5], 
and CS deficiency related to a mutation in the CHST3 gene is found in spondylo-epi(meta)
physeal dysplasia Omani type 6, 7. Mutations in the genes involved in the sulphation of 
proteoglycans are also known to cause several dysplasias (for a review, see Superti-Furga 
and Unger, 2007).
 Different approaches and models are available for studies on diseases/disorders 
caused by GAG/proteoglycan dysfunction. Zebrafish (Danio rerio) is a popular model due 
to its fast development, the transparency of its embryos, its ease of manipulation at the 
molecular level and the availability of various mutants. The simple organization of the 
zebrafish skeleton and a similar developmental pattern to that of mammals makes zebrafish 
particularly useful for studies on skeletal development and disease. The craniofacial cartilage 
is one of the first to be formed during fish development. The first elements develop as early 
as 2 days post-fertilization (dpf) to give a fully functional cartilaginous skeleton by 5 dpf [8].
 To learn more about the function of different glycans in human skeletal 
development and disease, we characterized the cartilage of wild-type (AB) zebrafish and 
five homozygous mutant lines with different defects in glycan synthesis. The mutants used 
in this study were identified by different groups: dackel (dak/ext2) and pinscher (pic/slc35b2, 
previously named papst1) [9], as well as hi307 (β3gat3) and hi954 (uxs1) [10] were selected 
based on their cartilage phenotypes, while knypek (kny/gpc4) was first recognized as a 
mutant with defective gastrulation movements [11]. Based on the functions of ext2, gpc4, 
slc35b2, β3gat3 and uxs1, the biosynthesis of GAGs/proteoglycans should be affected at 







should have reduced levels of sulphated CS, DS, HS, KS and non-GAG molecules, hi307 
should be deficient in CS, DS and HS, and hi954 (uxs1) should lacks CS, DS, HS and other 
molecules requiring xylosylation (Table 1). Using light microscopy and transmission electron 
microscopy, we characterised the skeletons of proteoglycans-deficient zebrafish mutants 
and addressed the functions of different glycans in cartilage development, allowing us to 
speculate on the potential homology with human skeletal dysplasias. 
Materials and methods
Animals
Zebrafish (Danìo rerio H.) embryos were obtained in natural crosses and staged in accordance 
with Kimmel et al [12]. Wild-type (AB) and five null mutants {dackel (dak), exostoses (multiple) 
2 allele ext2A0739; pinscher (pic), solute carrier family 35, member B2 allele slc35b214MX 
(previously named PAPS transporter 1, papst1) [9]; hi307, β1,3-glucuronyltransferase 3 allele 
β3gat3hi307 [10]; hi954, UDP–glucuronic acid decarboxylase 1 allele uxs1hi95410; and knypek 
(kny), and glypican 4 allele gpc4V348 [11]} were raised to 5 dpf. Prior to fixation or freezing 
(GAG assay), the fish were anaesthetized in Tricane, and homozygous mutants were sorted 
by phenotype.
Human cartilage
Postnatal growth plates and osteochondromas were sampled at the Leiden University 
Medical Centre. Growth plates were from orthopaedic resections for pathological conditions 
not related to osteochondroma. All samples were obtained and handled according to ethical 
guidelines as described in the Code for Proper Secondary Use of Human Tissue in The 
Netherlands of the Dutch Federation of Medical Scientific Societies. 
GAG assay
At 5 dpf, homozygous mutants were sorted by phenotype, and pools of 10 WT and sorted 
homozygote mutants were frozen for at least 1 h at − 20 °C prior to GAG extraction. GAG 
extraction and quantification was performed according to the Blyscan sulphated glycan 
assay manual (Biocolor, UK). GAG assays were performed three times in duplicate.
Light microscopy and immunohistology
Unless stated otherwise, all experimental procedures were performed as described 
previously 13. Fish were embedded in paraffin and cut into 4 µm sections. For glycogen 
detection only, after deparaffinization and rehydration, samples were incubated for 30 
min at 60 °C in periodic acid, rinsed in water and stained with Schiff reagent for 30 min at 
room temperature. After a 15 min wash in water, the slides were dehydrated, mounted in 
micromount (Surgipath) and analysed under a light microscope. 
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 Loss, full inhibition of biosynthesis; reduction, only some molecules are affected, eg the loss of 
 sulphated epitopes in the pic mutant; na, not affected.
Sections predigested for 30 min at 37 °C in α-amylase (0.5% w/v in PBS; Sigma) were included 
as negative controls. For immunostaining of the extracellular matrix, anti-CS (CS-56, Sigma) 
at 1:800, anti-collagen type II (II-II6B3, Developmental Studies Hybridoma Bank) at 1:200, 
anti-collagen I (Rockland) at 1:800 and anti-collagen VI at 1:50 (Abcam) were used as primary 
antibodies. The poly-HRP-Gam/R/R IgG system (ImmunoLogic), followed by DAB detection 
(Dako) or anti-mouse AP (Sigma) at 1:500, followed by BCIP/NBT (Sigma), was used to detect 
the signal. Each experiment was repeated at least three times with the same results.
Transmission electron microscopy
Fish were fixed in either: (a) 1.5% glutaraldehyde; (b) a mixture of 1.5% glutaraldehyde 
and 1% PFA; or (c) a mixture of 1.5% glutaraldehyde and 4% PFA; all were in 0.1 m sodium 
cacodylate for 1 h, followed by incubation in 1% osmium tetroxide (OsO4) in 0.1 m sodium 
cacodylate for 1 h. After each step of the fixation, the fish were rinsed twice with 0.1 m 
sodium cacodylate and finally dehydrated in a series of 70%, 80%, 90% and 3× 100% ethanol, 
prior to immersion in a 1:1 epon:propylene oxide solution for 1 h. The samples were washed 
afterwards with pure epon, embedded in pure epon LX112 and polymerized at 60 °C for 2 
days. Cross-sections (800 nm thick) from five homozygous mutant fish from each line were 
stained with toluidine blue and analysed for general morphological figures under a light 
microscope. The pilot experiment revealed that WT fish fixed in 1.5% glutaraldehyde with 
and without addition of PFA had similar morphologies, and for further analysis all fish were 
fixed in 1.5% glutaraldehyde, omitting the PFA. The cartilage ultrastructures were analysed 
by transmission electron microscopy in the WT and two homozygous mutants from each 
line. For this purpose, transverse sections of 100 nm thickness were transferred to slot grids 
for transmission electron microscopy and post-stained with 7% uranyl acetate and Reynolds’ 
lead citrate. The percentage of the extracellular matrix space that was filled with fibres was 
analysed on the electron micrographs.
Table 1. Theoretical changes in the biosynthesis of biologically active molecules predicted based on 
the known functions of the exostosin 2 (ext2), Glypican 4 (gpc4), solute carrier family 35, member 









Concentration of total sulphated GAGs
Although the Blyscan assay does not give any indication of the concentration of single CS, 
KS, DS or HS, it allows for the quantification of the total level of sulphated GAGs (free and 
as a part of proteoglycans) present in a sample. Compared to WT, significantly decreased 
levels of total sulphated GAGs were detected in pic, hi307 and hi954 homozygous mutants 
(Figure 1), which was in line with the theoretical predictions based on what is known 
about the functions of slc35b2, β3gat3 and uxs1, respectively (Table 1). A normal level of 
total sulphated GAGs was detected in the kny mutant, which lacks Glypican 4 (Figure 1). 
Intriguingly, the level of total sulphated GAGs in the dak mutant was elevated (Figure 1), 
even though a mutation in ext2 should inhibit HS synthesis (Table 1).
Figure 1. Relative levels of total sulphated GAGs at 
5 dpf in WT and homozygote mutants: dackel (dak/
ext2), knypek (kny/gpc4), pinscher (pic/slc35b2), 
hi307 (β3gat3) and hi954 (uxs1). The level of 
sulphated GAGs in kny is similar to that in WT. The 
dak mutant has a significantly higher content of 
sulphated GAGs than WT, whereas pic, hi307 and 
hi954 contain significantly lower levels of sulphated 
GAGs than WT.
Cartilage morphology
At 5 dpf, wild-type chondrocytes in pharyngeal arches were organized into neat stacks of cells 
flattened along the longitudinal axis, thus resembling chondrocytes from the proliferating 
zone of the mammalian growth plate (Figure 2C′,D). From the analysed mutants, the 
morphologies of hi307 (which in theory should lack most of proteoglycans) and kny (which 
should lack Glypican 4 only) were the most similar to WT. Although the chondrocytes in 
Meckel’s and ceratohyal cartilages did not stack well (Figure 3A), hi307- and kny-derived 
chondrocytes were properly stacked and flattened in other craniofacial cartilage elements 
(Figure 3B). dak, which should lack HS only, and pic, which has impaired sulphation, had 
very severe cartilage phenotypes (Figure 3A, B). In both mutants, all chondrocytes were 
similar to those from human OCs, ie they were rounded and did not intercalate into stacks 
but remained as a disorganized cluster of cells (Figures 2E, 3A, B). In the hi954 mutant, 
which should lack most GAGs and other xylated molecules, chondrocytes had an atypical 
appearance, often failed to intercalate and were deficient in the extracellular matrix (Figures 
3B, 5B).
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Figure 2. The organization of the cartilaginous skeleton in zebrafish at 5 dpf. WT chondrocytes in 
pharyngeal arches are organized into neat stacks of chondrocytes flattened along the longitudinal axis, 
thus resembling chondrocytes from the proliferating zone of the mammalian growth plate. Lateral 
view of 4 mm zebrafish WT larvae (A); craniofacial skeleton visualized by whole-mount staining with 
alcian blue (B); transverse section at the level indicated by aa (C); magnification of the area with 
palatoquadrate (C′); growth plate from a human fetus (D); cartilage cap from an osteochondroma (E). 
Scale bar = 5 µm (C) and 100 µm (D, E)
Figure 3. Defects in cartilage organization and 
extracellular matrix composition in proteoglycan-
deficient homozygote mutants: dackel (dak/
ext2), knypek (kny/gpc4), pinscher (pic/slc35b2), 
hi307 (β3gat3) and hi954 (uxs1). Neat stacks of 
chondrocytes flattened along the longitudinal axis 
are present in WT (A, B). In kny and hi307, mild 
chondrocyte clustering can be observed only in 
Meckel’s and ceratohyal cartilages (A), whereas 
other cartilage elements appear normal (B). A loss 
of stacking similar to that in human OCs is especially 
apparent in the dak and pic mutants (A, B). hi954 
chondrocytes have an atypical appearance, with 
severely reduced extracellular matrix and often 
failure to intercalate (A). The lack of blue staining 
(A) and purple staining (B) in cartilage from pic, 
hi307 and hi954 mutants confirms the absence of 
sulphated proteoglycan in the extracellular matrix. 
The severely reduced extracellular matrix in the 
hi954 mutant should be noted. Normally, cartilage 
elements are surrounded with a perichondrium 
made up of one to two layers of small, elongated 
cells, with little cytoplasm and extracellular matrix 
but rich in electron-dense material. dak, kny 
and hi307 show normal perichondrium; the pic 
perichondrium is thicker; no perichondrium can 
be identified in hi954. The whole-mount Meckels’ 
cartilage was stained by alcian blue (A). Sections at 
the level of the palatoquadrate were stained with 
toluidine blue (B). The perichondriums in WT and 
homozygous mutant fish are shown at 5 dpf (C). 






The spacing between WT fish chondrocytes was less pronounced than in human cartilage, 
but it was similarly filled with a glycan-rich extracellular matrix (Figures 2C′,3). The hi954 
mutant was the only mutant that showed a severely reduced extracellular matrix deposition. 
None of the other mutants showed any sign of reductions or increases in the extracellular 
matrix accumulation (Figure 3B). In contrast to what is known from higher vertebrates, 
numerous lacunae enclosing small groups of chondrocytes are not present in zebrafish. 
However, lacunae-like borders were observed at the periphery of each cartilage element 
(Figure 3B, C). Therefore, we concentrated on the areas between chondrocytes where the 
extracellular matrix was homogeneous and looked like typical immature hyaline cartilage.
Perichondrium
In WT fish, chondrocyte elements were surrounded with a thin layer of perichondrium made 
up of one or two layers of small, elongated cells, with little cytoplasm and extracellular matrix 
but rich in electron-dense material (Figure 3C). Similar perichondria were also observed in 
dak, kny and hi307 mutants (Figure 3C). The pic perichondrium was thickened, showing 
enlarged cells and a rough surface (Figure 3C). In the case of hi954, typical perichon-drium-
like cells were not present; however, chondrocytes were neighboured by slightly elongated 
cells that had variable sizes, rough surfaces and were rich in cytoplasm but were poor in 
electron-dense material (Figure 3C).
Bone ossification
As cartilage prefigures the development of cartilage bones in fish (analogous to endochondral 
bones in mammals), we were interested to determine whether bone development was affected 
in our mutants. By 5 dpf, most of the bones stained by alizarin red were of intramembranous 
origin (i.e. bones that do not form upon a cartilage template; see supporting information, 
Table S1). Of those, the cleithrum and opercle, the first bones to develop, were found in WT 
and all mutant fish; however, in dak, pic and hi307 mutants they were small and malformed 
(data not shown). Other dermal bones were unaffected in kny, hi307 and hi954 but were 
severely reduced/lost in dak and pic mutants (see supporting information, Table S1). When 
it comes to the cartilage bones (fish) that correspond to endochondral bones in mammals, 
by 5 dpf WT ossification was seen only in the 5th ceratobranchial. No alterations in bone 
development, including bone malformations and changes in the timing of ossification, were 
observed in the kny, hi307 and hi954 mutants. However, at later time-points, delays in the 
development of other cartilage bones were observed in hi307 and hi954 mutants (data 
not shown). The 5th arch from dak ossified normally despite severe malformations of its 
cartilaginous template, whereas pic ossification was reduced (see supporting information, 
Table S1). The blockage of cartilage bone formation in dak and pic mutants was more severe 
than in hi mutants and it persisted until at least 9 dpf (data not shown).
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Secretion and composition of the extracellular matrix
The zebrafish extracellular matrix, like any other cartilage matrix from vertebrates, consists 
mostly of water, collagens and proteoglycans. In WT cartilage, proteoglycans stain blue with 
alcian blue (Figure 3A) and purple with toluidine blue (Figure 3B). Cartilage from WT, dak 
and kny were stained with both dyes. hi954 remained unstained (Figure 3A, B), whereas the 
skeletons of pic and hi307 showed pale staining (Figure 3A, B). Those observations are in line 
with previous reports on alcian blue stains in dak and pic [13], hi307 [14] and hi954 [14, 15] 
and also correlate well with the results from the GAG assay (Figure 1). We also examined 
the deposition of Collagen II and found that this protein was absent in the hi954 mutant and 
significantly reduced in hi307, whereas other mutants did not show any abnormalities in 
the production of this extracellular matrix component (Figure 4B, Table 2). Collagen I and VI 
were normally expressed in dak and kny mutants but were reduced/absent in the hi307 and 
hi954 mutants (Figure 4B, Table 2). 
Ultrastructure of the extracellular matrix
The collagen network, consisting of a net of long and thin collagen fibres associated with 
proteoglycan granules (electron-dense particles), was clearly visible in the extracellular matrix 
of WT chondrocytes (Figure 4A). The fibrils present between well-stacked chondrocytes 
were mostly orientated perpendicular to the longitudinal axis of cartilage elements (aligned 
fibres), whereas presumptively intercalating chondro-cytes were surrounded with a radially 
running collagen network (radial fibres) (see supporting information, Figure S1). In WT, 
aligned fibres were observed in 47% and radial fibres in 37% of extracellular spaces. No 
apparent fibrils were observed in the remaining 16% of cases. A WT-like collagen network 
and proteoglycan granules were also observed in the kny mutant (Figure 4A). kny had aligned 
and radial fibres observed in 24% and 52% of extracellular spaces, respectively. In the dak 
mutant, collagen fibres were also arranged in a similar manner as in WT cells (21% aligned 
and 74% radial fibres), but the number of proteoglycan granules present in the extracellular 
matrix was clearly reduced (Figure 4A). In the hi307 extracellular matrix, the collagen fibres 
were present (Figure 4A) but, despite relatively normal stacking of chondrocytes (Figure 
3A), only 8% of fibrils were aligned and 59% were radial, while 33% lacked a distinct fibre 
orientation. Although a mutation in β3gat3 should block the biosynthesis of most GAGs 
(Table 1), many electron-dense particles (similar to those in WT proteoglycan granules) were 
observed in the hi307 mutant (Figure 4A). In the hi954 mutant, the extracellular matrix was 
drastically reduced and was limited to a very thin layer between chondrocytes and a slightly 
thicker layer at the edge of each cartilage element (Figure 4A).
 In comparison to other mutants and WT fish, the extracellular matrix from hi954 
appeared richer in electron-dense material and had numerous focal condensations (Figure 







the periphery of cartilage elements, but they were not composed of Collagen II, as indicated 
by the lack of immunostaining [15]. The collagen network was also disrupted in the pic 
mutant. Normal collagen fibres were occasionally present, whereas short and thick filaments 
arranged into bundles were found scattered throughout the extracellular matrix in 93% of 
gaps between pic chondrocytes (Figure 4A). The presence of proteoglycan granules in pic 
mutants was common, and they were found unbound as well as associated with collagen 
fibrils. 
Cell membranes and junctions
Cell membranes surrounding WT chondrocytes had many short protrusions that were in 
contact with the collagen network (Figure 5A). Evagination of the membrane was especially 
pronounced between chondrocytes that were not in line with the longitudinal axis but were 
most likely still moving into the final position (intercalating/stacking). A WT-like appearance 
of the cell membranes was observed in dak, kny and hi307 mutants (Figure 5A). Cell 
membranes from the pic mutant were considerably undulated and also had pronounced 
protrusions (Figure 5A). In contrast, cell membranes from the hi954 mutant chondrocytes 
were smooth and free from any protrusions (Figure 5).
 Cell junctions were not commonly observed in chondrocytes from WT, dak, pic, kny 
and hi307 mutants (data not shown). This is probably because, similarly to the development 
of mammalian cartilage, soon after cell division, zebrafish chondrocytes become separated 
from each other by a layer of extracellular matrix. Interestingly, in the hi954 mutant, minimal 
extracellular matrix secretion coincided with impaired cell separation. Cell junctions were 
maintained and often spanned relatively long fragments of cell membranes (Figure 5B). In 
consequence, the cells failed to separate, creating clusters of interconnected cells.
Intracellular ultrastructure of chondrocytes
The nuclei of the chondrocytes were well preserved in all fish strains. WT nuclei had regular 
shapes. Similar appearances of the nuclei were also observed in dak, kny and hi307 mutants 
(Figure 5A). The shape of hi954 nuclei reflected the shape of the cell, as less regular but still 
relatively normal. The pic mutant was the only one to show nuclei with irregular shapes 
(Figure 5A). Moreover, pic chondrocytes had mixed populations of normal- and dark-stained 
cells, with the latter resembling paraptotic T9-C2 cells [16]. An occasional margination of 
chromatin was observed in the hi954 mutant only (data not shown). The mitochondria, 
ER and Golgi apparatus were confirmed in WT and all mutants but, as they showed signs 
of osmotic stress, they were not subjected to further analysis. This apparently damaged 
appearance was restricted to chondrocytes only and was observed regardless of the type 
of fixative. Despite the poor preservation of Golgi, in their close proximity, well-preserved 
centrioles/basal bodies of primary cilia having typical (9 + 0) microtubule arrangements
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were found in WT and all mutant lines (data not shown).
Cytoplasmic inclusions
The presence of glycogen deposits in the cytoplasm has been reported in osteochondroma 
[17]. We expected to see similar deposits, at least in the dak mutant. To our surprise, the 
transmission electron microscopy images revealed that the cartilage cytoplasms of all six 
fish lines were devoid of an electron-dense material resembling glycogen. Furthermore, 
PAS staining for glycogen was negative in the zebrafish cytoplasm (data not shown). Black 
speckles looking like lipid droplets were found in all fish but only in a small population of 
chondrocytes, of which all had dark and irregular nuclei resembling cells undergoing cell 
death (data not shown). Large empty-looking areas devoid of electron-dense material were 
found in the cytoplasms of all analysed fish (Figure 5A). The content and function of those 
vacuoles remain unknown.
Figure 4. The organization of the 
extracellular matrix, unequally affected in 
different mutants. knypek (kny/gpc4) and 
dackel (dak/ext2) have WT-like collagen 
networks, whereas pincher (pic/slc35b2) 
shows a very severe disorganization of 
the collagen network (bundles of short 
fibres) (A). Only the remains of the 
extracellular matrix and no collagen fibres 
are observed in the hi954 (uxs1) mutant. 
Surprisingly, hi307 (β3gat3) shows only 
slight abnormalities in the length and 
orientation of the collagen network. 
Electron-dense particles of proteoglycans 
are observed in all mutants; however, 
their number is clearly reduced in the 
dak and hi954 mutants and is surprisingly 
unaffected in the hi307 mutant. Collagen 
I, Collagen II, Collagen VI and CS were 
immunodetected in WT and homozygote 
mutants at 5 dpf (B). Scale bar = 1 µm (A, 







Figure 5. The ultrastructure 
of chondrocytes in the dackel 
(dak/ext2), knypek (kny/
gpc4), pinscher (pic/slc35b2), 
hi307 (β3gat3) and hi954 
(uxs1) mutants. No apparent 
ultrastructural changes can be 
observed in dak, kny and hi307. 
pic has two types of cells (dark 
and pale), severe membrane 
undulation and frequent cell 
junctions; hi954 has smooth 
membranes that often fail to 
separate. Electron micrographs 
show the chondrocyte 
ultrastructure (A). Abnormal 
cell junctions and extracellular 
matrix are seen in the hi954 
homozygote mutant (B). N, 
nucleus; G, Golgi apparatus; m, 
mitochondria; *, areas devoid of 
electron-dense material. Scale 
bar = 1 µm.
Discussion
The zebrafish skeleton is composed of cartilage and bones, for which the organization and 
development is underlined by molecular mechanisms similar to those in mammals [18]. Here, 
we characterized the phenotypic changes caused by proteoglycan deficiencies in zebrafish, 
with the goal of shedding light on the function of proteoglycans in human skeletogenesis as 
well as on skeletal disorders for which mutations are still unknown [19].
 A summary of the defects found in each mutant is presented in Table 2. In short, 
dak (which is mutated in the ext2 gene) displays severe cartilage malformation and bone 
impairment, mild ultrastructural defects and a mild reduction of the body length; kny 
(which is mutated in gpc4) has very mild cartilage and bone phenotypes and no obvious 
ultrastructural defects, but it displays severe dwarfism; pic, which is mutated in slc35b2 
(papst1), has severe cartilage and bone defects, shows pronounced ultrastructural 
abnormalities (abnormal collagen filaments, enhanced cell death, frequent cell junctions), 
displays dwarfism and does not stain with basic dyes; hi307 (which is mutated in β3gat3) 
has a very mild cartilage and bone phenotype, shows ultrastructural abnormalities restricted 
to slightly abnormal collagen fibrils, displays dwarfism and does not stain with basic dyes; 
lastly, hi954 (which is mutated in uxs1) has a severe cartilage and bone phenotype, shows 
severe ultrastructural defects (reduced extracellular matrix, lack of Collagen II, fused cells, 
abnormal fibrils), displays dwarfism and does not stain with alcian or toluidine blue.
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Table 2. Overview of the defects found in each analysed mutant and information on the human 
correlates.
Staining intensity: +, strong; ± , weak; −, absent. More information on zebrafish mutants can be 









The similarities in the cartilage phenotype and its severity in dak (ext2; lacking HS), pic (slc35b2; 
lacking sulphation of various molecules, e.g., HS, CS, DS and KS) and hi954 (uxs1; lacking 
Notch and most proteoglycans) strengthen the importance of HS in cartilage morphology 
and ultrastructure [this report and 13, 15]. We anticipated that the lack of β3gat3 in the 
hi307 mutant would result in a total inhibition of the biosynthesis of HS, CS and DS and would 
consequently cause a severe phenotype but, to our surprise, it showed a relatively normal 
cartilage morphology. The presence of a mutation was confirmed by PCR in all phenotyped 
hi307 homozygote mutants (data not shown). However, the presence of other copies or 
splice variants of β3gat3 or the involvement of other genes having rescuing effects on the 
cartilage morphology cannot be excluded. Two other possibilities should be mentioned. First 
of all, GAGs have been described as the active part of proteoglycans, although it is possible 
that the protein cores might also be biologically active. Secondly, even if the mutation in 
β3gat3 totally inhibited HS, CS and DC, proteoglycans consisting of a protein core and a very 
short linker (a chain of up to four sugars) could be synthesized; indeed, we found electron-
dense particles in the hi307 mutant. It is possible that these incomplete proteoglycans are 
sufficient to maintain the cartilage morphology, although a more detailed analysis of the 
GAGs in hi307 might yield other explanations of this unexpectedly mild phenotype.
 There is no doubt that proteoglycans are important for cartilage development; 
however, questions have been raised as to whether proteoglycans are necessary, sufficient 
or non-essential for the induction of bone calcification [20]. Our findings imply that GAGs 
are not needed for intramembranous ossification (hi307 and hi954); however, reduced 
sulphation (pic) had a strong negative impact on both intramembranous and endochondral 
bone formation. At 5 dpf, zebrafish are just starting the ossification of cartilage bones, so 
conclusions about the influence of proteoglycans on endochondral ossification are premature. 
Carey [21] suggested that proteoglycans are not needed for cell viability or proliferation but 
that they are necessary for stable extracellular matrix assembly and extracellular matrix–cell 
interaction. Our data support this hypothesis, as severe defects in cartilage organization, 
including ultrastructural changes in the extracellular matrix, were observed in zebrafish with 
mutations in uxs1 (hi954), β3gat3 (hi307) and slc35b2 (pic). 
 Transmission electron microscopy fixation is known to have an impact on the 
morphology of cartilage. Chemical fixation of mammal cartilage in the absence of a cationic 
dye results in chondrocytes having a shrunken appearance and seeming to be surrounded 
by haloes. This is because many components of the surrounding matrix are lost by aqueous 
extraction, plasma membrane–extracellular matrix connections are lost, and a pericellular 
lacuna free of fibrillar collagen and proteoglycans, referred to as a rim, is formed. Similar 
fixation methods seem to work well for the extracellular matrix in zebrafish craniofacial 
cartilage, but internal structures such as the mitochondria, ER and Golgi apparatus show 
compromised preservation. However, as different fixatives resulted in similar chondrocyte
morphologies, it might be possible that this chondrocyte appearance is actually not an 
artefact but reflects changes occurring with time. Even if fine ultrastructural details might be 
affected and if topological relationships are sometimes difficult to interpret, potential fixation 
artefacts are expected to be identical for all the embryos, allowing conclusions to be drawn 
on the differences between WT and mutant cartilage. It is not clear why similar glycogen 
deposits were not observed in zebrafish cytoplasm. However, as glycogen deposition seems 
to increase upon cartilage differentiation [22], it is possible that zebrafish chondrocytes at 
5 dpf behaved like resting chondrocytes and had not yet started to accumulate glycogen.
 To date, several human disorders have been found to share phenotypical similarities 
with corresponding zebrafish models [13, 23–25]. The dak zebrafish mutant used in this 
study has a human correlate: solitary and multiple osteochondromas caused by mutation 
in the EXT1 or EXT2 genes [13, 26–28]. A deletion of GLYPICAN 4 was described in one 
patient with Simpson–Golabi–Behmel syndrome [29]. However, this deletion coincided with 
a mutation in the neighbouring gene, GLYPICAN 3, which on its own is a sufficient causative 
of Simpson–Golabi–Behmel syndrome. It is rather unlikely that GLYPICAN 4 is involved in 
the patient overgrowth phenotype, but it could contribute to the craniofacial phenotype 
and hydrocephalus [30, 31]. These conclusions are supported by the kny mutant zebrafish, 
where a mutation of the fish glypican 4 results in a short body length and craniofacial 
phenotype at the larvae stage; additionally, when Gpc4 function is rescued by an injection 
of WT-mRNA, some embryos survive and grow to be adults with normal overall body lengths 
[32]. However, those rescued mutants have smaller heads with short and thick jaw bones, 
forming domed skulls. Interestingly, even though they often miss some facial bones, their 
jaws remain functional [32]. Hence, it is quite likely that a mutation in GLYPICAN 4 only 
might cause a condition that sometime coincides with Simpson–Golabi–Behmel syndrome, 
influencing its phenotypic variability. Judging by the severity of the cartilage phenotypes 
found in homozygous fish mutants, putative mutations in human GPC4 or β3GAT3 should 
not cause skeletal problems in early life, whereas mutations in SLC35b2 or UXS1 might 
be involved in the more symptomatic changes already seen prenatally or in toddlers. At 
present, pic, hi307 and hi954 zebrafish models cannot be linked with any human disorders, 
but mutations in related genes are known to cause several skeletal dysplasias. For example, 
a mutation in GLYPICAN 6 causes recessive omodysplasia [5], a loss of function of NST (which 
is encoded by SLC35D1) causes Schneckenbecken dysplasia [33], and mutations in DTDST 
(SLC26A2 sulphate transporter) result in achondrogenesis type 1B, atelosteogenesis type 
2 and diastrophic dysplasia [34]. There are many more dysplasias for which the causative 
mutations are not known [19]. Some of them have been mapped and, interestingly, a few 
match the locations of the genes we modelled in zebrafish. For instance, split-hand/foot 
malformation 2 was linked to Xq26, where GLYPICAN 4 has its locus [35]. However, one has 
to keep in mind that Xq26 contains other genes besides GPC4, including SLC25A6, SLC26A5








and HS6ST2, which might be involved in disorders caused by proteoglycan deficiencies. For 
those diseases that are not mapped, phenotype matching might be useful. In Table 2, we 
present a summary of the defects found in each mutant, which can be used as a guideline to 
help link human diseases with the genes. With this work, we also aim to promote zebrafish 
as a model for studying human skeletal development and associated pathologies.
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Supporting Information 
Supporting Information: Table S1. Summary of bone ossification in WT and homozygous mutant 
fish at 5 days post-fertilization.
+, calcification detected by staining with alizarin red; +/-, reduced ossification in comparison 
to WT and siblings; nd, staining not detected; light grey, dermal bones; medium grey, 
cartilage bones; dark grey, other bones.
Supporting Information: Figure S1. Examples of the fibrillar organization found in the extracellular 
matrix of WT zebrafish at 5 days post-fertilization. Between the well-stacked chondrocytes, the fibres 
are mostly orientated parallel to the longitudinal axis of the cartilage elements (aligned fibres) (A), 
whereas presumptively intercalating chondrocytes are surrounded by a radially running collagen 








Heparan sulphate upholds osteoblastic lineage
Malgorzata I. Wiweger, Carlos E. de Andrea, 





Zebrafish (Danio rerio) dackel (dak) mutant has cartilage defects that strongly resemble 
those seen in patients with multiple osteochondromas. Osteochondromas are the most 
common benign cartilage-capped bone tumours caused by mutations in the EXT1 or EXT2. 
Mutations in the EXT genes prohibit polymerisation of heparan sulphate, molecules that are 
crucial control receptor-ligand binding of many growth factors. In the zebrafish dackel (dak) 
mutant, heparan sulphate deficiency caused by a mutation in the ext2 gene, affects cartilage 
organization and bone development. Interestingly, dermal bones (intra-membranous bones 
in mammals) that do not require a cartilage template are also malformed and often lost in the 
homozygote mutant. Normal expression of runx2 and impaired expression of osterix indicate 
that heparan sulphate is required by osteoblast precursors for further differentiation towards 
mature osteoblasts. Here, we showed that loss of bones in ext2-/- coincided with abnormally 
high lipid deposition. The presence of one functional copy of the ext2 gene is sufficient for 
the maintenance of normal osteoblast and adipocyte differentiation. Our findings indicate 
that heparan sulphate possibly controls mesenchymal differentiation towards osteoblastic 
lineage.
Keywords: Zebrafish, exostosin, heparan sulphate, bone, fat, mesenchymal precursor, 
osteoblastic lineage, osteochondroma, exostosis
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Introduction
Heparan sulphates are glycosaminoglycans, linear heavily sulphated polysaccharides that 
are present in all type of cells [1]. Heparan sulphate glycosaminoglycans once attached 
onto a protein form heparan sulphate proteoglycans. The biosynthesis of heparan sulphate 
takes place in Golgi apparatus and in the endoplasmic reticulum and the elongation 
of glycosaminoglycans chain is maintained by type II glycosyltransferases encoded by 
EXOSTOSIN genes, EXT1 and EXT2 genes [2;3]. Heparan sulphates affect receptor-ligand 
binding and shape gradients of various signalling molecules [1]. In this way heparan sulphate 
alone or as a part of proteoglycans regulates various signalling pathways and controlled 
by them cellular and developmental processes, such as endochondral bone formation and 
hepatocyte clearance. 
 During endochondral bone development, terminally differentiated chondrocytes 
secrete a specialized cartilaginous extracellular matrix rich in type X collagen, which is used 
by osteoblasts to build a new bone [4]. Osteoblasts originate from mesenchymal stem cells. 
Mesenchymal stem cells can also differentiate into a variety of other cell types, including 
e.g. chondrocytes, myocytes and adipocytes. Differentiation into osteoblast lineage is under 
a strict control of RUNX2 and OSTERIX. Additionally, Wingless (Wnt), bone morphogenic 
protein (BMP), peroxisome proliferator-activated receptor (PPAR-γ) and hedgehog (HH) 
signalling that are known to affect bones by triggering a switch between bone and other 
lineages. 
 Loss of osterix-expressing domain in all cartilage bones (endochondral bones in 
mammals) and in some dermal bones (intramembranous bones in mammals) were observed 
in the zebrafish ext2-/- mutant [5;6]. In this study we investigated whether the loss of bones 
in the ext2-/- mutant can be explained by a change in the fate of osteoblastic precursors. 
We found abnormally high lipid deposition in the ext2-/- mutant indicating that ext2 gene 
and thereby heparan sulphate is involved in bone-to-fat switch during mesenchymal 
differentiation. Inhibition of PPAR-γ or stimulation of HH was reducing lipid deposition in the 
ext2-/- fish and partially rescued ossification.
Materials and methods
Animals and histology
Zebrafish (Danio rerio H.) golden and AB strains were used as wild type (WT). Homozygote 
dackel (dak, ext2to273b), knypek (kny, gpcV348), pinscher (pic, slc35b214MX), hi307 (β3gat3hi307), 
hi954 (uxs1hi954) and hi1002 (csnk1α1hi1002) mutants were obtain in obtained in natural 
crosses and staged according to Kimmel et al. [7]. The dak mutant was also maintained in 
Tg (osterix:nuGFP) background (8). Unless stated otherwise, embryos were anesthetized in 








Cartilage and bones were stained with Alcian blue and alizarin red respectively as described 
previously [5]. Lipid deposits were visualized with Oil Red O as described by Li and co-authors 
[9]. 
In situ hybridization and immunohistochemistry
Whole mount mRNA in situ was done accordingly to Thiesse 2008 [10] using: collagen 10 
[11], osterix [5], cebpa and ppar-γ rybo-probes. Whole mount immunostaining on zebrafish 
embryos was performed as described previously [5] using as a primary antibodies from the 
Developmental Studies Hybridoma Bank: anti-MF-20 for muscles and collagen II for cartilage, 
both in dilution of 1:250. For light microscopy, the anti-Digoxigenin-AP, Fab fragments 
(Roche) at 1:4000 or anti-mouse AP (Sigma) at 1:500 followed by BCIP/NBT (Sigma) were 
used to detect the signal. For confocal microscopy, Alexa 488 and 546 were used as the 
secondary antibody in dilution 1:200. Each experiment was repeated at least three times 
with the same results.
Quantitative RT-PCR
The expression level of chosen bone-specific and adipocyte-specific marker was determined 
by quantitative RT-PCR. Quantitative PCR was performed as previously described [12] using 
on-column DNase I digestion. The absence of genomic contamination in cDNAs was confirmed 
by PCR. The sequence of the qPCR primers are listed in Table 1. Unless stated otherwise, the 
primers were designed as such that the amplicons were 100-150 bp, spanning at least one 
intron to avoid amplification from possible genomic DNA contaminant in the template. All 
the samples were examined in triplicate, and the expression of each marker was normalized 
to slc25a5 level. 
Results
The importance of the heparan sulphate for preosteoblast differentiation 
The presence of defects in the development of bones in the ext2-/- larvae was describe by 
Clément et al in 2008 (Figure 1A) [5]. In order to pinpoint at which step bone formation is 
affected and by which mechanism, we examined the expression of various bone molecular 
markers in the ext2-/- and compare it with WT fish. During bone development in zebrafish, 
the sequence of molecular events is similar to this seen in mammals i.e. the expression of 
runx2 precedes osterix and it is finally followed by osteocalcin and osteopontin. Real time 
PCR revealed that in the homozygote ext2 mutants, the expression level of early osteoblasts 
markers such as runx2a and runx2b was similar to the wild type levels (Figure 1B). However, 
the reduced expression of osterix, collagen1a1, osteopontin and osteocalcin in the ext2-/- 
fish (Figure 1B) indicated that heparan sulphate is needed by osteochondroprogenitors/
preosteoblasts to follow their commitment toward osteoblastic lineage. 
65
Heparan sulphate upholds osteoblastic lineage
Figure 1. Bone development is impaired in 
ext2-/- fish. A, Alizarin red stain for ossification 
in the craniofacial skeleton at 6 dpf. B, 
Expression levels of bone markers in the 
homozygote ext2 mutants vs. WT at 5 dpf. 
The results represent an average from four 
single embryos. Expression was normalized 
against slc25a5. C, Schematic representation 
of lineages into which mesenchymal stem cells 
can differentiate. Scale = 0.1 mm.
Figure 2. Lack of bones is not compensated by the development of  ectopic craniofacial muscles. A, 
Musco-skeletal phenotype in fish at 4 dpf; whole mount immunolocalisation using MF-20 antibody for 
muscles (green) and collagen II for cartilage (red) indicates that the overall musculature of mutant fish 
resembled this from WT, with exception for hh muscle that seems to be misplaced around the heart 
area in ext2-/- fish.
Figure 3. The expression levels lipogenic/
adipogenic markers confirms that decreased 
bone formation coincided with increased 
lipid metabolism in the ext2-/- fish. A, Oil red 
O stain for ossification in the craniofacial 
skeleton at 6 dpf. B, the amount of transcripts 
was determined by quantitative PCR and 
normalised to slc25a5 level. Primer sequences 








Bone loss coincides with the elevated levels of lipids in the ext2-/- fish
From mammal systems it is known that osteoblasts originate from mesenchymal precursors, 
but mesenchymal precursors can also differentiate toward other lineages such as: i) 
chondroblasts, ii) myoblasts and/or iii) adipocytes (Figure 1C). There why, we checked if 
diminished bone development in ext2-/- coincides with gain of other lineage(s). 
 Early differentiation of chondrocytes is known to be unaffected in the ext2-/- 
craniofacial cartilage [5]. However, the terminal differentiation is clearly impaired in the 
ext2-/- chondrocytes as indicated by reduced expression of collagen X [5]. 
 The whole mount immunohistology with MF-20, showed that muscles in ext2-/- fish 
were shorter and more spaced out as they fitted the misshapen cartilaginous skeleton, but 
the overall musculature of mutant fish resembled this from WT (Figure 2) with exception for 
hh muscle that was apparently absent in ext2-/- fish (Figure 2, Table 2). Possibly, this muscle 
is misplaced all around the heart area.
 Oil red O, a stain for neutral triglycerides, lipids and some lipoproteins, highlighted 
blood vessels, heart, tectum, guts, swim bladder and the remains of yolk in wild type 
and the ext2 mutant fish (Figure 3A). However, in the ext2-/- fish, the staining was more 
intense and additional patches of lipid deposits were visible (Figure 3A). Abnormally high 
lipid accumulation was observed especially in the head, partially but not explicitly at the 
position of missing bones (Figure 3A). The expression was not restricted to any cell, but 
first adipocytes are known to develop in zebrafish only by 8 dpf [23]. Stronger Oil Red O 
stain in the ext2-/- fish coincided with over two fold over-expression on ppar-γ and normal 
level of cebp (Figure 3B) suggesting that general lipid metabolism is up-regulated in the dak 
homozygote mutant. 
Abnormal lipid deposition is specific to the ext2-/- fish
The loss of bones coinciding with enhanced lipid deposition that we observed in the dak 
mutant was specific to the ext2-/- fish. For example, pinscher (pic) which in the result of 
mutation in a PAPS transporter fails to sulphate different molecules (including heparan 
sulphate) has even more strong bone phenotype then dak [5;6] but loss of bones in pic 
did not coincided with abnormal lipid deposition (data not shown). Oil Red O staining also 
did not show any alteration in the lipid deposition in hi307 and hi954, two proteoglycan-
deficient mutants with mild bone phenotype [6]. Those hi-mutants are mutated in β3gat3 
and uxs1 respectively, and lack various proteoglycans including heparan sulphate. Also 
mutant without defects in proteoglycans such as hi1002 which has a mutation in casein 
kinase 1 alpha1a having severely reduced bones did not deposit more lipids (data not 
shown). The specificity the phenotype in the dak mutant may suggests new function of the 
ext2 in controlling lipid metabolism.
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Table 1. Sequences of primers used for quantitative PCR. Unless stated otherwise, the primers were 
designed to construct amplicons of 100-150 bp, spanning at least one exon-exon junction to avoid 
errors due to possible genomic DNA contamination in the template. A, adipocyte-specific gene; B, 
bone specific gene; C, cartilage specific gene; HK, house keeping gene; #, gene with one exon, gDNA 








Impairment in chondrocyte terminal differentiation in Ext mutants suggests that a defect in 
the replacement of cartilage template by bone can be expected in the cartilaginous cap of 
multiple osteochondromas. Indeed, osteopontin has been shown to be down-regulated in 
osteochondromas [13]. Furthermore, the loss of osterix-expressing domain in all cartilage 
bones (endochondral bones in mammals) and in some dermal bones (intramembranous 
bones in mammals) have been reported in zebrafish ext2-/- mutant [5].
 The ext2-/- larvae at 5 dpf have 90% reduction in the level of heparan sulphate and 
that deficiency affects cartilage organization and bone development [5;14]. The presence of 
one functional copy of the ext2 gene seems to be sufficient for the maintenance of normal 
differentiation of chondrocytes and osteoblasts. Also the Ext2 heterozygote mice were 
shown to have normal ColX expression as indicated by the intensity and localisation of the 
mRNA transcript after in situ hybridisation [15]. However, the Ext1 heterozygote mice had 
reduced ColX expression in the growth plate as measured by quantitative RT-PCR [16]. It 
is not known if different methods used for evaluation of the terminal hypertrophy in mice 
account for the different results. However, it is more likely that a mutation in EXT1 might 
cause more severe reduction of the heparan sulphate level then mutation in EXT2.
Table 2. Cranial muscles in the zebrafish head at 4 dpf. Muscles were scored based on the MF-20 
immuno staining of myosin. Muscles were analysed under stereomicroscope as descrived in (26) and 
scores as present (x) or absent (a). Asterixs indicate muscles that were reduced to a small dot. Minimum 
seven fish were analysed in each group. B, Branchail arches; D, Dorsal posterior; E, extraocular; H, 
Hyoid arch; and M, Manibular arch.
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We have previously shown that there is a total loss of cartilage bones and partial loss of 
dermal bones in the ext2-/- fish [5;6]. The reduced expression of osterix and collagen X in 
the ext2-/- fish can be observed from 96 hpf. As this defect is getting more pronounced with 
time, it is highly unlikely that the impaired expression of bone markers could be only caused 
by the developmental delay in the ext2-/- fish. Osterix mRNA expression is restricted to the 
immature chondro/osteoprogenitor cells and mature osteoblasts, excluding hypertrophic 
chondrocytes [18]. Similarly to the ext2-/- fish, Osterix-null mice do not form bones as they 
are unable to differentiate preosteoblasts to osteoblasts [19]. Moreover, it was shown 
that cells treated with dexamethasone, an Osterix inhibitor, choose adipogenic instead 
of osteoblast lineage, whereas PPAR-γ -null mice have increased osteoblast number [20] 
Importantly, fat in bone marrow might not only suppress osteoblastogenesis, but might 
promote bone resorption because marrow adipocytes, much like fat cells elsewhere, secrete 
inflammatory cytokines capable of recruiting osteoclasts. Unfortunately, we were not able to 
test this hypothesis as, in zebrafish, first osteoclasts develop by 16 dpf, hence after the time 
of premature death of ext2-/- fish.
 Normal expression of runx2 and impaired expression of osterix that was observed 
in the ext2-/- fish indicates that heparan sulphate is required by osteoblast precursors 
for further differentiation towards osteoblastic lineage. Mesenchymal precursors can 
differentiate towards osteoblasts, but they also can become chondrocytes, adipocytes, 
myoblasts, fibroblasts and epithelial cells. Heparan sulphate deficiency does not affect early 
chondrocyte differentiation [5], but it affects differentiation of other lineages. Recently, 
it has been shown that embryonic stem cells derived from the Ext1-/- mice are unable to 
differentiate into hematopoietic lineages [21]. Our study shows that heparan sulphate 
maintains osteoblast differentiation by inhibiting adipocyte lineage in the ext2-/- fish. 
 In five-days-old zebrafish lipids can be observed in the remains of yolk as well 
as in the brain, heart, vasculature, liver, pancreas, gall and swim bladders [22]. Abnormal 
accumulation of lipids in the ext2-/- fish was not related to any cell/adipocytes, but filled 
spaces taken by fluids. Zebrafish adipocytes start to be formed by 8 dpf and only upon 
feeding [23]. Fatty acids, when not stored in adipocytes they accumulate into the circulation 
[24]. ppar-γ and fabp1la are being used as pre-adipocyte markers, however since they have 
more broad expression (ppar-γ is also present in the liver, intestines, kidney, skin, gills and 
skeletal muscles of juvenile zebrafish) [25]; whereas the fabp1la gene can be found in caudal 
hematopoietic tissue [23] they rather can be used as readout of lipid metabolism. 
 Our data indicate that heparan sulphate act as regulator of osteoblastogenesis by 
inhibiting PPAR-γ signalling and show that heparan sulphate has multiple functions during 
endochondral bone development. First of all, heparan sulphate is required for the terminal 
differentiation of the cartilaginous template and consecutive formation of a scaffold that 







differentiation in a runx2 independent process. It still remains to be established how exactly 
heparan sulphate controls the “bone-to-fat” switch and if PPAR-γ signalling targeted for 
therapy for osteochondroma. 
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Growth plate regulation and osteochondroma 
formation: insights from tracing proteoglycans 
in zebrafish models and human cartilage
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Proteoglycans are secreted into the extracellular matrix of virtually all cell types and function 
in several cellular processes. They consist of a core protein onto which glycosaminoglycans 
(e.g., heparan or chondroitin sulphates), are attached. Proteoglycans are important 
modulators of gradient formation and signal transduction. Impaired biosynthesis of heparan 
sulphate glycosaminoglycans causes osteochondroma, the most common bone tumour 
to occur during adolescence. Cytochemical staining with positively charged dyes (e.g., 
polyethyleneimine—PEI) allows, visualisation of proteoglycans and provides a detailed 
description of how proteoglycans are distributed throughout the cartilage matrix. PEI 
staining was studied by electron and reflection contrast microscopy in human growth plates, 
osteochondromas and five different proteoglycan-deficient zebrafish mutants displaying 
one of the following skeletal phenotypes: dackel (dak/ext2), lacking heparan sulphate and 
identified as a model for human multiple osteochondromas; hi307 (β3gat3), deficient for 
most glycosaminoglycans; pinscher (pic/slc35b2), presenting with defective sulphation of 
glycosaminoglycans; hi954 (uxs1), lacking most glycosaminoglycans; and knypek (kny/
gpc4), missing the protein core of the glypican-4 proteoglycan. The panel of genetically 
well-characterized proteoglycan-deficient zebrafish mutants serves as a convincing and 
comprehensive study model to investigate proteoglycan distribution and the relation of this 
distribution to the model mutation status. They also provide insight into the distributions 
and gradients that can be expected in the human homologue. Human growth plate, wild-
type zebrafish and fish mutants with mild proteoglycan defects (hi307 and kny) displayed 
proteoglycans distributed in a gradient throughout the matrix. Although the mutants pic and 
hi954, which had severely impaired proteoglycan biosynthesis, showed no PEI staining, dak 
mutants demonstrated reduced PEI staining and no gradient formation. Most chondrocytes 
from human osteochondromas showed normal PEI staining. However, approximately 10% 
of tumour chondrocytes were similar to those found in the dak mutant (e.g., lack of PEI 
gradients). The cells in the reduced PEI-stained areas are likely associated with loss-of-
function mutations in the EXT genes, and they might contribute to tumour initiation by 
disrupting the gradients.
Keywords: growth plate; osteochondroma; proteoglycans; heparan sulphate; gradients; 
exostosis; zebrafish; bone tumours
Introduction
Bone formation and development are governed by gradients of signalling molecules, which 
trigger specific cell responses. Proteoglycans are important modulators of gradient formation 
and signal transduction [1,2]. They are found in the extracellular matrix and attached to 
the cell membrane in virtually all types of tissue [2]. Proteoglycans are composed of highly 
diverse core proteins to which one or more glycosaminoglycans chains are covalently linked 
at specific sites (Figure 1). Glycosaminoglycans are unbranched polysaccharides that consist 
of a backbone of repeating disaccharide units, often containing negatively charged sulphate 
groups [3]. Some proteoglycans have only one glycosaminoglycan chain (e.g., decorin), 
whereas others have more than one hundred chains (e.g., aggrecan). For example, heparan 
sulphate proteoglycans are composed of diverse core proteins onto which two or three 
heparan sulphate glycosaminoglycan chains are attached. 
 Bone lengthening occurs in the epiphyseal growth plate, a specialised cartilage 
structure found at the ends of long bones. Bone elongation is achieved through successive 
rounds of growth plate chondrocyte divisions, matrix secretion, hypertrophy, apoptosis, 
calcification and replacement with mineralised. Growth plate regulation requires signalling 
molecules, such as members of the Wingless (Wnt/Wg), Hedgehog (Hh), Transforming growth 
factor-β (TGFβ), Bone morphogenetic protein (BMP) and fibroblast growth factor (FGF) 
families [4]. Many of these molecules bind proteoglycans, heparan sulphate proteoglycans 
in particular. Proteoglycans influence the distribution of these signalling molecules in the 
extracellular matrix, their receptor-binding affinity and the responses of cells to secreted 
protein factors [2]. Although studies have shown that several signal transduction pathways 
rely on gradients established by the proteoglycan distribution [5,6], it is still unclear how 
these gradients are formed and shaped.
 Mutations affecting the biosynthesis of either proteoglycan or glycosaminoglycan 
are the cause of several human disorders. Loss-of-function mutations in the EXT1 (8q24.1) 
and EXT2 (11p11) tumour suppressor genes have been linked to osteochondromas [7–10]. 
EXT1 and EXT2 encode type II transmembrane glycosyltransferases 11, which localise to the 
endoplasmic reticulum and Golgi complex. EXT1 and EXT2 form an oligomeric complex that 
catalyses the elongation of heparan sulphate glycosaminoglycan chains [3, 12]. Therefore, 
the impairment of heparan sulphate glycosaminoglycan chain elongation is thought to be 
the initiating event for osteochondroma formation.
 Osteochondromas are the most common benign bone tumours of adolescence 
[13]. They are characterised by sporadic (non-familial/solitary) or multiple (hereditary) 
cartilage-capped bony projections from the metaphyses of endochondral bones adjacent 
to the growth plate and develop during skeletal growth [14]. Multiple osteochondromas, 
previously called hereditary multiple exostoses, result from an autosomal dominant disorder, 
with a prevalence of 1 in 18 000 [15]. Patients with multiple osteochondromas are short in






stature and have bowed bones that can restrict movement and ultimately result in joint 
dislocation [15]. In contrast, patients with sporadic lesions may develop symptoms on the 
affected side. Sporadic and multiple lesions are morphologically indistinguishable [14].
 Model systems have provided significant insight into osteochondroma pathogenesis 
and show a detailed picture of the role of heparan sulphate proteoglycans in tumour 
formation. Reduced EXT1 and EXT2 co-polymerase activity results in the production of 
short heparan sulphate chains [16]. Short chains decrease fibroblast growth factor 2 signal 
transduction, which may impair chondrocyte differentiation. The zebrafish dackel (dak/ext2) 
mutant has a cartilage phenotype that strongly resembles that of human osteochondromas. 
dak cells transplanted into wild-type zebrafish cartilage behave normally when juxtaposed 
with wild-type cells and abnormally when implanted at the edge of cartilage [17]; these 
results indicate that ext-null cells are not autonomous and that the secretion of heparan 
sulphate proteoglycans from the neighbouring wild-type cells is able to rescue the mutant 
cells within the chondrocyte stack. However, at the edge of the cartilage elements, where 
the level of heparan sulphate proteoglycans is decreased, ext-null chondrocytes start to form 
outgrowths [17]. These outgrowths suggest that a pool of mutant chondrocytes at a specific 
location in the growth plate is required to escape the proteoglycan gradient generated by 
neighbouring cells and give rise to osteochondromas. Recent studies using Cre recombinase 
drivers to generate Ext1 knockouts in mouse skeletal cells show that somatic loss of the 
wild-type Ext1 allele is needed for osteochondroma formation. Loss of heterozygosity has 
also been detected in a subset of human sporadic and multiple osteochondromas [8,10,18, 
19]. Interestingly, during tumour formation in mice, wild-type chondrocytes are recruited 
from the growth plate or the neighbouring tissue to generate a non-clonal population of 
cells [20,21]. Given that cells require a certain threshold level and distribution of heparan 
sulphate proteoglycans to grow properly, the wild-type chondrocytes may create an 
environment conducive for EXT1−/− cells to proliferate and form a tumour [22]. We previously 
reported that growth plate-like polarity was retained in subpopulations of osteochondroma 
cells, which may also indicate the presence of a heterogeneous cell composition in human 
osteochondromas [23].
 Despite all of the progress in the understanding of the pathogenesis of 
osteochondroma, many questions remain unanswered: (a) how do the null-EXT1 cells give 
rise to an osteochondroma; and (b) what is the proteoglycan distribution in osteochondromas 
that are present within the cartilaginous matrix? Proteoglycans can be localised with an 
electron microscope using positively charged, electron-dense dyes. Polyethyleneimine 
(PEI) is a well-described cationic dye that binds to anionic sites, allowing visualisation and 
quantification of negatively charged sites of proteoglycans in cartilage and other tissues 
at the ultrastructural level [24–27]. Using electron and reflection contrast microscopy, we 
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osteochondromas and five different proteoglycan-deficient zebrafish mutants displaying 
a skeletal phenotype. The panel of genetically well-characterised proteoglycan-deficient 
zebrafish mutants served as a convincing and comprehensive study model to investigate 
proteoglycan distribution and provided insights into the distribution and gradients that could 
be expected in the human homologue. Our results provide clues to understand the biology 
of the growth plate and the pathogenic mechanism of osteochondroma by demonstrating 







showing the specific 




Figure 2. Spatial distribution of polyethyleneimine (PEI) in the normal human growth plate. The 
distribution of anionic sites by PEI was evaluated by reflection contrast (A) and electron microscopy 
(B). A concentration gradient of electron-dense deposits of PEI (black) is observed as a function of 
distance through the cartilage (B′ to B″). Negative controls show no PEI-positive structures in either the 
electron micrographs (C) or the reflection contrast image (D). CY, cytoplasm; MB, cell membrane; ECM, 








Zebrafish (Danio rerio H.) embryos were obtained by natural crosses and staged in accordance 
with Kimmel et al. [28]. Wild-type and five null mutants were selected: dackel (dak), exostoses 
(multiple) 2; pinscher (pic/slc35b2), solute carrier family 35, member B2 (previously named 
PAPS transporter 1, papst1); hi307, β-1,3-glucuronyltransferase 3; hi954, UDP-glucuronic 
acid decarboxylase 1; and knypek (kny) glypican 4. Zebrafish were raised until 5-days post-
fertilization. Each homozygous mutant line has been previously characterised [29]. Prior to 
these experiments, the fish were anaesthetised in Tricane, and the homozygous mutants 
were sorted by phenotype. 
Human cartilage
Two postnatal growth plates and two osteochondromas were obtained from surgical 
specimens at the Leiden University Medical Centre. One osteochondroma (L-2999) was a 
sporadic lesion from a 16 year-old patient. The other (L-2675) was a lesion from a 32 year-
old patient with multiple osteochondromas, confirmed in multidisciplinary discussions of 
the case by the National Bone Tumour Committee according to the Dutch guidelines. The 
growth plates were from orthopaedic resections for pathological conditions not related to 
osteochondroma. All samples were handled in a coded fashion, and all procedures were 
performed according to the ethical guidelines of the Code for Proper Secondary Use of 
Human Tissue in The Netherlands (Dutch Federation of Medical Scientific Societies).
Tissue preparation
The method of tissue preparation has been described previously [24–26,30]. Anionic 
sites in zebrafish cartilage, human growth plate and osteochondroma were labelled by 
tissue incubation in polyethyleneimine (PEI; PEI-600, Polysciences, Warrington, PA, USA), 
a synthetic polymer that is highly cationic and water-soluble and forms an electron-dense 
insoluble product upon reaction with osmic acid. Two methods were applied: (a) the PEI 
pre-embedding method, where PEI incubation precedes tissue fixation; and (b) the PEI post-
embedding method, where PEI incubation follows fixation in 2.5% glutaraldehyde in 0.1 m 
sodium cacodylate buffer, pH 7.4, for 1 h. Freshly collected tissues were incubated with 1% 
PEI in sodium cacodylate buffer at a pH of 7.4 or 1.0, each for 6 or 12 h, with constant 
agitation. After incubation, the samples were washed three times in sodium cacodylate 
buffer and fixed and/or stained with 2% phosphotungstic acid and 1% glutaraldehyde for 
1 h. Next, they were washed three times in sodium cacodylate buffer, fixed in 1% osmic acid 
and embedded in Epon. For the negative controls, the samples were incubated in sodium 
cacodylate buffer without PEI.
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Morphological techniques
Ultrathin sections of zebrafish cartilage, human growth plate and osteochondroma were 
obtained for each experimental condition and briefly stained with phosphotungstic acid. 
Two fish were analysed from each line. Sequential sections were placed on glass slides for 
reflection contrast microscopy or on grids for electron microscopy. The preparations were 
examined under a Leitz Orthoplan microscope (Leitz, Wetzlar, Germany) equipped for epi-
illumination, which was adapted for reflection contrast microscopy as described previously 
[31]. The slides were examined under a 100× objective lens. A JEOL JEM-1011 electron 
microscope equipped with a MegaView III digital camera was used for ultrastructural analysis.
Data analysis
For gradient analysis, the electron-dense deposits of PEI were plotted using ImageJ software, 
version 1.41h (National Institutes of Health, Bethesda, MD, USA). The plot profile represents 
the intensity of pixels along a line within a selected area in the cartilage, starting from the cell 
surface and moving to the periphery/neighbouring cell. The x axis shows the distance through 
the selection and the y axis the average pixel intensity, in which 0 is black and 255 is white.
Results
Distribution of the proteoglycan anionic sites in cartilage
PEI deposition was evaluated by electron and reflection contrast microscopy in zebrafish 
and human cartilage (Figure 2). Wild-type zebrafish and proteoglycan-deficient mutants 
were used to determine the optimal conditions for studying the distribution of anionic 
sites in cartilage and the specificity of binding at the given condition. PEI post-embedding 
methods showed a virtual absence of stained anionic sites at different pH levels (see 
Supporting information, Figure S1). In contrast, PEI pre-embedding methods revealed that 
the decrease in the number of stained anionic sites followed the reduction in the pH level, 
thereby reflecting the charge-dependent specificity of its binding. The PEI pre-embedding 
method usually affects the preservation of cell components. However, at pH 7.4, PEI staining 
provided good cell preservation and excellent contrast within the cartilage matrix. As a 
result, this condition was used for further studies. Electron-dense deposits were observed 
throughout the extracellular matrix, and they outlined branched, round to oval, winding 
structures (Figures 2,3). To confirm the binding of PEI to the anionic sites of the proteoglycans, 
zebrafish mutants with impaired proteoglycan synthesis were used. PEI-positive structures 
were found in the extracellular matrix in wild-type fish and in the cartilage of mutant fish 
that lacked the glypican 4-core protein (kny/gpc4) or some glycosaminoglycans (hi307/
b3gat3). No PEI staining was observed, either in mutants that were unable to add negatively 
charged sulphate groups to glycosaminoglycans (pic/slc35b2) or in ones that lack most of 








after incubation with PEI. Nuclear staining was present in all fish lines analysed and was most 
likely due to negatively charged phosphate ions present in the DNA structure [32]. 
Gradients of proteoglycans in cartilage
PEI-positive aggregates were identified in the cytoplasm and in the extracellular matrix of wild-
type zebrafish cartilage. Large and densely packed cytoplasmic aggregates of proteoglycans 
were found in close contact with the plasma membrane (Figure 3). In the matrix of the wild-
type, kny (gpc4) and hi307 (β3gat3) zebrafish mutants, there was a broader variation in the 
diameter of the PEI aggregates (Figure 3). Additionally, the aggregates resembled vesicles, 
which enclosed electron-dense deposits of PEI and were filled in with less densely packed 
deposits (Figure 3, arrowheads). The plot profile of the electron micrographs shows the 
gradient formation (Figure 4), in which the diameter of the PEI aggregates decreased with 
the distance from the cell surface. Although the human growth plate has a more complex 
organisation compared with fish cartilage, similar PEI distribution patterns were identified 
(Figure 5). Contrast-reflection images showed that all analysed cells in the growth plate 
(n = 64) were surrounded by PEI-positive aggregates (Figure 5). Growth plate chondrocytes 
are classically divided into three distinct zones: resting, proliferating and hypertrophic 
[23]. No differences between those zones were observed. The plot profiles of the electron 
micrographs showed gradient formation between columns of chondrocytes in the growth 
plate (Figure 5, cell–matrix plot profile). However, no gradient was found between cells 
within a column (Figure 5, cell–cell plot profile). 
Reduction in proteoglycan aggregates and no gradient formation in Ext mutant 
chondrocytes
The homozygous dak zebrafish mutant, which has a mutation in the homologue of the 
human EXT2 gene, has a cartilage phenotype that resembles that of osteochondroma 
[17]. Reduced PEI staining was observed in this mutant. Small electron-dense deposits of 
PEI were found homogeneously distributed throughout the extracellular matrix (Figure 
4). Reflection contrast images demonstrated a reduction in PEI staining in all cells of the 
cartilage elements (n = 84). PEI deposits were often observed in the nucleus of these cells 
and in the endoplasmic reticulum (Figure 3). The plot profile of the electron micrographs 
showed a prominent reduction in PEI aggregates and no gradient formation (Figure 4). 
Scattered proteoglycan distribution in osteochondroma
In both sporadic and multiple osteochondromas, contrast reflection microscopy showed that 
the majority of cells were surrounded by PEI-positive matrix (n = 53/59) (Figure 6A,C). The 
plot profile of the electron micrographs demonstrated gradient formation similar to that 
observed in wild-type zebrafish and in the human growth plate (Figure 5).
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Figure 3. The distribution of proteoglycans in the zebrafish cartilage in wild-type and proteoglycan-
deficient homozygous mutants. Electron-dense deposits of PEI were found in the cytoplasm (Cy) and 
accumulated in the endoplasmic reticulum (ER) and the extracellular matrix (ECM). In the wild-type 
zebrafish, kny and hi307 PEI staining revealed a gradient. No PEI staining was observed in the mutants 
with severe impairment of proteoglycan biosynthesis, pinscher (pic) and hi954. Reduced PEI staining 
was identified in heparan sulphate–deficient dackel (dak) mutants. PEI aggregates often formed 
vesicle-like structures, enclosed in a line of electron-dense deposits (wild-type, two arrowheads) 
containing, in its interior, more loosely packed deposits (wild-type, arrowhead). MB, cell membrane; 







However, approximately 10% of osteochondroma cells (n = 6/53) resembled dak chondrocytes 
(Figure 6A,B,D,E). Both contrast-reflection and electron micrographs showed a scattered 
distribution of proteoglycans and a prominent reduction in PEI aggregates in the matrix 
surrounding these cells (Figure 5). The plot profile indicated that no gradients were formed 
around small populations of osteochondroma cells. This finding suggests the presence of 
both normal and proteoglycan-deficient cells in the cartilage cap (Figure 6A,C).
Figure 4. The distribution of proteoglycans shows gradients in the normal cartilage and a lack of 
gradient in dackel (dak/ext2) zebrafish mutants. The line of the plot profile in wild-type zebrafish 
demonstrates a decrease in PEI staining intensity from A′ to A″, which reflects gradient formation. The 
plot profile in the dackel (dak/ext2) mutant shows a prominent reduction of PEI staining intensity and 
an absence of gradient (from B′ to B″). The PEI staining in dackel is similar to that found in the region 
close to the edge of the cartilage (**) of wild-type zebrafish. Cy, cytoplasm; ECM, extracellular matrix. 
All electron micrographs are × 30 000.
Discussion
We demonstrated a cytochemical method for the visualisation and quantification of 
negatively charged proteoglycan-associated sites in cartilage and confirmed this finding by 
observing an absence of PEI staining in zebrafish variants with severely impaired proteoglycan 
biosynthesis: pic (slc35b2) and hi954 (uxs1). At pH 7.4, the PEI staining pattern in the 
cartilage matrix of the growth plate and of wild-type zebrafish was similar to that observed 
in epiphyseal and osteoarthritic cartilage, which has been previously reported [26,33].
Regular histochemical stains (e.g., alcian blue) notoriously demonstrate different 
compositions, organisation of proteoglycans [34,35] and the presence of pericellular, 
territorial and interterritorial matrix compartments in cartilage [36]. The pattern of PEI staining 
also reflects a diverse proteoglycan distribution. The overall distribution of proteoglycans in 
gradients, as shown by PEI staining, may be either the cause or the consequence of the 
formation of compartments in cartilage. In any case, proteoglycans are well known to play a 
role in the physiological regulation and homeostasis of cartilage.
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Figure 5. The distribution of proteoglycans in the growth plate. Contrast-reflection images (four 
pictures shown together) (A) show all cells surrounded by PEI staining. Electron-dense deposits of PEI 
are found in the cytoplasm (Cy) (B, *) and in the extracellular matrix (ECM) (A–C). The plot profile of 
the electron micrographs demonstrates a larger gradient formation from C2 to C2′ in the peripheral 
region (between columns of cells, cell–matrix plot profile) and a smoother gradient from C1 to C1′ in 
the region inside the column (between cells of the same column, cell–cell plot profile). Nu, nucleus. 







The distribution of proteoglycans in zebrafish cartilage is neither affected by a lack of 
glypican-4 (kny mutant), nor a GPI-anchored cell surface heparan sulphate proteoglycan, nor 
by the absence of UDP–Gal transferase I (hi307 mutant). This enzyme, encoded by β3gat3, 
is involved in the construction of the tetrasaccharide linkage region required for heparan, 
chondroitin and dermatan sulphate biosynthesis (Figure 1).
 The development of the growth plate and its regulation are controlled by morphogen 
gradients (reviewed in 3). Heparan sulphate proteoglycans one of the essential regulators for 
morphogen gradient formation [6]. In this study, the gradient formed by proteoglycans is 
hypothesised to be involved in such regulation. The vesicle-like aggregates visualised by PEI 
staining might be related to a gradient formation of signalling molecules. The concentration 
of a given proteoglycan-binding molecule might be associated with the size of the aggregates 
at a certain position across the matrix. For example, the dilution of a signalling molecule 
increases with the distance from the cell surface, following the decrease in size of the 
proteoglycan aggregates. Proteoglycans in secretory vesicles have been described as having 
a role in packaging granular contents, maintaining enzymes (e.g., proteases) in an active 
state and regulating various tissue homeostasis-related biological activities after secretion 
[37].
 Recent studies have shown that the cartilage cap of mouse osteochondromas 
is a mosaic of wild-type chondrocytes and cells lacking functional Ext1 [20,21]. Here we 
demonstrate, using PEI staining, that human osteochondromas have a heterogeneous 
composition of both normal and proteoglycan-deficient cells. Approximately 10% of 
osteochondroma cells showed a prominent reduction in PEI aggregates in the surrounding 
matrix, with no gradient formation. Similar patterns were observed in the cartilage of dackel, 
the zebrafish homologue of human multiple osteochondromas. The human osteochondroma 
cells in the reduced PEI staining areas are likely associated with loss-of-function mutations 
in the EXT genes. Taken together, these findings provide major insight into human 
osteochondromagenesis. Cells in the growth plate or in the neighbouring tissue harbouring 
homozygous mutations in EXT1/2 disrupt the diffusion gradients and signal transduction, 
which may contribute to tumour initiation. Reflection contrast images of osteochondromas 
show a reduction, but not an absence, of proteoglycans in the pericellular region of the 
proteoglycan-deficient cells. It is well described that the EXT1-null mutation in mice is 
embryonic lethal [22], and EXT1-null cells are difficult to grow in culture [18]. Therefore, a 
certain threshold level of heparan sulphate seems to be critical for EXT1-null cell survival. 
The integration of wild-type chondrocytes into the osteochondroma cap could provide an 
environment conducive to tumour cell proliferation and development. The ability of mutant 
cells to recruit normal cells to participate in the formation of a lesion is well described in 
fibrous dysplasia of the bone [38].
Figure 6. The scattered distribution of proteoglycans in osteochondroma. Contrast reflection images 
(CRI, four pictures shown together) (A, D) show cells surrounded by PEI staining and unstained cells. 
Electron micrographs (B, C, E) taken from similar areas of the CRI represent two neighbouring cells 
(B), in which one cell (B2) has a normal distribution of PEI and the other (B1) has a reduction in PEI 
staining. The normal cells (C) show gradient formation of electron-dense deposits of PEI from C′ to C″ 
as a function of distance through the cartilage (normal cell plot profile). Proteoglycan-deficient cells 
(E) demonstrate few PEI aggregates and no gradient formation from E to E″ (proteoglycan-deficient 
cell plot profile); electron-dense deposits of PEI were observed in the endoplasmic reticulum (RE) (E). 
Cy, cytoplasm; MB, cell membrane; ECM, extracellular matrix. Magnifications: (A, D) × 90; (B) × 6000; 
(C, E) × 20 000.








Although these data significantly advance our understanding of growth plate regulation and 
the pathogenesis of osteochondroma, a number of questions remain. For instance, how are 
macromolecules trafficked across the extracellular matrix of the growth plate? How does the 
mixture of both normal and proteoglycan-deficient cells explain the severity of the phenotype 
in patients with multiple osteochondromas? Is this mixture of cells homogenously present 
throughout the tumour? How are proteoglycans distributed in osteochondroma cases 
that have functional EXT1/2? In any event, this study clearly demonstrates the existence 
of proteoglycan gradients within the growth plate and an absence of this gradient around 
a subset of osteochondroma cells, which affects the diffusion of signalling molecules and 
implies a distinct role in the pathogenic mechanisms of tumour formation.
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Primary cilia organization reflects polarity 
in the growth plate and implies loss of
polarity and mosaicism in osteochondroma
Carlos E de Andrea, Malgorzata Wiweger, 
Frans Prins, Judith VMG Bovée, 





Primary cilia are specialized cell surface projections found on most cell types. Involved in 
several signaling pathways, primary cilia have been reported to modulate cell and tissue 
organization. Although they have been implicated in regulating cartilage and bone growth, 
little is known about the organization of primary cilia in the growth plate cartilage and 
osteochondroma. Osteochondromas are bone tumors formed along the growth plate, and 
they are caused by mutations in EXT1 or EXT2 genes. In this study, we show the organization 
of primary cilia within and between the zones of the growth plate and osteochondroma. 
Using confocal and electron microscopy, we found that in both tissues, primary cilia have a 
similar formation but a distinct organization. The shortest ciliary length is associated with 
the proliferative state of the cells, as confirmed by Ki-67 immunostaining. Primary cilia 
organization in the growth plate showed that non-polarized chondrocytes (resting zone) 
are becoming polarized (proliferating and hypertrophic zones), orienting the primary cilia 
parallel to the longitudinal axis of the bone. The alignment of primary cilia forms one virtual 
axis that crosses the center of the columns of chondrocytes reflecting the polarity axis of 
the growth plate. We also show that primary cilia in osteochondromas are found randomly 
located on the cell surface. Strikingly, the growth plate-like polarity was retained in sub-
populations of osteochondroma cells that were organized into small columns. Based on this, 
we propose the existence of a mixture (‘mosaic’) of normal lining (EXT+/− or EXTwt/wt) and 
EXT−/− cells in the cartilaginous cap of osteochondromas.
Keywords: bone tumor; cartilage; cell polarity; growth plate; hereditary multiple exostoses; 
osteochondroma
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Introduction
The growth plate is a highly organized, cartilaginous template needed for the longitudinal 
growth of long bones. Structurally, the growth plate can be divided into three distinct zones 
[1]. The mitotic spindles of proliferating chondrocytes are aligned perpendicular to the long 
axis of the growing bone. The chondrocytes have to undertake a series of cell movements/
rotations and shape changes to align one on top of the other to generate the typical columns 
of the growth plate [2,3,4]. Once acquired, this columnar organization is maintained. On the 
metaphyseal side of the growth plate, the chondrocytes form the hypertrophic zone. The 
cells stop proliferating and change their expression profile to synthesize type X collagen and 
to prepare for programmed cell death and mineralization [1]. Regulation of the growth plate 
is tightly maintained by signaling pathways in which heparan sulfate proteoglycans have a 
crucial role in facilitating the transport of signaling molecules within the extracellular matrix 
and in modulating the receptor-ligand interactions.
 Mutations in EXT1 and EXT2 genes, which are involved in synthesis of heparan 
sulfate chains, lead to hereditary multiple osteochondromas (previously known as hereditary 
multiple exostoses), most likely by deregulating signaling pathways. Osteochondromas are 
the most common benign bone tumors [5] and usually arise from the juxta-epiphyseal 
region of the growth plate. Although the cells seem somewhat disorganized, the histological 
features of osteochondromas are similar to those of the growth plate [6].
 Primary cilia are specialized cell surface projections present on most eukaryotic 
cells [7,8]. The primary cilium can be viewed as the antenna of the cell, which receives and 
transduces mechanical and chemical signals from the surrounding cells and the extracellular 
matrix [9] Primary cilia are formed during interphase, when the centriole pair moves together 
to the plasma membrane. The mother centriole becomes the basal body of the cilium by 
generating a 9+0 microtubular doublet symmetry that represents the structural core of 
the axoneme [9] Construction of the axoneme requires effective intraflagellar transport, 
a bidirectional drive system for molecules run by motor protein complexes. Anterograde 
transport, from the base to the tip of the primary cilium, is driven by heteromeric kinesin-
II motor proteins, which are composed of KIF3A and KIF3B motor subunits. Retrograde 
transport, from the tip to the base of the cilium, is mediated by dynein 1B [10]. 
 The link between cilia function and growth plate development is described in 
several recent studies. Primary cilia have been implicated as recipients of some signaling 
pathways essential for the regulation of the growth plate, such as the non-canonical Wnt 
and Indian Hedgehog pathways [3,11,12,13,14]. KIF3A deficiency has been shown to cause 
abnormal topography of Hedgehog signaling and growth plate dysfunction [15]. In several 
tissues, the organization of primary cilia has been shown to reflect cell polarity [16,17,18]. 
In cartilage, it has been reported that primary cilia have a specific orientation pointing away 







cells in the growth plate [3,19,20]. In the extensor tendon, cilia are aligned parallel to the 
collagen fibers and the long axis of the tendon [8,21,22].
 In this study we show the organization of primary cilia within and between the 
zones of the growth plate and osteochondroma. In both tissues, cilia were found to have 
similar forms and ultrastructures but distinct organization. In the growth plate, non-polarized 
chondrocytes (resting zone) are becoming polarized (proliferating and hypertrophic zones), 
orienting the cilia parallel to the longitudinal axis of the bone. This reflects cell polarity. 
In osteochondromas, primary cilia are randomly located on the cell surface. Strikingly, the 
growth plate-like polarity was retained in sub-populations of osteochondroma cells that 
were organized into small columns. We also show that the shortest ciliary length was related 
to the proliferative state of the cells.
Materials and methods
Growth Plate and Osteochondroma Samples
Five postnatal growth plates were sampled from orthopedic resections for pathological 
conditions not related to osteochondroma. Five osteochondroma cases were retrieved from 
the surgical pathology files. Patient data were obtained by reviewing pathological reports 
or clinical charts (Supplementary Table 1). All samples were obtained from the Leiden 
University Medical Center and handled according to ethical guidelines as described in the 
Code for Proper Secondary Use of Human Tissue in the Netherlands of the Dutch Federation 
of Medical Scientific Societies.
Histopathological and Immunohistochemistry Evaluation
All the samples were fixed in formalin, decalcified and embedded in paraffin as previously 
described.23 For histopathological evaluation, 4 μm-thick sections were stained with 
hematoxylin and eosin (H&E).
 To compare osteochondromas with growth plates, three zones were identified in 
the cartilaginous cap of the tumor (Figure 1) according to the following morphologic features:
 - Resting zone: spherical chondrocytes, single or in pairs, irregularly arranged;
 - Proliferating zone: flattened chondrocytes arranged in columns or forming clusters;
 - Hypertrophic zone: medium/large and rounder chondrocytes. 
Pre-hypertrophic and hypertrophic zones were counted as a single zone because 
morphological distinction of the two is not reliable [24].
 Immunohistochemistry was performed for proliferation rate analysis using a 
monoclonal antibody against Ki-67 (clone MIB1, 1:100; Dako, Glostrup, Germany) according 
to standard laboratory procedures [25].
Figure 1. Histology of the growth plate and osteochondroma. The growth plate is formed by three 
zones: resting (RZ), proliferating (PZ) and pre/hypertrophic (HZ) that over time turn into bone (B). 
Along the growth plate, the chondrocytes undergo proliferation (PZ) and differentiation (HZ and B). 
During these processes, the cell columnar organization is maintained. Osteochondromas are formed 
by three layers: outer perichondrium (asterisk), cartilaginous cap and underlying bone. The histological 
features of osteochondromas are to some extent similar to the ones of the growth plate. The zonation 
is less defined (RZ, PZ and HZ), and the cells are irregularly arranged and rarely acquire columnar 
organization. Hypertrophic-like chondrocytes (arrowhead) are observed within the RZ and PZ. The 
osteochondroma cells also undergo terminal ossification (B). (RZ, resting zone; PZ, proliferating zone; 
HZ, hypertrophic zone; Scale bars, 100 μm).
Immunofluorescence Staining
For immunofluorescence studies, 20 μm-thick sections of growth plates and osteochondromas 
were cut parallel to the longitudinal axis of the bone or the tumor. The sections were 
incubated with testicular hyaluronidase (2 mg/ml in 0.1 M Tris saline, pH 5.0; Sigma-Aldrich, 
St Louis, MO, USA) at 37 °C for 2 h and with 0.5% Triton X-100 in PHEM buffer (PIPES 0.05 M, 
HEPES 0.025 M, EGTA 0.01 M and MgCl2 0.01 M) at room temperature for 5 min as previously 
described.7, 26 In addition, to increase antibody penetration, proteinase K (5 μl/ml in 0.1 M 
Tris-buffered saline, pH 5.0; DakoCytomation, Carpinteria, CA, USA) was applied at room 
temperature for 3 min. The sections were stained with primary monoclonal antibodies 
against acetylated α-tubulin (clone 6-11b-1, 1:1000; Sigma-Aldrich, Steinheim, Germany), 
γ-tubulin (clone GTU-88, 1:1000; Sigma-Aldrich, USA) and/or Ki-67 (1:100) and/or a polyclonal 
antibody against KIF3A (1:100; Abcam, Cambridge, UK) at 4 °C overnight. Secondary 
antibodies conjugated with Alexa Fluor 488 (1:200; Invitrogen Molecular Probes, Eugene, 
OR, USA) or Alexa Fluor 647 (1:200) were applied for 30 min to detect the primary antibody. 
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Finally, the sections were mounted in Vectashield with propidium iodide (Vector Laboratories, 
Burlingame, CA, USA). Negative controls were sections stained without adding the primary 
antibody.
Electron Microscopy
Electron microscopy studies were performed on two growth plates and two osteochondromas 
as previously described [27]. To evaluate the ultrastructure of primary cilia, ultrathin sections 
were examined in a JEOL JEM-1011 electron microscope equipped with a MegaView III 
digital camera.
Confocal Microscopy and Analysis of Primary Cilia
Fluorescently labeled primary cilia were imaged using a confocal laser scanning microscope 
(LSM 510; Zeiss, Jena, Germany) and a plan apochromat × 63/1.40 oil or a C-Apo × 40/1.2 
water immersion objective lens (both from Zeiss). All images were acquired at a resolution 
of 1024 × 1024 or 512 × 512 pixels, a pinhole of 1 Airy unit, and an average of two successive 
scans at a speed of 6. After initial scanning to orient the section parallel to the longitudinal 
axis of the bone/tumor, z-series were imaged at 0.5 μm intervals to depths as great as 20 μm. 
A total of 10 fields of randomly selected views from each zone of the growth plate and 
osteochondroma were scanned in their full depth and used to evaluate (ImageJ software; 
NIH Image, Bethesda, MD, USA) the presence of the cilium in each z-stack series as well as its 
characteristics (length, location, orientation and position). Only viable cells (with cytoplasm 
and a nucleus stained with propidium iodide) were selected. In addition, to avoid considering 
centrioles or auto-fluorescence of the tissue as a cilium, only cilia that appeared on at 
least three consecutive images and approximately 90° to the incident light were analyzed. 
Colocalization of the KIF3A subunit and α-tubulin was used to correctly identify primary cilia. 
The γ-tubulin antibody was used to analyze the orientation of the centrioles. In addition, 
the cell nuclei stained with propidium iodide were ‘pseudo-colored’ in blue by changing the 
color of the channel in the confocal microscope settings.
Statistical Analysis
Data are expressed as mean±s.e.m. Statistical significance was computed by one-way ANOVA 
followed by post hoc Tukey’s HSD test using the SPSS 16.0 software package. Results were 
considered significant when P<0.05.
Results
Morphology of the Growth Plate and Osteochondroma
All three zones (resting, proliferating and hypertrophic) were identified in all analyzed 
samples. Although present, the ‘zonation’ in the osteochondromas was less defined (Figure 
1) and the cells were irregularly arranged and rarely acquired columnar organization. 
In addition, hypertrophic-like chondrocytes were often observed within the resting and 
proliferating zones in osteochondromas but not in the growth plate (Figure 1).
The Presence of Primary Cilia
Primary cilia were found on cells at all stages of differentiation in both the growth plate and 
osteochondromas (Figure 2a and b). All the three zones of osteochondroma had a significantly 
higher percentage of cells with primary cilia when compared with the growth plate (resting: 
94.9 vs 89.4%, P=0.044; proliferating: 93.2 vs 71.9%, P<0.001; and hypertrophic: 94 vs 71.6%, 
P<0.001, respectively). In the growth plate analyzed with respect to zones, the percentage 
of ciliated cells was significantly higher in the resting (89.4%) than in the proliferating and 
hypertrophic zones (71.9 and 71.6%, respectively; P<0.001). No significant differences were 
observed between the three zones in osteochondroma samples (P=0.532). 
Proliferation Rate in the Growth Plate and Osteochondroma
A lower proliferation rate was observed in osteochondroma, as shown by Ki-67 
immunostaining, a known marker of cell proliferation. Fewer Ki-67-positive cells were 
identified along the tumor (Supplementary Figure 1b). In contrast, a difference in proliferation 
was observed between the zones of the growth plate. A higher proliferation rate was found 
in the proliferating than in the resting and hypertrophic zones (Supplementary Figure 1a).
Double staining for Ki-67 and primary cilia could not be evaluated because of tissue 
detachment from the glass slides during antigen retrieval procedures.
Length of Primary Cilia
The measurement of the length of primary cilia was performed in the three zones of the 
growth plate and in osteochondromas. A high variability of primary cilium length within and 
between zones was observed (Figure 2c). In the growth plate, primary cilia of the proliferating 
zone (mean length 1.62 μm) were significantly shorter than those in the resting (mean length 
2.39 μm) and the hypertrophic zones (mean length 2.23 μm) (in both, P<0.001; Figure 2c). In 
the osteochondromas, similar results were found. However, cilia were significantly shorter 
only in the proliferating zone (mean length 2.13 μm) than the hypertrophic zone (mean 
length 2.38 μm) (P<0.001; Figure 2c).








Figure 2. Primary cilia are found on cells at all stages of differentiation in both the growth plate and 
osteochondroma. Fluorescently labeled primary cilia (green) are found on the cell surface projecting 
into the extracellular matrix (a). Undulations along the axoneme length are observed (a; arrowheads). 
The percentage of nucleated cells with primary cilia is depicted (b). A high number of ciliated cells 
are observed among the proliferating cells of the growth plate. The average length of the cilium in 
each zone of both tissues is shown (c). High variability in length of the cilium was observed within and 
between the zones. Nuclei are stained with propidium iodide and pseudocolored in blue. Error bars 
represent s.e.m. *P<0.05, as determined by one-way ANOVA followed by post hoc Tukey’s HSD test. 
(RZ, resting zone; PZ, proliferating zone; HZ, hypertrophic zone; Arrow-bar, longitudinal axis of the 
bone or tumor; Scale bars, 5 μm).
In the osteochondromas, similar results were found. However, cilia were significantly shorter 
only in the proliferating zone (mean length 2.13 μm) than the hypertrophic zone (mean 
length 2.38 μm) (P<0.001; Figure 2c).
 The ciliary axonemes were found projecting into the extracellular matrix in both 
tissues. Undulations along the axoneme length were observed (Figure 2a, arrowheads), as 
previously described in chondrocytes [8].
The Ultrastructure of Primary Cilia
Electron microscopy revealed the presence of the centriole with a typical 9+0 microtubule 
doublet organization in the growth plate (Figure 3c) and osteochondromas (Figure 3f). 
The basal body of the cilium, which is formed by one centriole, was found supporting the 
axoneme (Figure 3a, b, d and e). At higher magnification, the ciliary axoneme was observed 
retracted within a plasma membrane invagination (Figure 3a, b and e).
 Numerous small clusters of glycogen were found in large areas of the cytoplasm in 
osteochondroma cells (Figure 3d), but not in the growth plate.
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Figure 3. Electron 
micrographs of the 
primary cilium and the 
centrioles. The cilium is 
observed with a similar 
ultrastructure in the cells 
of the growth plate (a–c) 
and osteochondroma 
(d–f). The centriole 
with a typical 9+0 
microtubule doublet 
organization is found in 
both tissues (c, f). One 
centriole forms the basal 
body of the cilium that 
supports the axoneme 
(arrowheads) (b, e). The 
axoneme is observed 
retracted within a 
plasma membrane 
invagination (a, b, e). 
Numerous small clusters 
of glycogen (asterisk) 
are found in large areas 
of the cytoplasm in 
osteochondroma cells 
but not in the growth 








Localization of KIF3A Kinesin II Subunit
The KIF3A subunit has been shown to have a critical role in growth plate formation [15]. 
Using an antibody against the KIF3A subunit, positive cells were found in the growth plate 
and osteochondromas. One strongly stained spot (Figure 4) could be observed, although the 
staining was diffuse throughout the cytoplasm in both tissues. We next analyzed whether 
the strongly stained KIF3A spot was properly located in the primary cilia, and we were able 
to colocalize the KIF3A spot with the cilia (Figure 4). 
Primary Cilia Organization in the Growth Plate and Osteochondroma
The typical architecture of the growth plate may reveal a specific location of the organelles 
within the chondrocytes [28]. To address this hypothesis, we studied the organization of 
primary cilia along the x–y axis of the growth plate and osteochondromas. In the growth plate, 
we found that primary cilia in the resting zone do not acquire a clear pattern of orientation 
(Figure 5c). However, in the proliferating and hypertrophic zones, primary cilia were oriented 
parallel to the longitudinal axis of the bone pointing either toward the epiphyseal side or the 
metaphyseal side of the growth plate (Figure 5a and d). At lower magnification, one virtual 
axis that is formed by the alignment of primary cilia and crosses the center of each column 
of chondrocytes could be identified (Figure 5a and 6a, left panel). The parallel axes seem to 
represent the axis of chondrocyte polarity inside the growth plate. 
Figure 3. KIF3A subunit, which facilitates 
intraflagellar transport, is present in the cells 
of the growth plate and osteochondroma. 
Immunolabeling with antibodies against 
acetylated α-tubulin (a–d; green) and KIF3A 
(a’–d’; red) shows colocalization of both 
proteins (merged) in the primary cilium in the 
growth plate (a” and b”) and osteochondroma 
(c” and d’’). Nuclei are stained with propidium 
iodide and pseudo-colored in blue. (Scale bars, 
5 μm).
To confirm this specific positioning of the cell region containing the cilium, we immunolabeled 
the centrioles using an antibody against γ-tubulin (Figure 5e). The centrioles are located in 
the centrosome of the cell next to the plasma membrane. The centrioles were found aligned 
inside the columns of cells, delineating one virtual axis (Figure 5e). In osteochondromas, 
primary cilia were randomly located along the x–y axis of the tumor either on the center 
or on the lateral-medial region of the cells in relation to the longitudinal axis of the tumor 
(Figure 5b and 6a, right panel). 
 In 5 osteochondromas analyzed, 12 sub-populations of cells were found organized 
into small columns. Interestingly, in 10 of the 12 small columns identified, the cilia were 
aligned in one axis parallel to the axis of tumor growth (Figure 5h).
Discussion
Primary cilia were found to reflect cell polarity in several tissues [16,17,29]. It has been shown 
that primary cilia have a critical role in the development of the growth plate. Disturbance of 
the intraflagellar transport system leads to a depletion of cells with primary cilia and defects 
in the growth plate such as disruption of cell shape and lack of columnar orientation, which 
suggests defects in cell movement/rotation [3,11,12].
 In this study, we showed that, in the proliferating and hypertrophic zones of the 
growth plate, the organization of primary cilia forms virtual axes parallel to the longitudinal 
axis of the bone. The fact that this orientation pattern of the cilium was not detected in the 
resting zone implies that polarization gradients exist inside the growth plate, driving the 
cells to their specific positions and orientations. It has been suggested that the polarization 
gradients are generated and maintained by the cartilage itself and that the resting zone 
establishes the organization of the growth plate [30].
 Several morphogens or signaling molecules are secreted from the two opposite 
poles of the growth plate, having an important role in chondrocyte proliferation and 
differentiation [1]. The normal diffusion and function of morphogens regulate the formation 
of zones in the growth plate [31]. Inside each zone of the growth plate, the chondrocytes 
respond in an orchestrated manner to the signaling molecules, which reflects a collective cell 
behavior that is typical for polarized tissues in which the cells adopt the same polarity axis 
and identical positioning of their organelles [32]. In conclusion, the results provide evidence 
that normal growth plate formation depends on the establishment and maintenance of 
individual and collective chondrocyte polarity.
 We also showed that the osteochondroma cells have a primary cilium and its 
formation is similar to that of the growth plate cilia. However, no clear orientation of the 
cilium was observed in the osteochondromas, with primary cilia often randomly located 
along the x–y axis either organized on the center or on the lateral-medial region of the cells 
in relation to the growth axis of the tumor. 
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This suggests that the presence of primary cilia is not sufficient to direct proper organization 
of the chondrocytes. The formation of the ciliary axis seems to be a final result of several 
factors (eg, signaling molecules and their effective transduction) that determine the final 
orientation of the cells.
 Primary cilia have been shown to mediate Indian Hedgehog signaling [9,15] Indian 
Hedgehog is secreted by pre-hypertrophic chondrocytes, and its diffusion generates a signal 
gradient inside the growth plate that coordinates cell proliferation and differentiation [1]. 
The alignment of primary cilia might be critical for transduction of this signaling molecule 
along the growth plate. Homogeneous expression of Indian Hedgehog has been shown in 
osteochondromas, which is suggestive of autonomous cell signaling [6]. Therefore, correct 
orientation of the cilium is no longer needed to receive and transduce the diffusion gradient 
of Indian Hedgehog signaling. Other deregulated signaling pathways might also contribute to 
the misorientation of primary cilia. Intriguingly, some sub-populations of osteochondroma 
cells, which were organized into small columns, appeared to keep the growth plate cell 
polarity. This leads us to hypothesize that a mixture (‘mosaic’) exists of normal lining (EXT+/− 
or EXTwt/wt) and EXT−/− cells in the cartilaginous cap. In this mixture, the normal lining cells 
would produce heparan sulfate proteoglycans and the receptor-ligand interactions would 
be modulated regularly. Consequently, these cells would respond to the polarization signals 
and align primary cilia in one axis. Further analysis will be required to identify mosaicism in 
osteochondromas.
 This study sheds light on the events related to primary cilia formation. For example, 
the smallest ciliary length was associated with the proliferative state of the cells. In addition, 
several proliferating cells were found to have primary cilia. Knowing that the cell turnover is 
increased in the proliferating zone and that primary cilia are absent in replicating cells [10], 
it is possible that only a subset of proliferating cells are in mitosis. This suggests that the cilia 
length is directly related to cell cycle duration. Further studies on cilia function are necessary. 
Interestingly, several hypertrophic cells with well-preserved morphology were found without 
cilia (Figure 5d and g, asterisks). As most of them undergo apoptosis [1], this observation 
might indicate that primary cilia were disassembled in the early stages of apoptosis. In 
addition, the osteochondroma cells were found to have a higher percentage of cells with 
primary cilia. The presence of primary cilia might be associated with the lower proliferation 
rate of the tumor, which was confirmed by Ki-67 immunostaining. Taken together, the 
primary cilia length observed in osteochondromas is similar to that in the growth plate, 
suggesting that ciliary formation is normal in these tumors. This also enforces the hypothesis 
that deregulation of cell–cell and/or cell–matrix signaling pathways is instrumental to the 
pathogenesis of osteochondromas.
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Figure 5. The organization of primary cilia in the growth plate and osteochondroma. Primary cilia 
(green) in the growth plate (a) are organized in such a way that they form a virtual axis crossing the 
center of the columns of proliferating and hypertrophic chondrocytes. The ciliary axis is always parallel 
to the longitudinal axis of the bone (arrow-bar). γ-Tubulin marks the location of the centrioles and 
confirms the existence of one virtual axis (e). Primary cilia in osteochondromas are randomly located 
along the x–y axis of the tumor (b). On rare occasions when osteochondroma cells are organized into 
small columns (h), primary cilia are aligned parallel to the longitudinal axis of the tumor (arrow-bar). 
In the resting zones of both tissues, primary cilia do not acquire any clear orientation (c, f). Some 
hypertrophic cells of the growth plate and osteochondroma with a well-preserved morphology are 
found without cilia (d, g). (RZ—resting zone; PZ—proliferating zone; HZ—hypertrophic zone; asterisks—
cells without primary cilia; f and h, inserted from b; arrow-bar—longitudinal axis of the bone or tumor; 
scale bars, 10 μm).
Figure 6. Primary cilia organization reflects cell polarity in the growth plate 
and in sub-populations of osteochondroma cells. Schematic representation 
shows the virtual axis that is formed by the alignment of primary cilia 
and crosses the center of each column of chondrocytes (a, left and right 
panels). Chondrocytes of the growth plate are known to divide parallel to 
the longitudinal axis of the bone (arrow-bar) (b, left panel). The daughter 
chondrocytes must undertake a series of cell movements/rotations and 
shape changes to generate the typical columns of the growth plate and align 
primary cilia on one common axis (a, b, left panel). A model is proposed in 
which an osteochondroma forms as a consequence of chondrocytes losing 
their ability to move/rotate to re-orient themselves with respect to the 
growth axis (arrow-bar) (b, right panel). Interestingly, some sub-populations 
of osteochondroma cells are able to form columns and to orient the cilium 











The alignment of primary cilia along the growth plate supports the idea that the chondrocytes 
of the growth plate have the ability to move/rotate (Figure 6b) [2,4,33]. Integrins are the 
major class of cell adhesion molecules that mediate cell–matrix signaling pathways [33]. 
Integrins have heparan-binding domains, which indicate that heparan sulfate proteoglycans 
may modulate integrin signaling and cell adhesion [34]. Movement/rotation problems in 
the chondrocytes of the growth plate have been reported in β1-integrin-null mice [33]. The 
β1-integrin-null growth plates show larger and round-shaped proliferating chondrocytes 
arranged side by side, possibly reflecting impaired movement and inability to form columns 
[33]. Strikingly, β1-integrin receptors have been reported to colocalize with α-tubulin in 
the primary cilia of chondrocytes [35]. The loss of EXT expression results in disordered 
distribution of heparan sulfate proteoglycans. Recently, we showed that in osteochondromas, 
heparan sulfate proteoglycans are no longer present at the cell surface but accumulate in 
the cytoplasm [36]. Therefore, it is possible that the lack of heparan sulfate proteoglycans 
at the cell surface might influence cell adhesion and motility. The random orientation of 
the cilium in osteochondromas leads to the assumption that osteochondroma cells have 
impaired movement (Figure 6b) that may underlie the lack of orientation of the cells, which 
is a morphological characteristic of this tumor. The impaired movement might be caused 
by diminished heparan sulfate proteoglycans, which in turn could reduce integrin signaling 
activity and cell adhesion to the surrounding matrix.
 In conclusion, we showed that the organization of primary cilia reflects cell polarity 
in the growth plate and in sub-populations of osteochondroma cells. We also showed that 
the ciliary formation in osteochondroma seems to be similar to that of the growth plate. The 
growth plate-like polarity retained in sub-populations of osteochondroma cells (organized 
into small columns) leads us to propose the existence of a mixture (‘mosaic’) of normal lining 
(EXT+/− or EXTwt/wt) and EXT−/− cells in the cartilaginous cap of osteochondromas.
Note added in proof
Since the work described in this paper was completed and submitted for publication, the 
mixture (“mosaic”) of normal lining (EXT+/− or EXTwt/wt) and EXT−/− cells in the cartilaginous 
cap of osteochondromas has been elegantly reported by Jones et al (Proc Natl Acad Sci U S 
A 2010;107:2054–2059) using a conditional mouse model for Ext1. 
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Supplementary Information
Supplementary Table S1. Summary of clinicopathological and tumor data.
Supplementary Figure S1. The proliferation 
rate of the growth plate and osteochondroma. 
Immunohistochemistry with Ki-67 antibody, a 
known marker for cell proliferation, is used 
to show that the proliferation rate is higher 
in proliferating zone of the growth plate 
and lower in an osteochondroma. Positive 
nuclei are often present in proliferating 
chondrocytes from the growth plate (a; 
from a 2-year-old patient) and rarely present 
in osteochondromas (b; from a 6-year-old 








Secondary peripheral chondrosarcoma evolving 
from osteochondroma as a result of 
outgrowth of cells with functional EXT
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Secondary peripheral chondrosarcoma is the result of malignant transformation of a pre-
existing osteochondroma, the most common benign bone tumor. Osteochondromas are 
caused by genetic abnormalities in EXT1 or EXT2: homozygous deletion of EXT1 characterizes 
sporadic osteochondromas (non-familial/solitary), and germline mutations in EXT1 or EXT2 
combined with loss of heterozygosity define hereditary multiple osteochondromas. While 
cells with homozygous inactivation of EXT and wild-type cells shape osteochondromas, 
the cellular composition of secondary peripheral chondrosarcomas and the role of EXT in 
their formation have remained unclear. We report using a targeted-tiling-resolution oligo-
array-CGH (array comparative genomic hybridization) that homozygous deletions of EXT1 
or EXT2 are much less frequently detected (2/17, 12%) in sporadic secondary peripheral 
chondrosarcomas than expected based on the assumption that they originate in sporadic 
osteochondromas, in which homozygous inactivation of EXT1 is found in ~80% of our cases. 
FISH with an EXT1 probe confirmed that, unlike sporadic osteochondromas, cells from 
sporadic secondary peripheral chondrosarcomas predominantly retained one (hemizygous 
deleted loci) or both copies (wild-type) of the EXT1 locus. By immunohistochemistry, we 
confirm the presence of cells with dysfunctional EXT1 in sporadic osteochondromas and 
show cells with functional EXT1 in sporadic secondary peripheral chondrosarcomas. 
These immuno results were verified in osteochondromas and secondary peripheral 
chondrosarcomas in the setting of hereditary multiple osteochondromas. Our data therefore 
point to a model of oncogenesis in which the osteochondroma creates a niche in which 
wild-type cells with functional EXT are predisposed to acquire other mutations giving rise 
to secondary peripheral chondrosarcoma, indicating that EXT-independent mechanisms are 
involved in the pathogenesis of secondary peripheral chondrosarcoma.
Keywords: chondrosarcoma; osteochondroma; EXT1; array-CGH; FISH; bone tumors
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Introduction 
Secondary peripheral chondrosarcomas arise in the cartilaginous cap of a pre-existing 
osteochondroma (Bertoni et al., 2002). Osteochondromas are the most common benign 
bone tumors of adolescence (Khurana et al., 2002; van den Berg et al., 2008). They occur as 
sporadic (non-familial/solitary) or multiple (hereditary) cartilage-capped bony projections 
from the metaphyses of endochondral bones adjacent to the growth plate (Khurana et al., 
2002; Bovee et al., 2010). Osteochondromas develop during skeletal growth (13–15 years) 
and cease to grow when the growth plate fuses at puberty (van den Berg et al., 2008).
 Sporadic and multiple osteochondromas have been linked to genetic alterations 
in two main loci, EXT1 at 8q24 (65%) or EXT2 at 11p11-13 (35%) (Bovee et al., 2010). 
The majority of the multiple osteochondromas (70–75%) are caused by point mutations. 
Deletions involving single or multiple exons are found in about 10% of all hereditary cases 
and no genomic alterations are detected in about 10–15%. In some of these negative cases, 
somatic mosaicism with large genomic deletions of EXT1 and EXT2 have been described as 
the underlying mechanism of multiple osteochondroma formation (Szuhai et al., 2011). In 
sporadic osteochondromas, homozygous deletions of EXT1 are identified (Hameetman et al., 
2007b; Reijnders et al., 2010; Zuntini et al., 2010; Szuhai et al., 2011). Recent experimental 
studies using mice and zebrafish knockdown models show that homozygous inactivation of 
Ext1 or Ext2 is required for osteochondromagenesis (Clément et al., 2008; Jones et al., 2010; 
Matsumoto et al., 2010). In humans, loss of the remaining wild-type allele of EXT has been 
detected in approximately 40% of sporadic and multiple osteochondromas (Hameetman et 
al., 2007b; Reijnders et al., 2010; Zuntini et al., 2010). In sporadic osteochondromas, we 
have described homozygous deletions of EXT1 in ~80% of the cases (Hameetman et al., 
2007b; Reijnders et al., 2010; Zuntini et al., 2010). It was shown recently that during the 
formation of osteochondromas, chondrocytes with functional EXT from the growth plate or 
the neighboring tissue are being integrated into the cartilaginous cap, generating a mosaic 
mixture of wild-type cells and cells with homozygous inactivation of EXT1 or EXT2 (de Andrea 
et al., 2010, 2011; Jones et al., 2010; Matsumoto et al., 2010).
 Less than 1% of patients with sporadic osteochondromas and 1–3% of patients with 
multiple osteochondromas at the age of 30–60 years will eventually develop a secondary 
peripheral chondrosarcoma (Dorfman et al., 2002). Secondary peripheral chondrosarcomas 
are malignant cartilage-producing tumors. Contrary to what is observed in osteochondromas, 
homozygous inactivations of the EXT genes are detected in a much smaller subset (~15%) of 
secondary peripheral chondrosarcomas (Hecht et al., 1995; Raskind et al., 1995; Bovée et al., 
1999; Hallor et al., 2009; Zuntini et al., 2010). 
 Although osteochondromas and secondary peripheral chondrosarcomas are 
associated, many aspects on the pathogenesis of this malignant bone tumor remain 
unestablished.







The homozygous inactivation of the EXT genes required for osteochondromagenesis, the 
mixture of cells with distinct genetic background within the osteochondroma cap and 
the low frequency of homozygous inactivation of the EXT genes in secondary peripheral 
chondrosarcomas lead to two central questions: (i) Are the cells with homozygous 
inactivation of EXT1/2 of osteochondromas the cellular origin of secondary peripheral 
chondrosarcomas? (ii) Do the EXT genes act as tumor-suppressor genes in the formation of 
secondary peripheral chondrosarcomas?
 To address these unsolved questions, we studied 17 clinically and radiologically 
well-documented secondary peripheral chondrosarcomas derived from sporadic 
osteochondromas. The copy-number alterations of EXT1 or EXT2 were assessed by targeted-
tiling-resolution oligo-array-CGH and the genetic changes involving the EXT1 locus were 
investigated by fluorescence in situ hybridization (FISH). Additionally, the potential function 
of EXT1 was explored by immunohistochemistry. Sporadic osteochondromas were used as a 
reference to understand the formation of a secondary peripheral chondrosarcoma. Multiple 
osteochondromas and secondary peripheral chondrosarcomas derived from patients with 
multiple osteochondromas were used to validate the generated model. 
Results 
Clinical findings and imaging studies
The anatomical distribution and the cartilaginous cap thickness of the 17 sporadic peripheral 
chondrosarcomas are shown in Table 1. Sixteen patients showed no adverse outcome 
(metastases or death of disease). However, one patient with a pelvic lesion developed a large 
local recurrence approximately 3 years after the primary surgery and died a few months later 
of the disease. No germline mutations in EXT1 or EXT2 were detected. In the imaging studies, 
a pre-existing osteochondroma and/or its stalk were identified in all 17 cases (Supplementary 
Figure 1). All cases diagnosed as grade-I secondary peripheral chondrosarcoma fulfilled 
the criteria for recommending resection for malignant concerns. These criteria included 
histological features in accordance with the WHO classification (Khurana et al., 2002; van 
den Berg et al., 2008) or a cartilage cap thickness of 1.5 cm or greater, or a clinical history 
and/or radiographic signs of tumor growth (Supplementary Figure 1B–B4). Case L-868 was 
radiologically classified as a borderline lesion. The criteria used for this case included age of 
the patient (18-year-old man) with a growing lesion on an almost mature skeleton, in which 
the growth plates were nearly closed (Supplementary Figure 2). 
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Homozygous deletions of EXT1/2 are uncommon in sporadic secondary peripheral 
chondrosarcomas
A custom-made, oligonucleotide-based microarray with a tiling coverage of EXT1/2 genes 
was used to detect deletions involving any part of EXT1 or EXT2 genes. At least 90% of 
tumor tissue was isolated and analyzed in each case. Table 1 summarizes the results of the 
array comparative genomic hybridization (array-CGH) analysis. In the 17 sporadic secondary 
peripheral chondrosarcomas, homozygous deletion of EXT1 was found in two cases (L-
1245, grade-I; and L-224, grade-II) (Figure 1). L-1245 showed deletions involving exon-2 to 
exon-11. Based on the array profile of L-1245, the proportion of the cell fraction containing 
homozygous deletion of EXT1 was ~25% (Figure 1). L-224 showed deletions in exon-10, which 
is smaller than the bacterial artificial chromosome probe used for FISH analysis. Hemizygous 
deletion of EXT1 was found in 12 cases (not shown). A significant gain of chromosome arm 
8q was identified in one case (L-123, not shown). No alterations involving the EXT1 gene 
were seen in two cases (Figure 1). Additionally, no alterations involving the EXT2 gene were 
identified (not shown). 
Retention of one or both copies of EXT1 in the cells of sporadic secondary peripheral 
chondrosarcomas
To further investigate the genetic changes in EXT1, FISH was performed in the setting of 
sporadic lesions and was successful in 10 out of 17 secondary peripheral chondrosarcomas 
and in 4 out of 5 sporadic osteochondromas. Failures were due to DNA damage as a result of 
decalcification. In sporadic osteochondromas, the majority of the cells showed loss of both 
copies (homozygous loss) of the EXT1 locus (mean of all cases: 91%; Figure 2 and Table 1), as 
expected. Surprisingly, within the tumor, cells retaining both copies of the EXT1 locus (wild-
type alleles) were also observed (mean of all cases: 7%; Figure 2 and Table 1), which were 
commonly located in the hypertrophic layer of the osteochondroma cap (Supplementary 
Figure 3). Although hemizygous losses were detected, the number of cells with one copy of 
the gene was below the cut-off value based on the correction factors obtained from FISH data 
from growth plate and articular cartilage, indicating that these losses reflected truncation 
artifacts. In each analyzed sporadic peripheral chondrosarcoma, the patterns of copy-
number alterations involving the EXT1 locus compared with the chromosome-8 centromere 
signals varied widely (Figure 2 and Table 1). Five cases showed cells with no losses (wild-
type alleles), as well as hemizygous and homozygous deletions. Two cases showed cells with 
wild-type and hemizygous deleted loci. One case showed cells with no loss, hemizygous 
deletion and gain of the EXT1 locus. Two cases showed cells with no losses, hemizygous and 
homozygous deletion, as well as gain of the EXT1 locus. Additionally, all except three cases 
(L-739, grade-I; L-868, borderline cases; L-2361, grade-I) showed aneuploid cells (>2 signals 
with a centromere-8 probe) ranging from 4 to 50% of the total amount of cells.
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Figure 1. Array-CGH results overview of the genomic 
region on chromosome-8, including the EXT1 gene 
area, shows the profile of samples with homozygous 
deletions (L-224, a grade-II secondary peripheral 
chondrosarcoma; and L-1245, a grade-I secondary 
peripheral chondrosarcoma). In both cases, loss of an 
area that exceeded the EXT1 region (indicated by the 
values lower than 0) containing a region with additional 
deletion ranging from ~100 kb (blue arrows) to ~10 kb 
(red arrow) reflecting the homozygous deletion were 
detected. As reference, a sample (L-1480, a grade-I 
secondary peripheral chondrosarcoma) with no 
alteration involving EXT1 was plotted in green.
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Figure 2. Genomic deletions detected by FISH using an EXT1 probe. The illustration (upper panel) is 
showing the exact locations and the assigned colors of the used EXT1 locus (red) and centromere-8 
(green) probes. Samples were counterstained using 4′,6-diamidino-2-phenylindole (DAPI), indicating 
the nucleus of individual cells in blue. (a) The lack of red signals with retained green signals indicates a 
homozygous loss of the EXT1 loci, which characterize the superficial layer of a sporadic osteochondroma 
(L-673). (a′) Cells with retained red signals (wild-type, asterisks) and loss of both copies were observed 
in the hypertrophic layer of a sporadic osteochondroma (L-673), indicating the presence of two 
cell populations. (b, b′) EXT1 wild-type cells and gain of the EXT1 genomic region were detected in 






In three remarkably large lesions (L-76, L-123 and L-739) no significant homozygous losses 
were identified; however, hemizygous loss was detected (Table 1). There was no correlation 
between the size of the lesion and the percentage of cells carrying a homozygous deletion 
(Spearman’s coefficient=0.31). 
Cells with functional EXT in sporadic and hereditary secondary peripheral 
chondrosarcomas
EXT1 and EXT2 genes encode ubiquitously expressed type-II transmembrane 
glycosyltransferases (EXT1 and EXT2) (McCormick et al., 1998), which localize to the 
endoplasmic reticulum and Golgi complex, and are required for the synthesis of heparan 
sulfate chains on proteoglycans (Zak et al., 2002; Bulow and Hobert, 2006). To assess the 
potential function of EXT1, we evaluated the expression of the EXT1 protein, using an EXT1 
antibody, and the production of heparan sulfate, using the 10E4 antibody, in the setting of 
sporadic and multiple lesions. The results are shown in Figures 3 and 4, and Supplementary 
Table 1. In both sporadic and multiple lesions, there were more EXT1- and heparan sulfate-
positive chondrocytes in the hypertrophic layer than in the superficial layer. The control 
growth plate is shown in Supplementary Figure 4. 
 In the setting of sporadic lesions (Figure 3), no significant changes in the number 
of cells staining with EXT1 and 10E4 were seen in the hypertrophic layer when comparing 
osteochondromas to secondary peripheral chondrosarcomas (P=0.70). Significant changes 
were observed in the superficial layer of these tumors; an increasing number of cells staining 
with EXT1 and 10E4 were observed with increasing histological grade (Figure 3). The number 
of cells staining with EXT1 and 10E4 were significantly higher in the superficial layer of 
grade-II secondary peripheral chondrosarcomas when compared with osteochondromas 
and grade I secondary peripheral chondrosarcomas (P=0.035 and P=0.032, respectively). No 
correlation was found between age of the patient and the percentage of EXT1/10E4-positive 
cells (Spearman’s coefficient=0.02 each), nor between size of the cartilage cap and the 
percentage of EXT1/10E4-positive cells (Spearman’s coefficient=0.27 and 0.20, respectively). 
 In the setting of multiple lesions (Figure 4), the number of cells staining with 
EXT1 and 10E4 were significantly higher in secondary peripheral chondrosarcomas when 
compared to osteochondromas (for EXT1 at hypertrophic layer: P=0.006; and at superficial 
layer: P<0.001; and for heparan sulfate at hypertrophic layer: P=0.007; and at hypertrophic 
layer: P=0.008). 
Discussion 
Osteochondromas originate either from the chondrocytes of the growth plate or the cells of 
the perichondrium due to homozygous inactivation of EXT1 or EXT2 (Clément et al., 2008; 
Jones et al., 2010; Matsumoto et al., 2010).
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Figure 3.  Immunohistochemical 
screening of cells with functional 
EXT1 in sporadic osteochondromas 
and peripheral chondrosarcomas. 
In the superficial layer of the 
cartilage cap, there was an increase 
of cells with functional EXT1 
(10E4- and EXT1-positive cells) 
upon neoplastic transformation 
from osteochondromas (a, 
c, respectively) to peripheral 
chondrosarcomas (b, d, 
respectively). In the hypertrophic 
layer, no significant changes were 
observed in the percentage of cells 
stained with EXT1 and 10E4 when 
comparing osteochondromas 
(a′, c′, respectively) to peripheral 
chondrosarcomas (b′, d′, 
respectively). The asterisks 
indicate P<0.05. Sol-OC, 
sporadic osteochondromas; PCS, 
sporadic secondary peripheral 
chondrosarcoma.
Figure 4.  Immunohistochemical 
screening of cells with 
functional EXT1 in multiple 
osteochondromas (a) and 
peripheral chondrosarcomas 
(b) related to patients with 
multiple osteochondromas. In 
the superficial layer and in the 
hypertrophic layer of the cartilage 
cap, there was a significant increase 
of cells with functional EXT1 
(10E4- and EXT1-positive cells) 
upon neoplastic transformation 
from osteochondromas to 
peripheral chondrosarcoma. The 
asterisks indicate P<0.05. MO-OC, 
multiple osteochondromas; MO-
PCS, peripheral chondrosarcoma 
related to patients with multiple 
osteochondroma.
During osteochondromagenesis, wild-type chondrocytes and cells with homozygous 
inactivation of EXT are shown to intermingle in the cartilaginous cap (de Andrea et al., 
2010, 2011; Jones et al., 2010; Matsumoto et al., 2010). We here show that, in human 
osteochondromas, the wild-type chondrocytes showing both EXT1 alleles are predominantly 







As the chance of detecting the second hit in the EXT1 gene depends on the ratio of wild-
type versus mutated cells, our data indicate that the probability to detect a homozygous 
deletion in osteochondromas increases when tumor sampling is more superficial (near 
the perichondrium), which may explain the conflicting data that have been published by 
independent institutions (Hameetman et al., 2007b; Reijnders et al., 2010; Zuntini et al., 
2010).
 The current multistep genetic model for secondary peripheral chondrosarcoma 
formation assumes that osteochondroma cells with homozygous inactivation of EXT1 or EXT2 
acquire one or more additional genetic alterations to progress into malignancy (Bovée et al., 
2000). By analyzing clinically and radiologically well-documented peripheral cartilaginous 
tumors, we demonstrate that homozygous inactivation of the EXT1 locus in sporadic 
secondary peripheral chondrosarcoma (2/17, 12%) is much less frequently detected than 
expected based on the assumption that it originates in a sporadic osteochondroma, in which 
homozygous inactivation of EXT1 is found in ~80% of the cases reported by our institution 
(Hameetman et al., 2007b; Reijnders et al., 2010). EXT tiling array demonstrated that the 
most frequent event in sporadic secondary peripheral chondrosarcomas is hemizygous loss 
of EXT1 (12/17, 70%), followed by no alterations in EXT1 (2/17, 12%) and gain of the EXT1 
region (1/17, 6%). No deletions involving the EXT2 gene were identified. FISH using an EXT1 
probe confirmed the presence of cells with hemizygous loss and, in addition, revealed a wide 
intra-tumoral heterogeneity for the EXT1 gene including homozygous losses, retentions and 
gains.
 Immunohistochemistry against EXT1 and heparan sulfate (10E4) was used to 
evaluate the spatial distribution of cells with functional or dysfunctional EXT1 in sporadic 
osteochondromas and sporadic secondary peripheral chondrosarcomas. The findings were 
further validated in multiple osteochondromas and secondary peripheral chondrosarcomas 
derived from patients with multiple osteochondromas. Cells with dysfunctional EXT1 (that 
is, non-staining with EXT1 and heparan sulfate) are mainly populating the superficial layer of 
sporadic and multiple osteochondromas, which is in line with our previous results showing 
homozygous loss of EXT1 in sporadic and multiple osteochondromas (Hameetman et al., 
2007b; Reijnders et al., 2010). By contrast, cells with functional EXT1 are present in the 
superficial layer (region near the perichondrium) of secondary peripheral chondrosarcomas 
related to sporadic or multiple osteochondromas, which is in line with the absence of 
homozygous deletions in the majority of sporadic peripheral chondrosarcomas. In addition, 
the amount of cells with functional EXT1 increases with increasing tumor grade. We also 
observed that the percentage of EXT1-positive cells is slightly higher than the percentage of 
heparan sulfate-positive cells, which suggests that the cell’s environment may enhance or 
diminish the production of heparan sulfate by modulating the activity of EXT1 in a cell.
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Taken together, whereas cells with homozygous inactivation of EXT1 constitute an 
osteochondroma, cells with wild-type, functional EXT1 compose a fully developed secondary 
peripheral chondrosarcoma (Figure 5). Therefore, it is possible to envision a model where 
secondary peripheral chondrosarcoma cells with functional EXT1 outgrow osteochondroma 
cells with dysfunctional EXT1. This model can be demonstrated in two distinct sets of tumors: 
(i) In lesions with a thin cartilaginous cap thickness, cells that lost both copies of EXT1 and 
cells that retain one or both copies of EXT1 are found (that is, L-868 and L-1245, both ~1 cm). 
In this situation, osteochondroma cells and secondary peripheral chondrosarcoma cells 
may be coexisting. (ii) In remarkably large lesions, cells that lost both copies of EXT1 are 
absent (that is, L-76, 30 cm; L-123, 15 cm and L-739, 11 cm). In this instance, only secondary 
peripheral chondrosarcoma cells that retain one or both copies of EXT1 may be growing. The 
proposed model is reinforced by the fact that cells carrying a homozygous deletion (having 
no copies of the involved genomic region left at all) are not able to regain the lost alleles 
during neoplastic progression.
Figure 5. Secondary peripheral chondrosarcomagenesis. (a) EXT-null cells (green) and EXT wild-
type cells (blue) compose the osteochondroma cap. (b) The EXT-null cells form a niche, a permissive 
microenvironment, which predisposes the EXT wild-type cell within the osteochondroma or 
from the perichondrium to acquire mutation(s) not related to EXTs to give rise to a secondary 
peripheral chondrosarcoma. The chondrosarcoma cells (red) get a proliferative advantage over the 
osteochondroma EXT-null cells. During neoplastic progression, the chondrosarcoma cells may or may 
not lose one copy of the EXT1 gene. (c) Only chondrosarcoma cells, which retained one or both copies 
of the EXT genes, form the fully developed secondary peripheral chondrosarcoma. MO, multiple 
osteochondromas.
In myelodysplasia and secondary leukemia, a ‘niche-based’ model of oncogenesis has been 
described, in which a change in a specific niche/microenvironmental cell can serve as the 
primary moment in a multi-step process toward the malignancy of a supported, but distinct, 
cell type (Raaijmakers et al., 2010; Raaijmakers, 2011). This model of oncogenesis seems to 







The osteochondroma cells with homozygous inactivation of EXT (loss of both copies of EXT) 
create a niche (a permissive microenvironment), which facilitates cells with functional EXT 
(retention of one or both copies of EXTs) located either in the osteochondroma cap or in 
the perichondrium that closely surrounds the lesion to acquire secondary genetic changes. 
Although the secondary peripheral chondrosarcoma-driving mutations are so far unknown, 
they differ from EXT mutations, indicating that EXT-independent mechanisms have a role 
in the pathogenesis of secondary peripheral chondrosarcoma. The need of functional EXT 
and heparan sulfate for cell proliferation is supported by the fact that inactivation of EXT1 in 
multiple myeloma leads to decreased tumor growth (Reijmers et al., 2010) and that EXT-null 
chondrocytes do not grow in vitro (Reijnders et al., 2010). Additionally, cells with functional 
EXT in the mosaic osteochondroma cap are suggested to provide a certain threshold level and 
distribution of heparan sulfate, creating an environment conducive to cells with homozygous 
inactivation of EXT to proliferate and form a tumor (de Andrea et al., 2010, 2011; Jones et al., 
2010; Matsumoto et al., 2010).
 Osteochondromas and secondary peripheral chondrosarcomas composed by 
distinct cell types is strengthened by some of our previous results. First, the mRNA expression 
level of EXT1 in osteochondromas is not completely absent, which suggests the presence of 
cells with functional EXT1 in the tumor. Second, although not significant, the mRNA level of 
EXT1 seems to increase from low- to high-grade in secondary peripheral chondrosarcomas 
(Hameetman et al., 2007a). We have also shown that signaling pathways dependent on 
heparan sulfate, such as fibroblast growth factor and parathyroid hormone-related protein, 
are inactive in osteochondromas and active in secondary peripheral chondrosarcomas. The 
heparan sulfate with normal chain length synthesized by the overgrown EXT1 wild-type cells 
might be related to the activation of fibroblast growth factor and parathyroid hormone-
related protein in secondary peripheral chondrosarcoma.
Although we show that the vast majority of sporadic secondary peripheral chondrosarcomas 
do not have homozygous deletions involving EXT1 or EXT2, the few reported cases with 
homozygous deletions of EXT1 or EXT2 (2/17 in the present series) suggest that malignant 
transformation of osteochondroma cells with homozygous inactivation of EXT1 or EXT2 is 
a rare event. Usually, these are small deletions of EXT1 (that is, case L-224) unable to be 
detected by FISH.
 While our data clarify the pathogenesis of secondary peripheral chondrosarcoma, 
a number of questions remain. For instance, which is the causative gene for peripheral 
chondrosarcoma formation? What factors make chondrocytes with functional EXT1 and 
EXT2 within/surrounding an osteochondroma more prone to acquire mutations that lead to 
malignancy?
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In summary, our study shows that (i) an osteochondroma is a niche that facilitates the 
EXT1 wild-type cells to acquire other mutations, distinct from mutations involving the 
EXT genes, for secondary peripheral chondrosarcoma formation; (ii) secondary peripheral 
chondrosarcoma is not per se originating from cells of osteochondroma with homozygous 
inactivation of EXT1, but arises predominantly and maybe even exclusively from cells with 
functional EXT1 (Figure 5). 
Materials and methods 
Patient data and tumor samples
Based on clinical information and radiological studies, 17 sporadic secondary peripheral 
chondrosarcomas, in which paraffin-embedded and frozen material were available, were 
retrieved from the Department of Pathology at Leiden University Medical Center collected 
between 1991 and 2008. In addition, paraffin-embedded material from sporadic (n=10) 
and multiple (n=10) osteochondromas, and secondary peripheral chondrosarcomas related 
to patients with multiple osteochondromas (n=5), were selected for comparison in the 
different used techniques. For controls, epiphyseal growth plate (n=2) and articular cartilage 
(n=2) were obtained from orthopedic resections for pathological conditions not related to 
osteochondroma or chondrosarcoma. Chondrosarcoma histological grading was evaluated 
according to the Evans classification (Evans et al., 1977). Imaging studies (radiography, 
computed tomographic scans and magnetic resonance imaging scans) were reviewed in all 
17 sporadic secondary peripheral chondrosarcomas and in five sporadic osteochondromas. 
The cartilaginous cap thickness was measured in accordance with Bernard et al. (2010). All 
samples were handled in a coded manner and all procedures were performed according to 
the ethical guidelines in Code for Proper Secondary Use of Human Tissue in The Netherlands 
(Dutch Federation of Medical Scientific Societies). 
DNA isolation
Per sample about 60 frozen tumor sections (16-μm thick) were cut. DNA was isolated by 
using the Wizard Genomic DNA Purification kit (Promega, Madison, WI, USA) according to the 
manufacturer’s manual. DNA concentration and purity were measured for each sample by 
using a NanoDrop spectrophotometer (Isogen, De Meern, the Netherlands) and a Bioanalyzer 
(Agilent, Santa Clara, CA, USA), respectively, according to the manufacturer’s protocol. The 
percentage of tumor cells within each sample was determined on hematoxylin and eosin-
stained sections and occasionally normal/reactive tissue was removed by macrodissection 
to achieve at least 90% of tumor tissue.
Mutation screening







EXT1 and EXT2. The mutation status from 12 cases has been reported previously (Hameetman 
et al., 2007a). Mutation screening of EXT1 or EXT2 genes was performed and analyzed as 
described earlier (Hameetman et al., 2007a; Reijnders et al., 2010).
EXT tiling array
Seventeen sporadic peripheral chondrosarcomas, well-known for not showing point 
mutations in the EXT genes (Bovée et al., 1999; Hallor et al., 2009; Zuntini et al., 2010), 
were collected to study DNA copy-number alterations by using a custom-made Agilent 
oligonucleotide-based microarray containing 44 000 probes with a tiling coverage of EXT1/2 
genes and additional 68 genes involved in heparan and chondroitin sulfate biosynthesis as 
described by Szuhai et al. (2011). Only alterations of EXT genes were investigated. EXT tiling 
array in sporadic osteochondromas has been described previously by our group in a series 
of 11 tumors (Hameetman et al., 2007b; Reijnders et al., 2010). Labeling and hybridization 
of genomic DNA from freshly frozen tumor, as well as data processing, were performed as 
described earlier (Reijnders et al., 2010; Szuhai et al., 2011).
Fluorescent in situ hybridization
Interphase FISH on 16-μm-thick paraffin sections was performed in all 17 sporadic secondary 
peripheral chondrosarcomas, as described previously (Szuhai et al., 2009). The five sporadic 
osteochondromas used for comparison were reported previously to show homozygous 
deletion of EXT1 (Hameetman et al., 2007b). Two sets of FISH probes were applied: Set 1 
with the RP11-728K22 bacterial artificial chromosome clones covering the EXT1 genomic 
region and Set-2 with the probe for the centromere of chromosome-8. RP11-728K22 was 
selected by using the UCSC Genome Browser (NCBI 36.1/hg18) (http://genome.ucsc.edu) 
(Figure 2). Copy-number and image analysis were performed as described by Mohseny et 
al. (2010) and Pansuriya et al. (2011). At least 100 cells were scored per case (more than 
200 for most of the cases) counting the centromere-8 probe and the EXT1 probe. Cells with 
more than two centromere-8 probes were considered aneuploid; loss of one copy of EXT1 
probe was considered as a hemizygous gene loss and loss of all copies of the EXT1 probe 
was considered as a homozygous deletion of the gene. Gain was defined as the presence 
of at least three copies of the EXT1 probe in diploid cells. To determine the cut-off values 
indicating true loss of the genomic region, the percentage of gene loss was determined in 
two epiphyseal growth plates and two articular cartilages. From the four cases the mean 
(7% for hemizygous loss and 2% for homozygous loss) and the s.d. of false positive losses 
(2% for hemizygous loss and 1% for homozygous loss) were calculated. The mean plus three 
times the s.d. (15% for hemizygous loss and 6% for homozygous loss) was used as cut-off for 
evident loss of the gene (Table 1) (Ventura et al., 2006; Mohseny et al., 2010).
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Immunohistochemistry
Immunohistochemistry was performed in all 17 sporadic secondary peripheral 
chondrosarcomas, as described previously (Pansuriya et al., 2011). For comparison, 10 
sporadic osteochondromas were used and, for validation, 10 osteochondromas and five 
secondary peripheral chondrosarcomas both related to multiple osteochondromas were 
investigated. For EXT1, antigens were retrieved by using microwave heating with EDTA 
buffer for 10 min and blocked in 5% non-fat milk in phosphate-buffered saline for 30 min 
and incubated overnight at 4 °C with anti-EXT1 (1:400; Aviva System Biology, San Diego, CA, 
USA). For 10E4 (1:400; US Biological, Marblehead, MA, USA), the protocol was described 
earlier (Reijnders et al., 2010). Positive controls were growth plate and placenta for the 
EXT1 antibody, and growth plate and skin for the 10E4 antibody. Each tumor section was 
divided into two regions: hypertrophic layer—next to the bone of origin, morphologically 
constituted by medium/large and round cells; and superficial layer—near the perichondrium, 
constituted by spherical/flattened cells either irregularly arranged or forming clusters. Two 
pathologists estimated the percentage of positive cells independently (CEA and JVMGB). 
Results are expressed as the means with a measure of variability (s.d.). Statistical significance 
was calculated by one-way analysis of variance with Bonferroni’s multiple comparison tests 
by using the SPSS 16.0 software package (IBM, Somers, NY, USA). P values <0.05 were 
considered significant. 
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EXT wild-type cells outgrowing EXT-null cells
Supplementary Figure 1. (A – A4) Sporadic 
osteochondroma of the proximal humerus in a 
12-year-old boy showing a regular lesion, with 
endochondral ossification, and marrow continuity 
with the underlying bone. The thickness of the 
cartilaginous cap is acceptable of the age of the 
patient and skeletal immaturity. (B – B3) Grade I 
peripheral chondrosarcoma of the proximal femur 
in a 21-year-old man showing a regular lesion with 
well-circumscribed lobular surfaces, with irregular 
mineralization, and continuity of the cortex with the 
parent bone. The thickness of the cartilaginous cap is 
too pronounced for the age of the patient and skeletal 
maturity. (C – C2) Grade II peripheral chondrosarcoma 
of the distal femur in a 60-year-old man showing a 
lesion with irregular surfaces composed by myxoid 
and cartilaginous nodules. Extensive invasion of the 
soft tissue can also be seen. On the coronal image, the 
stalk with continuity of the underlying marrow can be 
appreciated.
Supplementary Figure 2. Sporadic 
osteochondroma of the proximal humerus in a 
18-year-old boy. (A, B) History of tumor growth 
on an almost mature skeleton, in which the 
growth plates (arrowhead) were nearly closed. 
(C) The histology shows no conclusive criteria 








Supplementary Figure 3. Overview of a scanned FISH slide of a sporadic osteochondroma (L-1649) 
shows that cells with homozygous loss of the EXT1 loci (red tag) are located in the superficial layer 
of the tumor. On the contrary, cells that retained both copies of EXT1 (wild-type) are predominantly 
found in the hypertrophic layer of the tumor, near to the bone of origin.
Supplementary Figure 4. EXT1 (A) and 10E4 
(heparan sulfate; B) immunostaining in the human 
epiphyseal growth plate. The percentage of EXT1-
positive cells is slightly higher than the percentage 
of 10E4-positive cells.
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Interobserver Reliability in the Histopathological 
Diagnosis of Cartilaginous Tumors in 
Patients with Multiple Osteochondromas
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Esther Hauben; Edward F. McCarthy; Miguel Idoate; Nicholas A. Athanasou; 
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The distinction between benign and malignant cartilaginous tumors located peripherally 
in the bone may be a challenging task in surgical pathology. The aim of this study was to 
investigate inter-observer reliability in histological diagnosis of cartilaginous tumors in the 
setting of multiple osteochondromas and to evaluate possible histological parameters that 
could differentiate among osteochondroma, low- and high-grade secondary peripheral 
chondrosarcoma. Interobserver reliability was assessed by 12 specialized bone-tumor 
pathologists in a set of 38 cases. Substantial agreement on diagnosis among all the reviewers 
was observed (intraclass correlation coefficient = 0.78). Our study confirmed that mitotic 
figures and nuclear pleomorphism are hallmarks of high-grade secondary peripheral 
chondrosarcoma. However, despite the substantial agreement, we demonstrated that 
histology alone cannot distinguish osteochondroma from low-grade secondary peripheral 
chondrosarcoma in the setting of multiple osteochondromas, since nodularity, the presence 
of binucleated cells, irregular calcification, cystic/mucoid changes and necrosis were not 
helpful to indicate malignant transformation of an osteochondroma. On the other hand, 
among the concordant cases, the cartilage cap in osteochondroma was significantly less thick 
than in low- and high-grade secondary peripheral chondrosarcoma. Therefore, our study 
showed that a multidisciplinary approach integrating clinical and radiographical features and 
the size of the cartilaginous cap in combination with a histological assessment are crucial to 
the diagnosis of cartilaginous tumors. 
Keywords: osteochondroma, chondrosarcoma, diagnostic criteria, peripheral cartilage 
tumors, bone tumors.
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Introduction
Multiple osteochondromas, alternatively called multiple hereditary exostoses, is an 
autosomal dominant disorder with a prevalence estimated at 1 in 50,000 [1], and is caused 
by mutations in EXT1 at 8q24 or EXT2 at 11p11-13 [2]. Multiple osteochondromas develops 
during skeletal growth and is characterized by shortened long bones and formation of 
multiple cartilage-capped bony projections from the metaphyses of endochondral bones 
adjacent to the growth plate [3]. Osteochondroma can eventually transform into a secondary 
peripheral chondrosarcoma in 1–3% of patients with multiple osteochondromas [2]. 
 Secondary peripheral chondrosarcomas are malignant cartilage-producing tumors 
and comprise about 15% of all conventional chondrosarcomas in tertiary referral centers [4]. 
Patients with secondary peripheral chondrosarcomas show a diverse clinical course, ranging 
from slow insidious tumor growth to rapid neoplastic progression, especially when located 
in pelvis, shoulder and hip [5]. Secondary peripheral chondrosarcomas are often low-grade 
malignant tumors, i.e. grade I chondrosarcomas according to the Evans grading system [6], 
and are treated by limb salvage surgery with a wide or even with a marginal resection [7]. 
 The lack of consistent and reproducible criteria to determine neoplastic 
transformation in multiple osteochondromas often raises diagnostic dilemmas in 
differentiating osteochondroma from low-grade secondary peripheral chondrosarcoma. 
Malignant potential of an osteochondroma is often estimated by the thickness of its cartilage 
cap and the evidence of tumor growth in a skeletally mature patient [8]. Cap thickness 
greater than 2 cm in patients with fused growth plates should be considered suspicious for 
progression of an osteochondroma to a chondrosarcoma [9]. Moreover, cap thickness greater 
than 2 cm strongly indicates secondary peripheral chondrosarcoma [10,11]. Additionally, a 
wide range of histological parameters is described to determine malignant transformation 
of an osteochondroma, ranging from the formation of nodules to the presence of mitotic 
figures and cystic cavities [12]. For a general pathologist, the application of these criteria 
is often difficult, which gives room for a subjective interpretation. Therefore, identifying 
stringent and reproducible histological criteria may help the interpretation of peripheral 
cartilaginous tumors by general pathologists.
 As no “gold-standard” exists to directly assess tumor grade, prediction of 
peripheral cartilaginous tumor behavior cannot be ensured. Consequently, an initial step 
in the process of defining histological parameters for guiding the diagnosis of peripheral 
cartilaginous tumors in the setting of multiple osteochondromas is to assess diagnostic 
reliability, as measured by intraclass correlation coefficient [13]. A second step is to identify 
common histological criteria among the concordant cases, aiming to have histological 
parameters that characterize each tumor type. This study evaluated diagnostic concordance 
among a panel of experienced bone-tumor pathologists. Histological parameters noted 







the concordant cases, aiming to have histological parameters that characterize each tumor 
type. This study evaluated diagnostic concordance among a panel of experienced bone-
tumor pathologists. Histological parameters noted to be of diagnostic value in the literature 
were then systematically evaluated among the concordant cases to give best guidance on 
diagnosing peripheral cartilaginous tumors in the setting of multiple osteochondromas.
Materials and Methods
Cases Studied
Patients with multiple osteochondromas admitted to Leiden University Medical 
Center between 1985 and 2009 with either osteochondroma or secondary peripheral 
chondrosarcoma were retrieved from our database. Cases with neither radiologic 
documentation nor clinical information were excluded as well as cases with local recurrences 
and not enough material for histological examination. All the original diagnoses were made 
at the Leiden University Medical Center. In addition, twenty cases were further confirmed 
in multidisciplinary discussions organized by the Netherlands Committee on Bone Tumors, 
a national multidisciplinary committee for consultation on diagnosis and treatment of 
musculoskeletal tumors and tumor-like lesions.
 Medical records were studied to identify patient age, gender and tumor location. 
Imaging studies, including plain radiographs, magnetic resonance images and/or computed 
tomography scans, were available in 29 cases. The cartilage cap thickness was measured 
by a bone-tumor radiologist (H.M.K.) in accordance with Bernard et al [11]. Briefly, the cap 
thickness was assessed by measuring thickest portions of the cartilage cap perpendicular 
to the boundary between the medullary space of the osteochondroma stalk. For each case, 
at the minimum one complete section through the whole lesion including the maximal 
diameter of the cartilaginous cap was submitted for histology. Representative histological 
sections were subsequently selected for each case and were randomly labeled from 1 to 
38. All the unique identifiers were removed to protect patient anonymity. The study was 
performed according to the ethical guidelines in Code for Proper Secondary Use of Human 
Tissue in the Netherlands (Dutch Federation of Medical Scientific Societies). 
Interobserver Variability
Case series reviewers were 12 pathologists (C.E.A.; S.R.; A.E.R.; B.R.D.; B.L.A.; C.Y.I.; E.H.; 
E.F.M.; M.A.I.G.; N.A.A.; P.C.W.H. and J.V.M.G.B.) selected for their expertise in bone-tumor 
pathology. The case series consisted of (i) an Excel file with clinical information, in which 
the diagnosis, tumor grade and any possible remarks were asked to be filled in, (ii) digitized 
imaging studies, and (iii) glass slide from each case. Many pathologists classified malignant 
secondary peripheral cartilaginous lesions into grade-I, II or III. Many pathologists classified 
malignant secondary peripheral cartilaginous lesions into grade-I, II or III.
133
Osteochondroma and secondary chondrosarcoma
Few reviewers used grades of low-grade malignant or high-grade malignant. To have a 
common classification, grade- I tumors were considered low-grade malignant and grade- II 
and III were considered high-grade.
Table 1. Histological parameters scored among the concordant cases.
NA, not evaluable; *, statistically significant (adjusted Chi-Square test).
Histopathology 
The most common criteria noted to be of diagnostic value in the literature to distinguish 
osteochondroma, low-grade secondary peripheral chondrosarcoma, high-grade secondary 
peripheral chondrosarcoma, and dedifferentiated chondrosarcoma were evaluated among 
the concordant cases by 3 pathologists (C.E.A, J.V.M.G.B., and P.C.W.H.). Concordant cases 
were defined as agreement among the 12 pathologists greater than 75%. The list of 
histological parameters included: cellularity (high- or low cellular), the presence/absence of 







permeation of trabecular bone, cystic/mucoid changes, necrosis, and mitotic figures [3,12]. 
Histological parameters were defined as follows:
 - Cellularity: High cellularity was defined as a cell-rich lesion with closely packed 
cells with scant extracellular matrix in between. Low cellularity was defined as a matrix-rich 
lesion in which cells were more distant from each other.
 - Binucleated cells were defined as having two nuclei of a normal size sharing the 
same cytoplasm.
 - Nuclear pleomorphism was defined as variation in nuclear size (3 times normal 
size) and shape.
 - Irregular calcification was interpreted as coarse and irregular areas of calcification 
(Figure 1d).
 - Nodularity was defined by the presence of nodule(s) connected with the main 
lesion and separated from each other by cellular fibrous septa (Figure 1a).
 - Permeation of trabecular bone was defined by tumor filling up the trabecular 
marrow space entrapping pre-existing lamellar bone trabeculae [14].
 - Cystic/mucoid changes were defined as areas or cystic spaces containing mucoid 
material (Figure 1b).
 - Necrosis was identified by the presence of necrotic chondrocytes appearing as 
nuclei loosing hematoxylin staining (Figure 1c). 
 - Presence of mitotic figures was recorded whenever any mitotic figures were seen 
in any field at any rate.
Statistical Analysis
Intraclass correlation coefficients were calculated in a two-way random effects model to 
determine interobserver reliability among the 12 pathologists using the SPSS 16.0 software 
package (IBM, Somers, NY, USA). Intraclass correlations are equivalent to weighted κ 
coefficients with quadratic weights [13]. Intraclass correlation coefficients were calculated 
for the agreement on the diagnosis of osteochondroma, low-grade secondary peripheral 
chondrosarcoma, high-grade secondary peripheral chondrosarcoma and dedifferentiated 
chondrosarcoma. Interpretation of intraclass correlation coefficients was performed 
according to Landis and Koch [15]. A κ value below 0.20 is considered poor, 0.21 - 0.40 fair, 
0.41 - 0.60 moderate, 0.61 - 0.80 substantial, and 0.81 - 1.00 very good.15 One-way ANOVA 
was used to evaluate statistical differences of the cartilage cap thickness among the cases. 
Additionally, adjusted Chi-Square test was used to determine whether there are significant 
differences between the histological criteria in each tumor type. 
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Results
Thirty-eight tumors from 29 patients were included in the study. Clinical information and 
thickness of the cartilage cap of the 38 cases are summarized in Figure 2. None of the studied 
patients showed adverse outcome (metastases or death of disease) up to the study period 
(range 24–312 months, mean 148.8). Two patients had local recurrence.
Interobserver variability in diagnosis
The intraclass correlation coefficient for interobserver reliability was 0.78 (95% confidence 
interval: 0.694 to 0.859), which indicated substantial agreement. High diagnostic 
concordance (agreement ≥ 75% by all the reviewers) was observed in 31 cases (Figure 2). 
Among these concordant cases, 25 cases were diagnosed as osteochondroma, 3 cases as low-
grade secondary peripheral chondrosarcoma, 2 cases as high-grade secondary peripheral 
chondrosarcoma, and 1 case as dedifferentiated chondrosarcoma. Diagnostic concordance 
was not reached in 7 cases (agreement < 75% by all the reviewers) (Figure 2). All the non-
concordant cases were diagnosed by the Netherlands Committee on Bone Tumors as being 
low-grade secondary peripheral chondrosarcoma. Additionally, cases number 6 and 10 were 
described by the Netherlands Committee on Bone Tumors as progressing to high-grade 
lesions. Case 6 had a cartilage cap thickness of 6 cm and neither mitotic figures nor nuclear 
pleomorphism were found. Case 10 had a cartilage cap thickness of 10 cm and only nuclear 
pleomorphism was identified. These two cases had a local recurrence after surgery. One 
lesion (case 9) had a large spindle cell component, which was interpreted as dedifferentiated 
chondrosarcoma by 10/12 pathologists. 
Diagnostic value of histological parameters
All concordant cases were systematically evaluated by 3 bone-tumor pathologists (C.E.A, 
J.V.M.G.B., and P.C.W.H.) and data are shown in table 1. Interestingly, among osteochondromas, 
binucleated cells, irregular calcification and necrosis were observed in 72% of the cases (Figure 
1a-d). Additionally, nodularity and cystic/mucoid changes were identified in 56% and 76% 
of the osteochondroma cases, respectively (Figure 1a,b). All these histological parameters 
were also seen in low- and high-grade secondary peripheral chondrosarcomas (Figure 3a-f). 
Characteristically, mitotic figures at any rate and nuclear pleomorphism were only observed 
in high-grade secondary peripheral chondrosarcoma. Singly or collectively, no significant 
differences were observed between the histological criteria in each tumor type (Table 1). 
Only the presence of mitotic figures and nuclear pleomorphism in high-grade secondary 
peripheral chondrosarcoma were significant different compared to osteochondroma and 
low-grade secondary peripheral chondrosarcoma (P < 0.001). Permeation of trabecular bone 





Diagnostic value of cartilage cap thickness 
The average of cartilage cap thickness was 0.82 cm (ranged from 0.1 to 2 cm) in 
osteochondromas, 3.83 cm (ranged from 2.5 to 5 cm) in low-grade secondary peripheral 
chondrosarcomas and 5.50 cm (ranged from 2 to 9 cm) in high-grade secondary peripheral 
chondrosarcomas. With regard to cartilage cap thickness among the concordant cases, a 
statistically significant difference was found in osteochondroma compared to low- and high-
grade secondary peripheral chondrosarcoma (P = 0.001). In addition, among the concordant 
cases, no significant difference was seen between low- and high-grade secondary peripheral 
chondrosarcoma (P = 0.272). Among the non-concordant cases (Figure 2), the average of 
cartilage cap thickness varied from 1 to 10 cm.  
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Figure 1. (a-c) Histological features often observed in lesions interpreted as osteochondromas. (a) 
Nodularity: a nodule is connected with the main lesion (a1) and separated from the main lesion by 
fibrous septa (a2). (b) Cystic changes (areas of cystic spaces containing mucoid material) are irregularly 
distributed in the osteochondroma cartilage cap. (c) Necrosis: necrotic chondrocytes appeared 
as swollen nuclei that lost haematoxylin staining. (d) Irregular calcification: coarse and irregular 
calcification is often seen.
Discussion
Analysis of a series of peripheral cartilaginous tumors in the setting of multiple 
osteochondromas by 12 experienced bone-tumor pathologists showed that there 
was a substantial agreement on diagnosis among all the reviewers. We here confirm 
that mitotic figures and nuclear pleomorphism are hallmarks of high-grade secondary 
peripheral. We here confirm that mitotic figures and nuclear pleomorphism are 
hallmarks of high-grade secondary peripheral chondrosarcoma, and that a malignant 
spindle cell component indicates dedifferentiated peripheral chondrosarcoma.
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We previously assessed interobserver variability in central cartilaginous lesions [16,17]. 
Similar intraclass correlation coefficient was found for diagnosing central and peripheral 
lesions (in both 0.78) [17]. For central lesions, we were able to identify 5 parameters (high 
cellularity, presence of host bone entrapment, open chromatin, mucoid matrix quality, 
and age above 45 years) that could optimally differentiate between enchondroma and 
low-grade central chondrosarcoma, of which mucoid/myxoid matrix degenerative changes 
and host bone entrapment were the most important [17]. The present study however 
demonstrates that these criteria cannot be applied for cartilaginous tumors in the setting 
of multiple osteochondromas.  In addition, we show that histology alone cannot distinguish 
osteochondroma from low-grade secondary peripheral chondrosarcoma since nodularity, 
the presence of binucleated cells, irregular calcification, cystic/mucoid changes and necrosis 
were not helpful to indicate malignant transformation of an osteochondroma.
 Instead, our results emphasize that the evaluation of the size of the cartilage cap at 
radiology and gross pathology is crucial. Among the concordant cases, osteochondromas had 
a significantly thinner cartilage cap compared to secondary peripheral chondrosarcomas. 
This reinforces the general consensus of distinguishing osteochondroma from low-grade 
secondary peripheral chondrosarcoma by cartilage cap thickness [11]. A standardized 
measuring technique with computed tomography and magnetic resonance imaging has 
been described to assess the cartilage cap thickness [11]. 
 Histologically, nodularity was observed in about half of osteochondromas. Nodules 
in osteochondromas have previously been considered a feature of malignant transformation 
[12,18]. Interestingly, cases 21, 27, and 28 showed disagreement on distinguishing benign 
from low-grade malignant. Although the thickness of the cartilage cap in these three cases 
is not increased (1 cm, 1.5 cm, and 0.5 cm, respectively), they display histological and 
radiological features of nodularity. The presence of nodularity in these tumors possibly led 
some pathologists to interpret this as suspicious for low-grade sarcoma. On the other hand, 
the thin cartilage cap of case 28 has probably influenced the decision of most pathologists 
to sign it out as a benign lesion. Although treatment planning was beyond the scope of this 
study, the presence of nodularity on imaging may have been interpreted as a sign suspicious 
of malignant transformation leading to subsequent resection. In the magnetic resonance 
imaging scan, nodules are often associated with vascularized septa with high intensity signal 
and are found in low grade chondrosarcomas and in active cartilaginous lesions [17]. 
 Considering that Leiden University Medical Center is a tertiary hospital for treatment 
of bone tumors in the Netherlands, we cannot exclude that our series is slightly biased 
towards lesions that are more prone to malignant transformation. The major limitation 
of our study is the lack of “gold-standard” to distinguish osteochondroma from low-grade 
secondary peripheral chondrosarcoma, which has hampered the case selection. Low-







peripheral chondrosarcomas are extremely rare. A selection of a set of cases with an equal 
ratio of benign, low- and high-grade tumors was therefore not feasible. Despite their rarity 
we showed that high-grade secondary peripheral chondrosarcomas were distinguished 
from the low-grade lesions by the presence of mitotic figures at any rate and nuclear 
pleomorphism, which is in line with previous literature [12,18].
 Histologically, osteochondroma and low-grade secondary peripheral 
chondrosarcoma in the setting of multiple osteochondromas were not distinguished by 
the presence of binucleated cells, irregular calcification, cystic/mucoid changes, and focal 
necrosis. It has been described that osteochondromas occasionally have binucleated cells 
[3]. Radiographically, areas of calcification in osteochondromas become disorganized and 
irregular, as the patient grows older [10]. Cystic/mucoid changes are related to degenerative 
processes, such as mucinous degeneration. Similar degenerative processes have been 
described in osteoarthritis [18]. Necrosis most likely is secondary to ischemia, as the cartilage 
cap is not vascularized and often traumatized [21].
 Sporadic peripheral cartilaginous tumors are histologically indistinguishable from 
peripheral cartilaginous tumors occurring in the setting of multiple osteochondromas [20]. 
It is therefore most likely that we can extrapolate our findings indicating that histology alone 
is unable to confidently differentiate sporadic osteochondroma from low-grade sporadic 
secondary peripheral chondrosarcoma as well. 
 Thus, our data indicate that a multi-disciplinary team, including pathologists, 
radiologists, and orthopedic surgeons, is critical to establish a final diagnosis in sporadic and 
multiple peripheral cartilaginous tumors. Suspicious signs for malignancy in osteochondromas 
include: tumor growth after pubertal growth spurt and pain. Osteochondromas located in 
the pelvis, hips, and shoulders more often undergo malignant transformation [18]. 
  On plain radiographs, malignant progression of osteochondroma is suggested 
when osteolysis or change of chondroid calcification is observed [10]. In addition, 
computed tomography scan might reveal new osteolytic areas and a change in the nature 
of calcifications in the periphery of osteochondromas [21]. Moreover, soft-tissue swelling 
containing calcification is very suggestive of the development of a secondary peripheral 
chondrosarcoma on plain radiographs and computed tomography. 
 The cartilage cap of peripheral cartilaginous tumors is best evaluated by magnetic 
resonance imaging with T2-weighted images using fat-selective pre-saturation, which allows 
standardized measurements of the cap. A cartilage cap thickness greater than 2 cm in a 
skeletally mature patient is suspicious for neoplastic transformation of osteochondroma 
[11]. Additionally, magnetic resonance imaging is used to delineate the extent of soft-tissue 
extension and its relation to the surrounding structures, specifically the neurovascular bundle 
[10]. Contrast-enhanced magnetic resonance imaging sequences are used to differentiate a 
thickened cartilage cap from an overlying bursa.
139
Figure 2. Chart displaying the raw data from pathologists and clinical details of the 38 cases to study 
interobserver reliability. Concordant cases show agreement among the 12 pathologists greater than 
75% (dashed line).  Asterisk indicates cases with local recurrence.
Figure 3. (a-f) Lesion interpreted 
as low-grade secondary peripheral 
chondrosarcoma by the majority of the 
study pathologists (Case 31). (a) Antero-
posterior conventional radiograph of the 
proximal femur. Ossifying and calcifying 
mass in close relation to the surface of 
the femur. Arrow indicates the stalk of 
the original osteochondroma. (b) Coronal 
T1-weighted magnetic resonance imaging 
after intravenous administration of 
contrast. Large soft-tissue mass anterior 
and lateral to the femur with a serpentine 
pattern of enhancement characteristic 
of a chondromatous tumor, in this case 
the soft-tissue extension of a secondary 
chondrosarcoma arising from an 
osteochondroma. (c) Axial T1-weighted, 
magnetic resonance imaging after 
intravenous administration of contrast 
shows a secondary chondrosarcoma 
arising from an osteochondroma. The 
stalk of the original osteochondroma 
arises from the latero-posterior surface 
the proximal femur. Large soft-tissue mass 
lateral and anterior of the femur with 
a serpentine pattern of enhancement 
characteristic of a chondromatous tumor. 
(d) Large lobules of cartilage contained 
closely arranged cells in lacunae define 
the lesion. (e,f) Cystic changes are often 
observed, and no nuclear pleomorphism 
or mitotic figures are seen.







Whole-body bone scintigraphy in adult patients with multiple osteochondromas shows that 
lesions with increased uptake of the tracer may indicate malignant transformation [22].
 In summary, review of 38 cases of peripheral cartilaginous tumors by 12 experienced 
bone-tumor pathologists showed general agreement in the diagnosis of these tumors in 
the setting of multiple osteochondromas. Histological parameters generally associated with 
malignant transformation could not reliably distinguish osteochondroma from low-grade 
secondary peripheral chondrosarcoma. Instead, a multidisciplinary approach integrating 
clinical and radiographical features and the size of the cartilaginous cap in combination with 
a histological assessment are crucial to the diagnosis of peripheral cartilaginous tumors.
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Chapter 9
Peripheral chondrosarcoma progression 
is associated with increased 
type X collagen and vascularisation
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Endochondral bone formation requires a cartilage template, known as the growth plate, 
and vascular invasion, bringing osteoblasts and osteoclasts. Endochondral chondrocytes 
undergo sequences of cell division, matrix secretion, cell hypertrophy, apoptosis, and 
matrix calcification/mineralisation. In this study, two critical steps of endochondral bone 
formation, the deposition of collagen X-rich matrix and blood vessel attraction/invasion, 
were investigated by immunohistochemistry. Fourteen multiple osteochondromas and six 
secondary peripheral chondrosarcomas occurring in patients with multiple osteochondromas 
were studied and compared to epiphyseal growth plate samples. Mutation analysis showed 
all studied patients (expect one) to harbour a germ-line mutations in either EXT1 or EXT2. 
Here, we described that homozygous mutations in EXT1/EXT2, which are causative for 
osteochondroma formation, are likely to affect terminal chondrocyte differentiation and 
vascularisation in the osteocartilaginous interface. Contrastingly, terminal chondrocyte 
differentiation and vascularisation seem to be unaffected in secondary peripheral 
chondrosarcoma. In addition, osteochondromas with high vascular density displayed a higher 
proliferation rate. A similar apoptotic rate was observed in osteochondromas and secondary 
peripheral chondrosarcomas. Recently, it has been shown that cells with functional EXT1 and 
EXT2 are outnumbering EXT1/EXT2 mutated cells in secondary peripheral chondrosarcomas. 
This might explain the increased type X collagen production and blood vessel attraction in 
these malignant tumours.





Elongation of long bones is a complex process that requires a cartilage template, known as 
the epiphyseal growth plate, and a strict coordination and synchronisation of cell–cell and 
cell–matrix signalling events [1]. The key events in this process can be divided into two major 
sequential morphogenesis phases. The first phase is characterised by the proliferation of the 
growth plate chondrocytes, which maintains the pool of cells needed for bone lengthening. 
The second phase is a multistep process characterised by the hypertrophy of proliferating 
chondrocytes and bone formation. Hypertrophic chondrocytes increase their volume and 
secrete a specialised extracellular matrix rich in type X collagen [2]. The ossifying collagen 
X-rich matrix attracts blood vessels and bone precursor cells, allowing bone development 
[3].
 The process of endochondral ossification is also observed in cartilaginous 
tumours [4]. An active endochondral ossification takes place deep to the cartilage cap of 
osteochondroma and secondary peripheral chondrosarcoma [5].
 Osteochondromas are the most common benign bone tumours at childhood 
and adolescence [6]. They can occur either as a sporadic lesion or multiple tumours in 
hereditary multiple osteochondromas syndrome (previously known as hereditary multiple 
exostoses) [7]. Osteochondromas are caused by mutations in either EXT1 or EXT2 genes [7]. 
They are pedunculated or sessile cartilage-capped bony projections from the metaphyses 
of endochondral bones adjacent to the growth plate [5]. In less than 1% of patients with 
sporadic osteochondromas and 1–3% of patients with multiple osteochondromas at the age 
of 30–60 years, an osteochondroma may eventually transform into a secondary peripheral 
chondrosarcoma [8].
 Whereas osteochondromas have been linked to homozygous mutations in EXT1 or 
EXT2 genes, cells with functional EXT1 and EXT2 have been shown to be the predominant 
subclone in secondary peripheral chondrosarcomas [9].
 Mutations in EXT1 have been demonstrated to impair angiogenesis in mice [10] 
and to affect endochondral bone formation by reducing type X collagen deposition [11]. 
Endochondral bone formation has been shown to be affected in the homozygous dak/ext2 
zebrafish mutant [12].
 EXT1 and EXT2 genes encode enzymes that catalyse the biosynthesis of heparan 
sulphate. Heparan sulphate is a key component of the extracellular matrix acting as co-
receptors for signalling molecules, including vascular endothelial growth factors (VEGF), 
fibroblast growth factors (FGF), and others [13, 14]. The impact of mutations in EXT1 or EXT2 
genes with regards to production of a collagen X-rich matrix and attraction of blood vessels 








Here, we describe that terminal chondrocyte differentiation and vascularisation are affected 
in osteochondromas. Contrastingly, these two critical steps of endochondral bone formation 
seem to be unaffected in secondary peripheral chondrosarcomas. 
Materials and methods
Patient material
Paraffin-embedded tissues from 14 osteochondromas and 6 low-grade secondary peripheral 
chondrosarcomas from patients with multiple osteochondromas, collected between 1991 
and 2008, were retrieved from the files of the Leiden University Medical Centre (Table 1). 
One patient had two tumours from distinct location included in this study. For comparison, 
paraffin-embedded epiphyseal growth plates (n = 3) were obtained from orthopaedic 
resections for pathological conditions not related to osteochondroma or chondrosarcoma. 
Clinical information and the thickness of the cartilage cap were obtained from pathology/
radiology reports. All samples were handled in a coded fashion, and all procedures were 
performed according to the ethical guidelines in “Code for Proper Secondary Use of Human 
Tissue in the Netherlands” (Dutch Federation of Medical Scientific Societies). 
Immunohistochemistry
Deparaffinised sections were treated with testicular hyaluronidase (2 mg/ml in 0.1-M Tris 
saline, pH 5.0; Sigma-Aldrich, St Louis, MO, USA, 60 min at 37°C) and proteinase K (5 μl/
ml in 0.1-M Tris-buffered saline, pH 5.0; DakoCytomation, Carpinteria, CA, USA) followed 
by overnight incubation at 4°C with monoclonal antibody to collagen X (clone X53, 1:100, 
Quartett, Berlin, Germany), as previously described [4, 15]. Monoclonal antibody to CD31 
(clone JC70A, 1:10,000, DakoCytomation, Glostrup, Denmark), cleaved caspase-3 (clone 
5A1E, 1:100, Cell Signaling Technology, Danvas, MA, USA), and Ki-67 (clone MIB-1, 1:100, 
Dako, Glostrup, Germany) were used as earlier described [16–18]. The thickness of collagen 
X-rich matrix was evaluated jointly by two observers (C.E.A. and S.R.). The thickest collagen 
X stained area was identified in each section and measured by an eye-piece graticule, 
as described in Fig. 1a. The apoptotic rate was defined as the number of apoptotic cells 
(positive for caspase-3) out of the total number of nucleated cells. The proliferation rate was 
determined by counting the numbers of Ki-67-positive cells.
Estimating vascular density by Chalkley counting
The Chalkley counting method has been previously described in detail [19]. Briefly, the 
three most vascular areas (hot spots) of each section stained with CD31 were selected and 
analysed (Fig. 1b). Each vascular hotspot was viewed at × 200 magnification, and a 25-point 
Chalkley graticule was applied and oriented to permit the maximum number of points to hit 
in or within the CD31 stained blood vessels [19, 20].
Secondary chondrosarcoma progression
147
Table 1. Clinical information of patients with osteochondroma and secondary peripheral 
chondrosarcoma
GP, epiphyseal growth plate; OC, osteochondroma; PCH, low grade secondary peripheral chondrosarcoma; NA, not 
analysed
a - Mutation nomenclature was according to the Nomenclature Working Group [30]; ns non-sense, del deletion, uv 
unclassified variant, fs frame shift, pm polymorphism
b - Results of mutation previously reported [15, 23, 24]
The Chalkley count for each section was taken as the mean value of the three counts and 
performed by two observers independently (C.E.A. and J.V.M.G.B.).
Mutation analysis
Eleven patients were screened by direct sequencing for DNA mutations in the coding 
sequence of EXT1 or EXT2 genes [21]. After informed consent, DNA was isolated from 
resected tumours. If no alterations were found, a multiplex ligation-dependent probe 
amplification assay designed for EXT1 and EXT2 genes was performed to identify possible 
large deletions, as previously described [22]. Mutation analysis from six patients has been 








Results are expressed as the means with a measure of variability (standard deviation, S.D.). 
Statistical significance was calculated by one-way analysis of variance with Bonferroni’s 
multiple comparison tests. Spearman’s rank correlation coefficient was calculated to verify 
statistical dependence between two variables. Both tests were performed using the SPSS 
16.0 software package (IBM, Somers, NY, USA). P values <0.05 were considered significant.
Results
Collagen X-rich matrix in peripheral cartilaginous tumours
The epiphyseal growth plate is organised in columns of stacked chondrocytes (Fig. 2a). The 
interface between cartilaginous and osseous parts in the growth plate (osteocartilaginous 
interface) was well defined and formed by hypertrophic chondrocytes immersed in a strong 
stained collagen X-rich matrix (Fig. 2d). In the growth plate, the collagen X-rich matrix was 
restricted to the hypertrophic zone and had, on average, 0.8 (± 0.47) mm thickness.  
 Osteochondromas showed less structured tissue organisation. The osteocartilaginous 
interface was also less well defined (Fig. 2b). The collagen X-rich matrix was restricted to 
the hypertrophic zone and had, on average, 1.5 (± 1.48) mm thickness. Additionally, in 
osteochondroma, not all chondrocytes with a hypertrophic morphology expressed type 
X collagen (Fig. 2e), and when type X collagen was present, the staining was mainly seen 
around the chondrocytes and not across the matrix (Fig. 2e). In osteochondromas, no 
correlation was found between the age of the patient and the thickness of the collagen 
X-rich matrix (Spearman’s coefficient = 0.25).
 Secondary peripheral chondrosarcomas showed no structured tissue organisation 
(Fig. 2c) and had an average cap thickness of 10 mm. Secondary peripheral chondrosarcomas 
showed a thick, uniformly and strongly stained collagen X-rich matrix (Fig. 2f) with an 
average 6.5 (± 3.66) mm thickness. Type X collagen expression in secondary peripheral 
chondrosarcomas was not restricted to the osteocartilaginous interface but was also 
detected throughout the extracellular tumour matrix and close to the perichondrium (data 
not shown). In secondary peripheral chondrosarcomas, no correlation was found between 
the age of the patient and the thickness of the collagen X-rich matrix (Spearman’s coefficient 
= 0.01).
 In osteochondromas and secondary peripheral chondrosarcomas, the thickness of 
the collagen X-rich matrix correlated with the thickness of the cartilage cap (Spearman’s 
coefficient = 0.63) (Fig. 2g).
 Similar apoptotic rates were observed in osteochondromas and secondary 




Figure 1. Collagen X-rich matrix and 
vascular density by Chalkley counting. 
Collagen X-rich matrix produced 
by hypertrophic chondrocytes was 
measured from the beginning to the 
end of the hypertrophic zone (a). 
Chalkley count reflects the number 
of grid points that hit CD31 stained 
vessels (red circles) (b). It is more of an 
estimate of the relative area than a true 
vessel count (a scale bar 10 μm; b scale 
bars 5 μm).
Figure 2. Collagen X-rich matrix. The epiphyseal growth plate is organised in columns of stacked 
chondrocytes (a). Osteochondromas show less structured organisation (b), and secondary peripheral 
chondrosarcomas (c) display no clear organisation. Hypertrophic chondrocytes secrete a collagen 
X-rich matrix, which, ultimately, is replaced by bone (d). In osteochondromas, chondrocytes 
with a hypertrophic morphology are not always secreting collagen X (e). In secondary peripheral 
chondrosarcoma, a thick layer of collagen X-rich matrix is observed (f). In osteochondromas and 
secondary peripheral chondrosarcomas, the thickness of the cartilage cap correlates with the thickness 







Vascular density in the ossification area
Invasion of blood vessels is a critical step towards ossification of the collagen X-rich matrix. 
Strong CD31 staining was observed along the cell membrane of endothelial cells in the 
epiphyseal growth plate, osteochondroma, and secondary peripheral chondrosarcoma. 
The median CD31 vascular density in the growth plate osteocartilaginous interface was 
significantly higher than in osteochondroma, with a value of 10.8 (± 0.83) vs. 6.1 (± 1.79), 
respectively (P = 0.007) (Fig. 3a, b, d). Interestingly, no differences in vascularisation of 
the osteocartilaginous interface were observed between the growth plate and secondary 
peripheral chondrosarcoma; a value of 10.8 (± 0.83) vs. 10 (± 0.70) was, respectively, found 
(P = 0.464) (Fig. 3a, c, d). Moreover, an irregular distribution of blood vessels was identified 
in the osteocartilaginous interface of osteochondromas and peripheral chondrosarcomas, 
but not in the epiphyseal growth plates. 
 In osteochondromas and secondary peripheral chondrosarcomas, no association 
between the age of the patient and vascular density was found (Spearman’s rho correlation 
coefficient = 0.39 and 0.27, respectively).
 In osteochondromas, the proliferation rate ranged from 0–24% in 9 cases to 25–
49% in 5 cases. The cases with a higher proliferation rate (25–49%) showed a higher vascular 
density when compared to the cases with a lower proliferation rate (0–24%); a value of 8 (± 
0.83) vs. 5.2 (± 1.58) was, respectively, found (P = 0.008).
Mutation analysis
Fifteen of 16 patients with multiple osteochondromas demonstrated a mutation in EXT1 
or EXT2 (Table 1). One patient, from whom two distinct tumours were studied (L-317 and 
L-332), displayed no mutations in EXT1 or EXT2. Additionally, no correlation was found 
between mutation type and (a) either tumour type (P = 0.564) (b) or the thickness of the 
collagen X-rich matrix (P = 0.564) (c) or vascular density (P = 0.556). 
Discussion
In this study, two crucial steps of endochondral ossification, formation of a collagen 
X-rich matrix and invasion/attraction of blood vessels, were assessed and compared in 
the epiphyseal growth plate and peripheral cartilaginous tumours (osteochondroma and 
secondary peripheral chondrosarcoma). The protein expression level of type X collagen in 
human osteochondroma was shown to be similar to the one found in human epiphyseal 
growth plate [4]. Interestingly, in the EXT1 heterozygous mutant mice, in situ hybridisation 
studies have demonstrated that the mRNA expression of type X collagen is reduced in 
the growth plate as compared to wild-type mice [11, 25]. In addition, endochondral bone 
formation has been shown to be affected in the homozygous dak/ext2 zebrafish mutant [12]. 
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Here, we describe that not all of the osteochondroma cells undergo terminal differentiation. 
These cells, although displaying a hypertrophic phenotype, do not express type X collagen 
(Fig. 2e). This may suggest that mutations in EXT1 or EXT2 genes may affect terminal 
chondrocyte differentiation in humans. Interestingly, progression of osteochondroma 
towards secondary peripheral chondrosarcoma showed an increased production of type X 
collagen. Therefore, the secondary peripheral chondrosarcoma cells expressing abundant 
type X collagen indicated that they have undergone terminal chondrocyte differentiation.
Figure 3. Vascular density in the ossification zone. The epiphyseal growth plate (a, d) and secondary 
peripheral chondrosarcoma (c, d) show similar vascular density. Osteochondroma displays low vascular 
density (b, d) (asterisk indicates P < 0.05; scale bars 5 μm).
Osteochondromas and secondary peripheral chondrosarcoma had a similar apoptotic rate. 
This indicates that, although secondary peripheral chondrosarcoma cells undergo terminal 
differentiation, the differentiation process does not induce apoptosis. Hence, low cell death 







Several pro-angiogenic growth factors, such as FGF-2 and VEGFs, bind to heparan sulphate 
proteoglycans [26]. Heparan sulphate proteoglycans have been shown to regulate the 
distribution of these signalling molecules throughout the extracellular matrix and their 
receptor binding affinity [27]. Syndecan-2 is a cell surface heparan sulphate proteoglycan 
[26]. Syndecan-2 has been demonstrated to bind to VEGF, thereby regulating the distribution 
of VEGF nearby its receptor [28]. Interestingly, in osteochondromas, syndecan-2 is no longer 
located in the plasma membrane, but is shown to be accumulated in the Golgi apparatus 
[24]. The abnormal intracellular location of syndecan-2 may affect the distribution of VEGF, 
explaining the low efficiency of the osteochondroma cells in attracting blood vessels. 
Osteochondromas with high vascular density in the osteocartilaginous interface displayed a 
higher proliferation rate. This might suggest that proliferation of tumour cells is associated 
with increased vascularisation in the osteocartilaginous interface. Interestingly, secondary 
peripheral chondrosarcomas showed similar efficiency in attracting blood vessels as the 
epiphyseal growth plate.
 We have recently shown that cells with functional EXT1 and EXT2 genes are the 
predominant subclone in secondary peripheral chondrosarcomas [9]. Therefore, the 
increased type X collagen deposition and blood vessel attraction in the osteocartilaginous 
interface of secondary peripheral chondrosarcoma are possibly associated with cells 
with functional EXT1 and EXT2 genes. In addition, collagen X-rich matrix formation and 
vascularisation might be useful prognostic markers of neoplastic transformation of an 
osteochondroma, but further validation is required before they can be proposed as a routine 
and as a reliable diagnostic tool.
 In conclusion, we show that terminal chondrocyte differentiation and vascularisation 
are affected in osteochondromas, suggesting that EXT1 and EXT2 genes are critical for 
endochondral bone formation. Terminal chondrocyte differentiation and vascularisation 
seem to be unaffected in secondary peripheral chondrosarcomas, which might be associated 
with the presence of cells with functional EXT1 and EXT2 genes.
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I. Zebrafish as a model system to study human skeletal disorders
Mutations in the exostosin genes, dackel (dak/ext2) and boxer (box/exlt3), cause defects 
in zebrafish cartilage that strongly resemble those seen in patients with multiple 
osteochondromas [1;2]. Chapters 3, 4 and 5 address the use of the dak mutant zebrafish as 
a model to understand the formation of human osteochondroma. 
 Cartilage is formed by the interweaving of collagen fibres and proteoglycans. 
Polyethyleneimine (PEI) is a well-described cationic dye used in reflection contrast- and 
electron microscopy. PEI binds to anionic sites on proteoglycans and allows visualisation 
and quantification of the negatively charged sites at the ultrastructural level. Using PEI 
pre-embedding staining, we showed wild-type zebrafish and fish mutants with a mild 
cartilage phenotype display proteoglycans distributed in a gradient fashion throughout the 
cartilaginous extracellular matrix (Chapter 5). A similar pattern of distribution was observed 
in normal human growth plate. In contrast, chondrocytes from dak mutant fish did not display 
proteoglycans distributed in a gradient fashion throughout the cartilaginous extracellular 
matrix (Chapter 5) which was similar to human osteochondroma in which gradients were 
also absent. Interestingly, only a subset of osteochondroma cells displayed absence of 
extracellular gradients of proteoglycans, which suggests that those cells have homozygous 
inactivation of EXT1/EXT2. Moreover, these homozygous mutant cells have been shown 
to be intermingled with a population of cells that appeared to have an intact distribution 
of proteoglycans in a gradient fashion (Chapter 5). Therefore, the distinct subset of cells 
that compose an osteochondroma indicate that this bone tumour is a mosaic of EXT1/EXT2 
mutant and wild-type cells. The mosaic cell population of osteochondroma has been also 
elegantly reported by Jones et al. using a conditional mouse model for Ext1 [3]. Additionally, 
using these mutant zebrafish, we showed that heparan sulphate controls mesenchymal 
differentiation towards the osteoblastic lineage (Chapter 4). Our data suggest that heparan 
sulphate is involved in the “bone-to-fat” switch during mesenchymal differentiation, without 
affecting chondrogenic- or muscle lineages. The over-expression of PPAR-γ signalling is 
possibly involved in the inhibition of osteoblastogenesis in zebrafish. However, it still remains 
to be established how exactly heparan sulphate controls the “bone-to-fat” switch. Whether 
this phenomenon plays a role in human osteochondroma formation is so far unclear.
II. Developmental regulation of the epiphyseal growth plate in relation to the 
formation of osteochondroma
The growth and structure of the epiphyseal growth plate is regulated by short and long range 
signalling molecules. The diffusion of these molecules across the cartilaginous extracellular 
matrix is shown to be mediated by proteoglycans [4]. 
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Proteoglycans are distributed across the cartilaginous extracellular matrix in a gradient 
fashion, as was shown in Chapter 5. Nevertheless, the question remains: how the gradients 
of proteoglycans are formed? 
 Proteoglycans are polyanionic chains. Their molecules have negatively charged 
sites that arise from their sulphate and carboxyl groups. In solution, the mutual repulsion 
of these negative charges causes an aggregated proteoglycan molecule to spread out and 
occupy a large volume [5]. This mutual repulsion of negative charges may partially explain 
the formation of gradients of proteoglycans across the cartilaginous extracellular matrix. 
 Osteochondromas have been linked to loss-of-function mutations in EXT1/EXT2. 
The EXT genes encode glycosyltransferases involved in heparan sulphate biosynthesis. The 
mechanism by which alterations in heparan sulphate biosynthesis lead to osteochondroma 
is not entirely understood. As heparan sulphate acts as a co-receptor for fibroblast growth 
factors and BMPs [6], and regulates the diffusion of Ihh [7] and members of the Wnt family [8], 
improper elongation of heparan sulphate chains may result in loss of extracellular gradients 
of proteoglycans as well as in a variety of growth factor signalling defects and impaired cell-
cell and cell-matrix interactions, which ultimately may result in osteochondroma formation. 
 Cells with homozygous inactivation of EXT1/EXT2 are thought to disrupt gradients 
of signalling molecules, by affecting the gradient distribution of proteoglycans (Chapter 
2 and 5). As heparan sulphate modulates the formation of gradients of Ihh and Wnt, 
altered gradients may disturb these pathways, which may contribute to the initiation of 
an osteochondroma. The diffusion of Ihh molecules and their ligand-receptor interaction 
have been demonstrated to be affected by the dysfunction of Ext1 in chondrocytes during 
endochondral ossification [9]. Additionally, improper diffusion of Ihh may affect osteogenesis 
at the perichondrium. The perichondrium then fails form a bone collar, which may facilitate 
the formation of an osteochondroma. The gradients of Wnt signalling are involved in planar 
cell polarity, providing positional information to govern morphogenesis [10]. Planar cell 
polarity has been linked to a microtubule-based subcellular organelle that projects from 
the surface of the cell called the primary cilium [11]. Primary cilia function as a signalling 
apparatus of the cell that receives and transduces mechanical and chemical signals from 
the neighbouring cells and the extracellular matrix. In the proliferating and hypertrophic 
chondrocytes of the epiphyseal growth plate, primary cilia are polarized and oriented 
parallel to the longitudinal axis of the bone (Chapter 6). Shorter heparan sulphate chains 
produced by osteochondroma cells may affect the formation of gradients of Wnt signalling. 
Hypothetically, the lack of adequate positional information may impair the polarity function 
of primary cilia in osteochondroma cells. The loss of cell/tissue polarity may contribute to 








III. The role of EXT1 and EXT2 genes in the formation of a secondary peripheral 
chondrosarcoma
Neoplastic transformation of an osteochondroma occurs in less than 1% of patients with 
sporadic osteochondromas and 1-3% of patients with multiple osteochondromas [12].
 A custom-made oligonucleotide-based microarray with a tiling coverage of EXT1/
EXT2 genes was used to detect deletions involving any part of EXT1 or EXT2 genes. We 
showed that, unlike in osteochondromas, homozygous deletions of EXT1/EXT2 are rare 
events in sporadic secondary peripheral chondrosarcomas (Chapter 7). FISH with an EXT1 
probe showed that cells with retention of one-, or both copies of EXT1 constitute the major 
population of cells in the tumour. As cells carrying a homozygous deletion (having no copies of 
the involved genomic region left at all) are not able to regain the lost alleles during neoplastic 
progression, the cellular origin of secondary peripheral chondrosarcomas is possibly the 
wild-type cells located either in the osteochondroma cap or in the neighbouring tissue. The 
presence of these wild-type cells in the cartilage cap of osteochondroma was suggested 
earlier by the PEI- and primary cilia studies (Chapters 5 and 6) as well as in mice using a 
conditional model for Ext1 [3]. Using FISH, we showed the wild-type cells to predominate 
in the hypertrophic zone of osteochondroma (Chapter 7). Consequently, while homozygous 
inactivation of EXT1/EXT2 is essential for osteochondroma formation, EXT1 and EXT2 seem 
not to play a role in the formation of most secondary peripheral chondrosarcomas (Chapter 
7).
V. Clues to the mechanisms of neoplastic transformation of osteochondroma 
towards secondary peripheral chondrosarcoma
We have shown that morphological parameters alone cannot distinguish between 
osteochondroma and low-grade peripheral chondrosarcoma (Chapter 8 and 9). It remains 
very difficult and observer dependent to identify early malignant progression of an 
osteochondroma. We could not formulate a set of reliable histological criteria based upon 
a large multinational study (Chapter 8). On the other hand, we showed that malignant 
progression of an osteochondroma is associated with increased expression of type X 
collagen and increased vascularisation (Chapter 9). Formation of a collagen X-rich matrix and 
increased vascularisation might be useful prognostic markers of neoplastic transformation 
of an osteochondroma, but further validation is required before they can be proposed as a 
routine and reliable diagnostic tool. 
 Malignant progression of secondary peripheral chondrosarcoma is characterized 
by a high percentage of loss of heterozygosity (i.e., CDKN2A/p16, TP53, RB1) and ploidy 
ranging from half to twice the normal DNA content [13-15]. Therefore, during neoplastic 
transformation of most osteochondromas, the EXT wild-type cells may acquire genetic 
alterations in p16, p53, RB1, or an as yet not identified gene to give rise to secondary
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Figure 1. Schematic representation of changes in morphology and expression of signalling pathways 
during neoplastic transformation of an osteochondroma. Different tumours are represented by their 
histology. Progression towards secondary peripheral chondrosarcoma is characterized by a decrease 
in chondroid matrix and an increase in cellularity and cellular disorganization.  Clonal cell selection 
occurs during the formation of a secondary peripheral chondrosarcoma. EXT-null cells (green cells) and 
EXT wild-type cells (blue cells) compose the osteochondroma cap. The EXT-null cells acquire genetic 
alteration(s) to give rise to a secondary peripheral chondrosarcoma. The chondrosarcoma cells (red 
cells) get a proliferative advantage, overgrowing the osteochondroma EXT-null cells. During neoplastic 
transformation/progression, PTHLH, TGF-β and FGF signalling increase. Similar increase is found for 
EXT1 and heparan sulphate. In addition, IHH and Wnt signalling decrease. (Adapted from Hameetman 
L et al. 2006).  Figure references:  
1- Bovee JVMG, et al. Lab Invest 2000;80:1925-33.
2- Hameetman L, et al. J Pathol 2006;209:501-11.
3- de Andrea CE, et al. Oncogene 2012;31:1095-104. 








peripheral chondrosarcomas. While mutations in IDH1/IDH2 have been associated with 
enchondromas and central chondrosarcomas [16;21], these genes are not involved in 
osteochondromas and peripheral chondrosarcomas [17;18], again proving their different 
genetic make up as compared to central cartilaginous tumours. 
 Previously, we have described that signalling pathways dependent on heparan 
sulphate, such as fibroblast growth factor (FGF) and parathyroid hormone-related 
protein (PTHLH), are inactive in osteochondromas and active in secondary peripheral 
chondrosarcomas [17;18]. We have shown that cells with functional EXT1 and EXT2 are the 
predominant clone in secondary peripheral chondrosarcomas (Chapter 7). Probably, these 
EXT1/EXT2 wild-type cells synthesize heparan sulphate with normal chain length, which may 
explain the active PTHLH and FGF in secondary peripheral chondrosarcomas (Figure 1). 
 The contribution of FGFs and PTHLH to secondary peripheral chondrosarcoma 
formation is still unclear. In the epiphyseal growth plate, PTHLH suppresses chondrocyte 
differentiation into hypertrophic chondrocytes [19] and FGF regulates chondrocyte 
proliferation and differentiation [20]. 
 
VI. Conclusions
In the epiphyseal growth plate, the way that chondrocytes interact with each other and 
with their micro-environment via extracellular matrix has gradually been unveiled. In the 
epiphyseal growth plate, these interactions lead to the formation of a polarized tissue 
structure. Cells in the epiphyseal growth plate harbouring homozygous mutations in EXT1/
EXT2 disrupt the diffusion gradients and signal transduction, leading to the loss of cell polarity, 
which may contribute to the formation of an osteochondroma. In addition, osteochondroma 
may act as a permissive environment, which facilitates EXT1/EXT2 wild-type cells located in 
its cartilage cap to acquire genetic changes to form a secondary peripheral chondrosarcoma.
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I. De zebravis als een modelsysteem voor de studie van menselijke skelet 
aandoeningen 
Mutaties in de exostosin genen, dackel (dak/ext2) en boxer (box/exlt3), leiden tot defecten 
in zebravis kraakbeen, die sterk lijken op de afwijkingen in patiënten met multipele 
osteochondromen. De hoofdstukken 3, 4 en 5 hebben betrekking op het gebruik van de dak 
mutant zebravis als model voor de vorming van de menselijke osteochondroom.
 Kraakbeen wordt gevormd door de verwevenheid van collageen vezels en 
proteoglycanen. Polyethyleenimine (PEI) is een goed gedefiniëerde kationische kleurstof 
voor toepassing in reflectiecontrast- en elektronenmicroscopie. PEI bindt aan anionische 
sites op proteoglycanen en maakt visualisatie en kwantificering van de negatief geladen 
sites op het ultrastructurele niveau mogelijk. Met behulp van PEI pre-embedding kleuring 
toonden we aan dat in wild-type zebravissen en in mutanten met een mild fenotype de 
proteoglycanen in een gradient gedistribueerd zijn over de gehele kraakbenige extracellulaire 
matrix (hoofdstuk 5). Een soortgelijk patroon van de distributie werd waargenomen in de 
normale humane groeischijf. Chondrocyten van de dak mutant vertoonden daarentegen 
geen gradueel verdeelde proteoglycanen (hoofdstuk 5). Dit was vergelijkbaar met het 
humane osteochondroom waarin de gradiënten ook afwezig waren. Interessant is dat slechts 
een deel van de osteochondroom cellen de extracellulaire gradiënten van proteoglycanen 
missen, wat doet vermoeden dat alleen die cellen homozygote inactivatie van EXT1/EXT2 
hebben. De homozygoot mutant cellen bleken gemengd te zijn met een populatie van cellen 
met een correcte verdeling van proteoglycanen in een gradiënt (hoofdstuk 5). Het lijkt er 
derhalve op dat de verschillende cellen die het osteochondroom vormen bestaan uit een 
mozaïek van EXT1/EXT2 mutant en het wild-type cellen. De mozaïek celpopulatie van het 
osteochondroom is ook fraai gerapporteerd door Jones et al. met een conditioneel muismodel 
voor Ext1. Bovendien hebben we met deze mutant zebravis  aangetoond dat heparansulfaat 
de mesenchymale differentiatie naar de osteoblastische lijn controleert (hoofdstuk 4). 
Onze gegevens suggereren dat heparansulfaat betrokken is bij de “bot-naar-vet”-schakelaar 
tijdens de mesenchymale differentiatie, zonder dat dit invloed heeft op de ontwikkeling van 
chondrocyten of spiercellen. De over-expressie van PPAR-γ signaaltransductie is mogelijk 
betrokken bij de inhibitie van osteoblast ontwikkeling in de zebravis. Er is nog niet precies 
vastgesteld hoe heparansulfaat de “bot-naar-vet” schakelaar controleert. Of dit verschijnsel 
een rol speelt in het humane osteochondroom is tot dusver onduidelijk.
II. Epifysaire groeischijf ontwikkelingsregulatie en de vorming van het 
osteochondroom
De groei en structuur van de epifysaire groeischijf worden geregeld door korte en lange 
afstand signaalmoleculen. De diffusie van deze moleculen in de kraakbeenachtige 
extracellulaire matrix wordt gemediëerd door proteoglycanen. Proteoglycanen zijn verdeeld
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over de kraakbenige extracellulaire matrix in een gegradeerd verloop, zoals bleek in 
hoofdstuk 5. Toch blijft de vraag hoe de gradiënten van proteoglycanen worden gevormd. 
 Proteoglycanen zijn polyanionische ketens van moleculen met negatief geladen 
gebieden bestaand uit de sulfaat en carboxylgroepen. In opgeloste vorm zorgt ,de onderlinge 
afstoting van de negatieve lading ervoor dat de geaggregeerde proteoglycaan molecule 
uitspreiden en een groot volume innemen. Deze wederzijdse afstoting van negatieve ladingen 
kan deels de vorming van gradiënten van proteoglycanen in het kraakbeen extracellulaire 
matrix verklaren. 
 Osteochondromen worden geassociëerd met verlies-van-functie mutaties in EXT1/
EXT2. De EXT genen coderen voor glycosyltransferases die betrokken zijn bij de  heparansulfaat 
biosynthese. Het mechanisme hoe  veranderingen in heparansulfaat biosynthese leiden tot 
het osteochondroom is niet volledig begrepen. Aangezien heparansulfaat werkt als een co-
receptor voor fibroblast groeifactoren en BMP’s, en het de diffusie van Ihh en leden van 
de Wnt-familie reguleert, kan een verkeerde verlenging van heparansulfaat ketens leiden 
tot verlies van extracellulaire proteoglycaan gradiënten. Dit resulteert dan in verschillende 
groeifactor signaleringsdefecten en verminderde cel-cel en cel-matrix interacties en 
uiteindelijk een osteochondroom. 
 Er wordt gedacht dat de gradiënten van signaalmoleculen rond cellen met 
homozygote inactivatie van EXT1/EXT2 verstoord zijn, omdat daar de gradiënt distributie 
van proteoglycanen is aangetast (hoofdstuk 2 en 5). Aangezien heparansulfaat de vorming 
van gradiënten van IHH en Wnt moduleert, kunnen veranderingen in de gradiënten deze 
routes verstoren, en zo bijdragen aan het ontstaan van een osteochondroom. De diffusie 
van Ihh moleculen en hun ligand-receptor interactie toont aan dat zij worden beïnvloed 
door de dysfunctie van Ext1 in chondrocyten tijdens de endochondrale ossificatie. Daarnaast 
geeft foute  diffusie van Ihh een afwijking van de osteogenese bij het perichondrium. Het 
perichondrium kan dan geen bot kraag maken, wat bijdraagt aan de vorming van een 
osteochondroom. De gradiënten van Wnt signalering zijn  betrokken bij “planar cell polarity”, 
een proces wat zorgt voor positionering van de morfogenese. “Planar cell polarity” is 
gekoppeld aan een op een microtubulair gebaseerd subcellulair organel, het primaire cilium, 
wat uitsteekt aan de oppervlakte van de cel. Primaire cilia werken als een communicatie 
apparaat van de cel en ontvangen en transduceren mechanische en chemische signalen 
van de naburige cellen en van de extracellulaire matrix. In proliferende en hypertrofe 
chondrocyten van de epifysaire groeischijf zijn de primaire cilia gepolariseerd en evenwijdig 
aan de lengteas van het bot (hoofdstuk 6). Kortere heparansulfaat ketens die worden 
geproduceerd door osteochondroom cellen kunnen de vorming van gradiënten voor Wnt 
signalering beïnvloeden. Hypothetisch zou het gebrek aan adequate positionele informatie 




Het verlies van cel/weefsel polariteit kan zo bijdragen aan de vorming van een osteochondroom 
(hoofdstukken 2 en 6).
III. De rol van EXT1 en EXT2 genen bij de vorming van een secundair perifeer 
chondrosarcoom
Neoplastische transformatie van een osteochondroom komt voor bij minder dan 1% van de 
patiënten met sporadische osteochondromen en bij 1-3% van de patiënten met meerdere 
osteochondromen.
 Een op maat gemaakte oligonucleotide-gebaseerde microarray met een 
overlappende dekking van EXT1/EXT2 genen werd gebruikt om deleties in  elk stukje van de 
EXT1 of EXT2 genen op te sporen. We toonden aan dat, anders dan in osteochondromen, 
homozygote deleties van EXT1/EXT2 zelden voorkomen in sporadische perifere 
chondrosarcomen (hoofdstuk 7). FISH met een EXT1 probe toonde aan dat cellen met 
behoud  van één of beide kopieën van EXT1 een grote populatie van cellen vormt in de tumor. 
Aangezien cellen met een homozygote deletie (die derhalve geen kopieën van de betrokken 
genomische regio meer hebben) niet in staat zijn om de verloren allelen tijdens neoplastische 
progressie terug te krijgen, moet de cellulaire oorsprong van perifere chondrosarcomen 
misschien wel te zoeken zijn in de wild-type cellen welke zich bevinden zich in de kap van het 
osteochondroom of in het naburige weefsel. De aanwezigheid van deze wild-type cellen in 
de kraakbeenkap van osteochondroom is eerder gesuggereerd door de PEI- en de primaire 
cilia studies (hoofdstuk 5 en 6) en ook in muizen met een conditioneel Ext1 gen. Met behulp 
van FISH toonden we aan dat de wild-type cellen in de meerderheid zijn in de hypertrofische 
zone van osteochondromen (hoofdstuk 7). Daarom, terwijl de homozygote inactivatie van 
EXT1/EXT2  essentieel is voor het osteochondroom, lijken EXT1 en EXT2 geen rol te spelen in 
de vorming van de meeste perifere chondrosarcomen (hoofdstuk 7).
IV. Mogelijke oplossingen voor  de mechanismen van neoplastische transformatie 
van osteochondromen  naar perifere chondrosarcomen
We hebben aangetoond dat morfologische parameters alleen geen onderscheid maken tussen 
osteochondromen en laaggradige perifere chondrosarcomen (hoofdstuk 8 en 9). Het blijft 
heel moeilijk en afhankelijk van de waarnemer om vroege kwaadaardige progressie van een 
osteochondroom te identificeren. We konden het geen betrouwbare histologische criteria 
fomuleren op basis van een grote multinationale studie (hoofdstuk 8). Echter, we hebben 
wel aangetoond dat kwaadaardige progressie van een osteochondroom geassocieerd is met 
verhoogde expressie van type X collageen en met verhoogde vascularisatie (hoofdstuk 9). De 
vorming van een collageen X-rijke matrix en een verhoogde vascularisatie kunnen bruikbare 
prognostische markers zijn van de neoplastische transformatie van een osteochondroom, 
maar verdere validatie is vereist voordat ze klinisch kunnen worden toegpast.
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 Kwaadaardige progressie van perifere chondrosarcomen wordt gekenmerkt door 
een hoog percentage van verlies van heterozygotie (bijvoorbeeld CDKN2A/p16, TP53, RB1) 
waarbij de ploïdie variëert van half tot tweemaal het normale DNA-gehalte. Daarom kunnen 
de EXT wild-type cellen in de meeste osteochondromen tijdens neoplastische transformatie 
genetische veranderingen oplopen in p16, p53, RB1 of een nog niet geïdentificeerd gen, 
wat leidt tot de vorming van perifere chondrosarcomen. Terwijl de mutaties in IDH1/IDH2 
zijn geassocieerd met enchondromen en centrale chondrosarcomen, blijken deze genen niet 
betrokken bij de osteochondromen en perifere chondrosarcomen. Dit toont opnieuw de 
verschillende genetische make-up aan ten opzichte van centrale kraakbeen tumoren.
 Eerder hebben wij beschreven dat signaaltransductie routes die afhankelijk zijn van 
heparansulfaat, zoals fibroblastgroeifactor (FGF) en parathyroïde hormoon-gerelateerde 
eiwit (PTHLH),  inactief zijn in osteochondromen en actief in perifere tumoren. We hebben 
aangetoond dat cellen met functionele EXT1 en EXT2 genen de belangrijkste kloon vormen 
in perifere chondrosarcomen (hoofdstuk 7). Waarschijnlijk synthetiseren deze EXT1/EXT2 
wild-type cellen heparansulfaat met een normale ketenlengte, die de activiteit van PTHLH 
en FGF in perifere tumoren (figuur 10.1) kunnen verklaren.
 De bijdrage van FGF en PTHLH aan secundair perifeer chondrosarcoom formatie is 
nog onduidelijk. In de epifysaire groeischijf onderdrukt PTHLH chondrocyten differentiatie in 
hypertrofische chondrocyten en FGF regelt chondrocyten proliferatie en differentiatie.
V. Conclusies
In de epifysaire groeischijf is geleidelijk onthuld hoe chondrocyten met elkaar en met de 
micro-omgeving communiceren via extracellulaire matrix. Deze interacties in de epifysaire 
groeischijf leiden tot de vorming van een gepolariseerde weefselstructuur. Cellen in de 
epifysaire groeischijf hebben homozygote mutaties in EXT1/EXT2  wat de gradiënten 
en daardoor de signaaltransductie verstoort, en wat uiteindelijk leidt tot het verlies van 
celpolariteit. ,Dit kan dan bijdragen tot de vorming van een osteochondroom. Bovendien kan 
osteochondroom werken als een permissieve omgeving, waarin EXT1/EXT2 wild-type cellen 
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